|
|
Home
The Word Brain
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
|
Bladder Cancer, January 2024
Retrieve all available abstracts of the following 1155 articles:
|
| Single Articles |
AMEDEO Bladder Cancer is free of charge.
PrECOG PrE0807: A Phase 1b Feasibility Trial of Neoadjuvant Nivolumab Without and
with Lirilumab in Patients with Muscle-invasive Bladder Cancer Ineligible for or
Refusing Cisplatin-based Neoadjuvant Chemotherapy.
Eur Urol Oncol. 2023 Dec 27:S2588-9311(23)00288.
Abstract
Related articles
Expression of EPB41L2 in Cancer-Associated Fibroblasts: Prognostic Implications
for Bladder Cancer and Response to Immunotherapy.
Arch Med Res. 2023;55:102927.
Abstract
Related articles
Significance of Normalized Apparent Diffusion Coefficient in the Vesical
Imaging-Reporting and Data System for Diagnosing Muscle-Invasive Bladder Cancer.
J Magn Reson Imaging. 2023 Dec 28. doi: 10.1002/jmri.29208.
Abstract
Related articles
Immune Contexture Changes Following Blue Light Cystoscopy with Hexaminolevulinate
in Bladder Cancer.
Eur Urol Open Sci. 2023;58:37-46.
Abstract
Related articles
Retraction: Kinesin family member 3A stimulates cell proliferation, migration,
and invasion of bladder cancer cells in vitro and in vivo.
FEBS Open Bio. 2023 Dec 27. doi: 10.1002/2211-5463.13756.
Abstract
Related articles
Development and validation of a novel nomogram model for predicting the survival
of patients with T2-4a, N0-x, M0 bladder cancer: a retrospective cohort study.
Am J Clin Exp Urol. 2023;11:500-515.
Abstract
Related articles
Five-year overall survival of patients with advanced bladder cancer in
Kazakhstan: OSURK registry study.
Am J Clin Exp Urol. 2023;11:542-548.
Abstract
Related articles
Changes in Urinary Exosomal Nuclear Matrix Protein-22 in Dogs With Urothelial
Carcinoma: A Pilot Study.
In Vivo. 2024;38:190-195.
Abstract
Related articles
Effect of Danshen for improving clinical outcomes in patients with bladder
cancer: a retrospective, population-based study.
Front Pharmacol. 2023;14:1260683.
Abstract
Related articles
Immunotherapy-Induced Hypophysitis Following Treatment With Tislelizumab in an
Elderly Patient With Bladder Cancer and Prostate Cancer: A Case Report.
Cureus. 2023;15:e51015.
Abstract
Related articles
HER2 positivity predicts BCG unresponsiveness and adaptive immune cell exhaustion
in EORTC risk-stratified cohort of bladder cancer.
Front Immunol. 2023;14:1301510.
Abstract
Related articles
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in
muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an
open-label, randomised, phase 3 study.
Lancet Oncol. 2023 Dec 21:S1470-2045(23)00587.
Abstract
Related articles
Accelerating neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Lancet Oncol. 2023 Dec 21:S1470-2045(23)00626.
Abstract
Related articles
Differentiation of bladder cancer with water flow elastography (WaFE).
J Mech Behav Biomed Mater. 2023;150:106319.
Abstract
Related articles
A new era for bladder cancer: Enfortumab vedotin and pembrolizumab milestone
approval.
Tumori. 2023 Dec 23:3008916231221508. doi: 10.1177/03008916231221508.
Abstract
Related articles
Effect of a Single Light-intensity Walking Session on Sleep Quality of Patients
with Bladder Cancer: A Randomized Cross-Over Study.
Semin Oncol Nurs. 2023 Dec 22:151571. doi: 10.1016/j.soncn.2023.151571.
Abstract
Related articles
Emerging Prognostic and Predictive Significance of Stress Keratin 17 in
HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review.
Viruses. 2023;15:2320.
Abstract
Related articles
Local Drug Delivery in Bladder Cancer: Advances of Nano/Micro/Macro-Scale Drug
Delivery Systems.
Pharmaceutics. 2023;15:2724.
Abstract
Related articles
Effects of Lactate Transport Inhibition by AZD3965 in Muscle-Invasive Urothelial
Bladder Cancer.
Pharmaceutics. 2023;15:2688.
Abstract
Related articles
Therapeutic Potential of Regorafenib in Cisplatin-Resistant Bladder Cancer with
High Epithelial-Mesenchymal Transition and Stemness Properties.
Int J Mol Sci. 2023;24:17610.
Abstract
Related articles
Metabolomic Signatures of Treatment Response in Bladder Cancer.
Int J Mol Sci. 2023;24:17543.
Abstract
Related articles
OncoTherad((R)) (MRB-CFI-1) Nanoimmunotherapy: A Promising Strategy to Treat
Bacillus Calmette-Guerin-Unresponsive Non-Muscle-Invasive Bladder Cancer:
Crosstalk among T-Cell CX3CR1, Immune Checkpoints, and the Toll-Like Receptor 4
Signaling Pathway.
Int J Mol Sci. 2023;24:17535.
Abstract
Related articles
Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict
Oncological Outcomes in Patients Eligible for Radical Cystectomy?
Medicina (Kaunas). 2023;59:2063.
Abstract
Related articles
Health Related Quality of Life in Patients with Bladder Cancer Receiving a
Radical Cystectomy.
Cancers (Basel). 2023;15:5830.
Abstract
Related articles
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in
Non-Muscle-Invasive Bladder Cancer.
Cancers (Basel). 2023;15:5770.
Abstract
Related articles
Radiomics Prediction of Muscle Invasion in Bladder Cancer Using Semi-Automatic
Lesion Segmentation of MRI Compared with Manual Segmentation.
Bioengineering (Basel). 2023;10:1355.
Abstract
Related articles
Oncologic outcomes of intravesical therapy in the management of nonmuscle
invasive bladder cancer with variant histology.
Urol Oncol. 2023 Dec 21:S1078-1439(23)00471.
Abstract
Related articles
The Role of c-MET as a Biomarker in Patients with Bladder Cancer Treated with
Radical Chemo-Radiotherapy.
Curr Oncol. 2023;30:10550-10555.
Abstract
Related articles
Identifying Optimal Candidates for Trimodality Therapy among Nonmetastatic
Muscle-Invasive Bladder Cancer Patients.
Curr Oncol. 2023;30:10166-10178.
Abstract
Related articles
Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution
in urothelial bladder carcinoma.
Commun Biol. 2023;6:1292.
Abstract
Related articles
The bladder microbiota is not significantly altered by intravesical BCG therapy.
Urol Oncol. 2024;42:22.
Abstract
Related articles
The Prognostic Value of Preoperative Naples Prognostic Score in Upper Tract
Urothelial Carcinoma Patients after Radical Nephroureterectomy.
Nutr Cancer. 2024;76:80-88.
Abstract
Related articles
Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically
non-invasive high-grade upper tract urothelial carcinoma.
Urol Oncol. 2024;42:20.
Abstract
Related articles
Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary
Tract: A Multi-institutional Study.
Mod Pathol. 2023;36:100333.
Abstract
Related articles
First analysis of the safety and efficacy of UGN-101 in the treatment of ureteral
tumors.
Urol Oncol. 2024;42:20.
Abstract
Related articles
Hsa_circ_0001583 fuels bladder cancer metastasis by promoting staphylococcal
nuclease and tudor domain containing 1-mediated MicroRNA decay.
Neoplasia. 2024;47:100963.
Abstract
Related articles
Longitudinal Analysis of Bladder Cancer-Specific Mortality Trends in the United
States.
Bladder Cancer. 2023;9:345-353.
Abstract
Related articles
Wake-Up Call to Address Sleep Health in Non-Muscle Invasive Bladder Cancer:
Underappreciated Contributor to Poor Quality of Life.
Bladder Cancer. 2023;9:323-326.
Abstract
Related articles
A case of neoadjuvant chemotherapy-resistant muscle-invasive bladder cancer that
markedly responded to pembrolizumab before conversion radical cystectomy.
IJU Case Rep. 2023;7:64-67.
Abstract
Related articles
Bladder cancer with urinary diversion by a sigmoid colon conduit after transverse
colon stoma.
IJU Case Rep. 2023;7:46-49.
Abstract
Related articles
Identification of genes associated with gall bladder cell carcinogenesis:
Implications in targeted therapy of gall bladder cancer.
World J Gastrointest Oncol. 2023;15:2053-2063.
Abstract
Related articles
Identification of clinical prognostic factors and analysis of ferroptosis-related
gene signatures in the bladder cancer immune microenvironment.
BMC Urol. 2024;24:6.
Abstract
Related articles
CT findings and clinical characteristics in distinguishing renal urothelial
carcinoma mimicking renal cell carcinoma from clear cell renal cell carcinoma.
BMC Urol. 2024;24:4.
Abstract
Related articles
Identification and validation of prognostic signature genes of bladder cancer by
integrating methylation and transcriptomic analysis.
Sci Rep. 2024;14:368.
Abstract
Related articles
Modulation of tumor microenvironment by targeting histone acetylation in bladder
cancer.
Cell Death Discov. 2024;10:1.
Abstract
Related articles
The efficacy of immune checkpoint inhibitors therapy versus chemotherapy in the
treatment of advanced and metastatic urothelial carcinoma: a meta-analysis.
J Cancer Res Clin Oncol. 2024;150:5.
Abstract
Related articles
Exploring Pembrolizumab-Induced Myocarditis, Myositis, and Myasthenia Gravis: A
Comprehensive Literature Review and Case Presentation on Bladder Cancer.
Cureus. 2023;15:e49867.
Abstract
Related articles
Acyl-coenzyme A: cholesterol acyltransferase inhibitor avasimibe suppresses
tumorigenesis and induces G1-phase cell-cycle arrest by activating PPARgamma
signaling pathway in bladder cancer.
J Cancer. 2024;15:370-382.
Abstract
Related articles
JS-K activates G2/M checkpoints through the DNA damage response and induces
autophagy via CAMKKbeta/AMPKalpha/mTOR pathway in bladder cancer cells.
J Cancer. 2024;15:343-355.
Abstract
Related articles
PIGT promotes cell growth, glycolysis, and metastasis in bladder cancer by
modulating GLUT1 glycosylation and membrane trafficking.
J Transl Med. 2024;22:5.
Abstract
Related articles
Siglec-15 regulates cell proliferation, migration and invasion in bladder cancer.
Asian J Surg. 2024 Jan 1:S1015-9584(23)02105.
Abstract
Related articles
Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a
STING agonist.
bioRxiv. 2023 Dec 15:2023.12.15.571740. doi: 10.1101/2023.12.15.571740.
Abstract
Related articles
TRIM29 promotes bladder cancer invasion by regulating the intermediate filament
network and focal adhesion.
Res Sq. 2023 Dec 12:rs.3.rs-3697712. doi: 10.21203/rs.3.rs-3697712.
Abstract
Related articles
Bladder cancer risk stratification with the Oncuria 10-plex bead-based urinalysis
assay using three different Luminex xMAP instrumentation platforms.
J Transl Med. 2024;22:8.
Abstract
Related articles
Hepatoid adenocarcinoma in ureter with next-generation sequencing: A case report
and literature review.
BMC Med Genomics. 2024;17:7.
Abstract
Related articles
EIF4A3-mediated biogenesis of circSTX6 promotes bladder cancer metastasis and
cisplatin resistance.
J Exp Clin Cancer Res. 2024;43:2.
Abstract
Related articles
PDE3B regulates KRT6B and increases the sensitivity of bladder cancer cells to
copper ionophores.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan 2. doi: 10.1007/s00210-023-02928.
Abstract
Related articles
Immunotherapeutic prospects and progress in bladder cancer.
J Cell Mol Med. 2024 Jan 2. doi: 10.1111/jcmm.18101.
Abstract
Related articles
Role of heat shock protein 70 in silibinin-induced apoptosis in bladder cancer.
J Cancer. 2024;15:79-89.
Abstract
Related articles
Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by
fluorinated polylysine nanoparticles for bladder cancer intravesical gene
therapy.
Theranostics. 2024;14:203-219.
Abstract
Related articles
The Long-Term Impact of 5-alpha Reductase Inhibitors on the Development of
Bladder Cancer and the Need for Radical Cystectomy: A Nationwide Observational
Study.
World J Mens Health. 2024 Jan 2. doi: 10.5534/wjmh.230137.
Abstract
Related articles
Preliminary study on the role of the CSMD2 gene in bladder cancer.
Heliyon. 2023;10:e22593.
Abstract
Related articles
Patterns of chemotherapy use in muscle-invasive bladder cancer in a tertiary
centre.
Bladder (San Franc). 2023;10:e21200013.
Abstract
Related articles
Single-cell analyses EMP1 as a marker of the ratio of M1/M2 macrophages is
associated with EMT, immune infiltration, and prognosis in bladder cancer.
Bladder (San Franc). 2023;10:e21200011.
Abstract
Related articles
Surgeon experience in second-look transurethral resection of bladder cancer - a
prospective study.
Actas Urol Esp (Engl Ed). 2023 Dec 29:S2173-5786(23)00143.
Abstract
Related articles
Small cell bladder carcinoma treated with nivolumab as adjuvant maintenance
therapy.
BMJ Case Rep. 2023;16:e257402.
Abstract
Related articles
Non-Mixture Cure Model Estimation in Bladder Cancer Patients: A Novel Approach
with Exponentiated Weibull Exponential Distribution.
Asian Pac J Cancer Prev. 2023;24:4167-4177.
Abstract
Related articles
The addition of tislelizumab to gemcitabine and cisplatin chemotherapy increases
thrombocytopenia in patients with urothelial carcinoma: A single-center study
based on propensity score matching.
Cancer Med. 2023;12:22071-22080.
Abstract
Related articles
Pemigatinib, a selective FGFR inhibitor overcomes ABCB1-mediated multidrug
resistance in cancer cells.
Biochem Biophys Res Commun. 2024;691:149314.
Abstract
Related articles
ASO Visual Abstract: Development and Validation of a Preoperative Nomogram for
Endoscopic Management Decision Making in Upper Urinary Tract Urothelial
Carcinoma.
Ann Surg Oncol. 2024;31:1416-1417.
Abstract
Related articles
Pan-cancer analysis of PLAU indicates its potential prognostic value and
correlation with neutrophil infiltration in BLCA.
Biochim Biophys Acta Mol Basis Dis. 2024;1870:166965.
Abstract
Related articles
The mutational pattern of homologous recombination repair genes in urothelial
carcinoma and its correlation with immunotherapeutic response.
Cancer Med. 2023;12:22370-22380.
Abstract
Related articles
Avelumab first-line maintenance treatment for advanced urothelial carcinoma:
review of evidence to guide clinical practice.
ESMO Open. 2023;8:102050.
Abstract
Related articles
ASO Author Reflections: Endoscopic Management of Upper Urinary Tract Urothelial
Carcinoma: A Preoperative Nomogram.
Ann Surg Oncol. 2024;31:1412-1413.
Abstract
Related articles
Development and Validation of a Preoperative Nomogram for Endoscopic Management
Decision Making in Upper Urinary Tract Urothelial Carcinoma.
Ann Surg Oncol. 2024;31:1393-1401.
Abstract
Related articles
Comparison of perioperative outcomes and complications between intracorporeal,
extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted
radical cystectomy: a comparative propensity score-matched analysis from
nationwide multi-i
Int J Clin Oncol. 2024;29:64-71.
Abstract
Related articles
Real-world outcomes of adjuvant immunotherapy candidates with upper tract
urothelial carcinoma: results of a multicenter cohort study.
Int J Clin Oncol. 2024;29:55-63.
Abstract
Related articles
Robot-assisted partial cystectomy for the treatment of inflammatory
myofibroblastic tumor of urinary bladder: A case report.
Asian J Surg. 2024;47:681-682.
Abstract
Related articles
Urinary IL-6 and IL-8 as predictive markers in bladder urothelial carcinoma: A
pilot study.
Cancer Cytopathol. 2024;132:50-59.
Abstract
Related articles
Intracavitary Chemotherapy after kidney-Sparing Therapy for Upper Tract
Urothelial Carcinoma: A Meta-Analysis.
Urol J. 2023;20:369-378.
Abstract
Related articles
Comparison of different prediction tools for the risk of intravesical recurrence
after radical nephroureterectomy for upper tract urothelial carcinoma: a
propensity-matched analysis.
Clin Transl Oncol. 2024;26:136-146.
Abstract
Related articles
GW4064 inhibits migration and invasion through cathepsin B and MMP2
downregulation in human bladder cancer.
Chem Biol Interact. 2024 Jan 10:110869. doi: 10.1016/j.cbi.2024.110869.
Abstract
Related articles
Deciphering the significance of anoikis in bladder cancer and systematic analysis
of S100A7 as a potential therapeutic target.
Eur J Med Res. 2024;29:52.
Abstract
Related articles
Single-cell sequencing reveals the heterogeneity of B cells and tertiary lymphoid
structures in muscle-invasive bladder cancer.
J Transl Med. 2024;22:48.
Abstract
Related articles
Identification of an inflammation-related risk signature for prognosis and
immunotherapeutic response prediction in bladder cancer.
Sci Rep. 2024;14:1216.
Abstract
Related articles
Preoperative Immunonutrition Significantly Reduced Surgical Site Infection After
Urinary Diversion for Invasive Bladder Cancer: A Retrospective Cohort Study.
Clin Genitourin Cancer. 2023 Dec 13:S1558-7673(23)00269.
Abstract
Related articles
Explore the prognostic influence of the treatment sequence of TURBT-chemotherapy
combination for patients with localized muscle-invasive bladder cancer.
Asian J Surg. 2024 Jan 11:S1015-9584(24)00014.
Abstract
Related articles
E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction
for human bladder cancer.
Medicine (Baltimore). 2024;103:e35722.
Abstract
Related articles
Robotic versus open radical cystectomy for bladder cancer: evaluation of
complications, survival, and opioid prescribing patterns.
J Robot Surg. 2024;18:10.
Abstract
Related articles
Prognostic Value of Fatty Acid Metabolism-related Genes in Patients with Bladder
Cancer.
Recent Pat Anticancer Drug Discov. 2024;19:328-341.
Abstract
Related articles
Treatment patterns in metastatic bladder cancer in Japan: results of the
CancerMPact((R)) survey 2020.
Future Oncol. 2024 Jan 12. doi: 10.2217/fon-2023-0197.
Abstract
Related articles
BCG immunotherapy promotes tumor-derived T-cell activation through the
FLT3/FLT3LG pathway in bladder cancer.
J Cancer. 2024;15:623-631.
Abstract
Related articles
HSPB8 Facilitates the Oncogenesis and Advancement of Bladder Cancer via
Activation of HSP27.
J Cancer. 2024;15:645-658.
Abstract
Related articles
CENPW knockdown inhibits progression of bladder cancer through inducing cell
cycle arrest and apoptosis.
J Cancer. 2024;15:858-870.
Abstract
Related articles
Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with
Metastatic Bladder Cancer in a Dutch Nationwide Cohort.
Eur Urol Open Sci. 2023;59:50-54.
Abstract
Related articles
N6-methyladenosine-modified CircPSMA7 enhances bladder cancer malignancy through
the mir-128-3p/MAPK1 axis.
Cancer Lett. 2024 Jan 9:216613. doi: 10.1016/j.canlet.2024.216613.
Abstract
Related articles
Immuno-Oncology Advances in Genitourinary Cancers.
Am Soc Clin Oncol Educ Book. 2024;44:e430428.
Abstract
Related articles
circPVT1 Inhibits the Proliferation and Aids in Prediction of the Prognosis of
Bladder Cancer.
Pharmgenomics Pers Med. 2024;17:1-11.
Abstract
Related articles
Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder
cancer: Insights from multiple omics analysis.
Chin J Cancer Res. 2023;35:686-701.
Abstract
Related articles
Results Obtained from a Pivotal Validation Trial of a Microsatellite Analysis
(MSA) Assay for Bladder Cancer Detection through a Statistical Approach Using a
Four-Stage Pipeline of Modern Machine Learning Techniques.
Int J Mol Sci. 2023;25:472.
Abstract
Related articles
The Potential of Congo Red Supplied Aggregates of Multitargeted Tyrosine Kinase
Inhibitor (Sorafenib, BAY-43-9006) in Enhancing Therapeutic Impact on Bladder
Cancer.
Int J Mol Sci. 2023;25:269.
Abstract
Related articles
Qualification of the Microsatellite Instability Analysis (MSA) for Bladder Cancer
Detection: The Technical Challenges of Concordance Analysis.
Int J Mol Sci. 2023;25:209.
Abstract
Related articles
Longitudinal Transcription Profiling of Bladder Cancers Dictate the Response to
BCG Treatment and Disease Progression.
Int J Mol Sci. 2023;25:144.
Abstract
Related articles
MRI/RNA-Seq-Based Radiogenomics and Artificial Intelligence for More Accurate
Staging of Muscle-Invasive Bladder Cancer.
Int J Mol Sci. 2023;25:88.
Abstract
Related articles
Low Alanine Aminotransferase as a Marker for Sarcopenia and Frailty, Is
Associated with Decreased Survival of Bladder Cancer Patients and Survivors-A
Retrospective Data Analysis of 3075 Patients.
Cancers (Basel). 2023;16:174.
Abstract
Related articles
SIRT1 Promotes Cisplatin Resistance in Bladder Cancer via Beclin1
Deacetylation-Mediated Autophagy.
Cancers (Basel). 2023;16:125.
Abstract
Related articles
Hesperetin promotes bladder cancer cells death via the PI3K/AKT pathway by
network pharmacology and molecular docking.
Sci Rep. 2024;14:1009.
Abstract
Related articles
Bladder Cancer, Loss of Y Chromosome, and New Opportunities for Immunotherapy.
Adv Ther. 2024 Jan 10. doi: 10.1007/s12325-023-02758.
Abstract
Related articles
The effect of hospital caseload on perioperative mortality, morbidity and costs
in bladder cancer patients undergoing radical cystectomy: results of the German
nationwide inpatient data.
World J Urol. 2024;42:19.
Abstract
Related articles
Prognostic factors of intravesical recurrence after radical nephroureterectomy
for upper tract urothelial carcinoma.
World J Urol. 2024;42:22.
Abstract
Related articles
COL6A1 expression as a potential prognostic biomarker for risk stratification of
T1 high grade bladder cancer: Unveiling the aggressive nature of a distinct
non-muscle invasive subtype.
Investig Clin Urol. 2024;65:94-103.
Abstract
Related articles
Editorial for "Significance of Normalized Apparent Diffusion Coefficient in the
Vesical Imaging-Reporting and Data System for Diagnosing Muscle-Invasive Bladder
Cancer".
J Magn Reson Imaging. 2024 Jan 10. doi: 10.1002/jmri.29233.
Abstract
Related articles
SPP1 mRNA determination based on molecular beacon for the recurrence prognosis of
bladder cancer.
Transl Androl Urol. 2023;12:1834-1844.
Abstract
Related articles
CCL5 promotes the proliferation and metastasis of bladder cancer via the
JAK2/STAT3 signaling pathway.
Transl Androl Urol. 2023;12:1845-1858.
Abstract
Related articles
Risk Factors Analysis and Pathogen Distribution of Urinary Tract Infection in
Patients Undergoing Cutaneous Ureterostomy After Radical Cystectomy for Bladder
Cancer.
Biol Res Nurs. 2024 Jan 9:10998004241226948. doi: 10.1177/10998004241226948.
Abstract
Related articles
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes,
PD-L1 expression, and FGFR3 mutational status in two advanced urothelial bladder
cancer cohorts.
Histopathology. 2024 Jan 9. doi: 10.1111/his.15130.
Abstract
Related articles
Integration of the cancer cell secretome and transcriptome reveals potential
noninvasive diagnostic markers for bladder cancer.
Proteomics Clin Appl. 2024 Jan 9:e2300033. doi: 10.1002/prca.202300033.
Abstract
Related articles
Granulomatous myocarditis arising from intravesical Bacillus Calmette-Guerin
therapy leading to death diagnosed by postmortem examination: a case report.
J Med Case Rep. 2024;18:12.
Abstract
Related articles
Ewing's sarcoma of the urinary bladder - the urologic and pathologic differential
diagnosis and current therapeutic options.
Klin Onkol. 2023;37:314-319.
Abstract
Related articles
Meticulous initial clinical and pathological staging with standardized long-term
follow-up after radical cystectomy is required to validate and improve overall
prognostic performance in patients undergoing neoadjuvant chemotherapy for
bladder cancer.
Minerva Urol Nephrol. 2024 Jan 9. doi: 10.23736/S2724-6051.23.05563.
Abstract
Related articles
Immunohistochemical expression of androgen receptors in urothelial carcinoma of
urinary bladder. Is it significant? Experience from coastal India.
Arch Ital Urol Androl. 2023;95:11514.
Abstract
Related articles
Predictive nomograms for risk and prognostic factors in metastatic bladder
cancer: a population-based study.
Transl Cancer Res. 2023;12:3284-3302.
Abstract
Related articles
LASS2 enhances chemosensitivity to cisplatin by inhibiting PP2A-mediated
beta-catenin dephosphorylation in a subset of stem-like bladder cancer cells.
BMC Med. 2024;22:19.
Abstract
Related articles
Response to letter to the editor on the systematic review "Narrow band imaging
versus white light cystoscopy alone for transurethral resection of non-muscle
invasive bladder cancer".
World J Urol. 2024;42:11.
Abstract
Related articles
CREST: phase III study of sasanlimab and Bacillus Calmette-Guerin for patients
with Bacillus Calmette-Guerin-naive high-risk non-muscle-invasive bladder cancer.
Future Oncol. 2024 Jan 8. doi: 10.2217/fon-2023-0271.
Abstract
Related articles
Unraveling neoantigen-associated genes in bladder cancer: An in-depth analysis
employing 101 machine learning algorithms.
Environ Toxicol. 2024 Jan 8. doi: 10.1002/tox.24123.
Abstract
Related articles
Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a
Mendelian randomization study.
Front Nutr. 2023;10:992608.
Abstract
Related articles
Retracted: Susceptibility Loci in SLC15A1, UGT1A3, and CWC27 Genes Associated
with Bladder Cancer in the Northeast Chinese Population.
Biomed Res Int. 2023;2023:9767851.
Abstract
Related articles
Evaluation of response to gemcitabine plus cisplatin-based chemotherapy using
positron emission computed tomography for metastatic bladder cancer.
World J Clin Cases. 2023;11:8447-8457.
Abstract
Related articles
Xanthogranulomatous Cholecystitis Mimicking Gall Bladder Cancer: a Diagnostic
Dilemma and Review of Literature.
Indian J Surg Oncol. 2023;14:796-799.
Abstract
Related articles
Ureteral obstruction following transurethral resection of bladder cancer within
the Hutch's diverticulum.
Int Cancer Conf J. 2023;13:45-48.
Abstract
Related articles
Fatty acid metabolism-related molecular subtypes and a novel model for predicting
prognosis in bladder cancer patients.
J Biosci. 2024;49:11.
Abstract
Related articles
Incidental carcinoma of the prostate in cystoprostatectomy specimens - is it
always a toothless lion?
Rom J Morphol Embryol. 2023;64:501-507.
Abstract
Related articles
Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based
Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive
Urothelial Bladder Cancer.
Eur Urol Oncol. 2024 Jan 5:S2588-9311(23)00296-1. doi: 10.1016/j.euo.2023.
Abstract
Related articles
Prostate cancer was detected after radical resection of bladder cancer.
Asian J Surg. 2024 Jan 5:S1015-9584(23)02075.
Abstract
Related articles
Multiple mask and boundary scoring R-CNN with cGAN data augmentation for bladder
tumor segmentation in WLC videos.
Artif Intell Med. 2024;147:102723.
Abstract
Related articles
Transcriptomic insights into UTUC: role of inflammatory fibrosis and potential
for personalized treatment.
J Transl Med. 2024;22:24.
Abstract
Related articles
CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA
and promote bladder cancer progression.
Cell Death Dis. 2024;15:9.
Abstract
Related articles
Genetically proxied intestinal microbiota and risk of bladder cancer.
Int J Surg. 2024 Jan 4. doi: 10.1097/JS9.0000000000001019.
Abstract
Related articles
Unveiling an Association between Waterpipe Smoking and Bladder Cancer Risk: A
Multicenter Case-Control Study in Iran.
Cancer Epidemiol Biomarkers Prev. 2024 Jan 5. doi: 10.1158/1055-9965.EPI-23-0773
Abstract
Related articles
Emerging Insights in Small-Cell Carcinoma of the Genitourinary Tract: From
Diagnosis to Novel Therapeutic Horizons.
Am Soc Clin Oncol Educ Book. 2024;44:e430336.
Abstract
Related articles
Endoplasmic Reticulum-Targeting AIE Photosensitizers to Boost Immunogenic Cell
Death for Immunotherapy of Bladder Carcinoma.
ACS Appl Mater Interfaces. 2024;16:245-260.
Abstract
Related articles
Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated
locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall
survival analysis results from a randomised, controlled, phase 3 study.
Lancet Oncol. 2024;25:29-45.
Abstract
Related articles
Evolution of front-line immunotherapy for metastatic urothelial cancer.
Lancet Oncol. 2024;25:2-3.
Abstract
Related articles
Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or
metastatic urothelial carcinoma (IMvigor130): final overall survival analysis
from a randomised, controlled, phase 3 study.
Lancet Oncol. 2024;25:46-61.
Abstract
Related articles
Precision Medicine in Urothelial Carcinoma: Current Markers to Guide Treatment
and Promising Future Directions.
Curr Treat Options Oncol. 2023;24:1870-1888.
Abstract
Related articles
Correlation between second and first primary cancer: systematic review and
meta-analysis of 9 million cancer patients.
Br J Surg. 2024;111:znad377.
Abstract
Related articles
TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle
invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly
specific and sensitive for a breast primary?
Hum Pathol. 2024;143:42-49.
Abstract
Related articles
FDG PET/CT in a Case of Primary Lymphoma of the Ureter.
Clin Nucl Med. 2023 Nov 17. doi: 10.1097/RLU.0000000000004976.
Abstract
Related articles
Aberrant expression of GATA3 in metastatic adenocarcinoma of the prostate: an
important pitfall.
Histopathology. 2024;84:507-514.
Abstract
Related articles
Head-to-head: how many categories for grading urothelial carcinoma?
Histopathology. 2024;84:421-428.
Abstract
Related articles
Turning up the heat: CTLA4 blockade in urothelial cancer.
Nat Rev Urol. 2024;21:22-34.
Abstract
Related articles
Epigenetic Regulation in Urothelial Carcinoma.
Curr Mol Med. 2024;24:85-97.
Abstract
Related articles
Regarding the role of HER2 overexpression on the survival in muscle-invasive
bladder cancer.
Int J Surg. 2024 Jan 18. doi: 10.1097/JS9.0000000000001091.
Abstract
Related articles
Molecular mechanism of anticancer effect of heat shock protein 90 inhibitor
BIIB021 in human bladder cancer cell line.
Naunyn Schmiedebergs Arch Pharmacol. 2024.
Abstract
Related articles
Molecular map of cGAS-STING pathway-related genes in bladder cancer: the
perspective toward immune microenvironment and prognosis.
Aging (Albany NY). 2024;15.
Abstract
Related articles
Snai2-mediated upregulation of NADSYN1 promotes bladder cancer progression by
interacting with PHB.
Clin Transl Med. 2024;14:e1555.
Abstract
Related articles
Age related trends in the utilization of neoadjuvant chemotherapy for muscle
invasive bladder cancer.
Urol Oncol. 2024 Jan 17:S1078-1439(24)00007.
Abstract
Related articles
Establishment of Mouse Orthotopic Urinary Bladder Tumor Model and Its Analysis by
Light and Electron Microscopy.
Methods Mol Biol. 2024;2773:33-49.
Abstract
Related articles
Urinary Bladder Cancer Induced by N-Butyl-N-(4-Hydroxybutyl)-Nitrosamine.
Methods Mol Biol. 2024;2773:25-32.
Abstract
Related articles
Effect of herniarin on cell viability, cell cycle, and Erk protein levels in
different stages of bladder cancer cells.
Chem Biodivers. 2024 Jan 18:e202301645. doi: 10.1002/cbdv.202301645.
Abstract
Related articles
Urinary microbiota signatures associated with different types of urinary
diversion: a comparative study.
Front Cell Infect Microbiol. 2024;13:1302870.
Abstract
Related articles
Retinoids and EZH2 inhibitors cooperate to orchestrate anti-oncogenic effects on
bladder cancer cells.
Cancer Gene Ther. 2024 Jan 17. doi: 10.1038/s41417-024-00725.
Abstract
Related articles
Molecular Subtypes of Bladder Cancer: Component Signatures and Potential Value in
Clinical Decision-making.
Adv Anat Pathol. 2024 Jan 18. doi: 10.1097/PAP.0000000000000430.
Abstract
Related articles
Guillain-Barre Syndrome following intravesical Bacillus Calmette-Guerin therapy
for bladder cancer: a rare and intriguing case report.
Cent European J Urol. 2023;76:311-314.
Abstract
Related articles
Local solutions to shorten treatment delays in bladder cancer. Results of a
survey among CEJU authors.
Cent European J Urol. 2023;76:280-282.
Abstract
Related articles
Retracted: Urinary Angiogenin as a Marker for Bladder Cancer: A Meta-Analysis.
Biomed Res Int. 2024;2024:9869348.
Abstract
Related articles
Retracted: The Use of BT-ESD Technology under General Intravenous Anesthesia in
the Treatment of Nonmuscle Invasive Bladder Cancer and the Effect of PI3K/Akt
Signaling Pathway on Tumor Recurrence.
Biomed Res Int. 2024;2024:9815062.
Abstract
Related articles
Comparative Outcomes of Radical Cystectomy in Muscle-Invasive Bladder Cancer: A
Systematic Review and Meta-Analysis.
Cureus. 2023;15:e50646.
Abstract
Related articles
Classification of bladder cancer based on immune cell infiltration and
construction of a risk prediction model for prognosis.
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024.
Abstract
Related articles
USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein.
Cancer Cell Int. 2024;24:32.
Abstract
Related articles
Urinoids - a new tool to study bladder cancer.
Nat Rev Urol. 2024 Jan 16. doi: 10.1038/s41585-024-00853.
Abstract
Related articles
Pathological complete response to neoadjuvant chemotherapy may improve antitumor
immune response via reduction of regulatory T cells in muscle-invasive bladder
cancer.
Sci Rep. 2024;14:1442.
Abstract
Related articles
Exosomal noncoding RNAs as noninvasive biomarkers in bladder cancer: a diagnostic
meta-analysis.
Clin Transl Oncol. 2024 Jan 16. doi: 10.1007/s12094-023-03374.
Abstract
Related articles
Quality of Life in the Phase 2/3 Trial of N-803 Plus BCG in BCG-Unresponsive
Non-Muscle Invasive Bladder Cancer.
Urol Pract. 2024 Jan 16:101097UPJ0000000000000517.
Abstract
Related articles
Diagnostic pathways and treatment strategies in upper tract urothelial carcinoma
in Sweden between 2015 and 2021: a population-based survey.
Scand J Urol. 2024;59:19-25.
Abstract
Related articles
circRNA TATA-box binding protein associated factor 15 acts as an oncogene to
facilitate bladder cancer progression through targeting miR-502-5p/high mobility
group box 3.
Mol Carcinog. 2024 Jan 16. doi: 10.1002/mc.23677.
Abstract
Related articles
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer
by abrogating immunosuppression.
J Clin Invest. 2024;134:e169241.
Abstract
Related articles
Unraveling Bacillus Calmette-Guerin (BCG) Therapy Side Effects in Bladder Cancer:
A Tale of Triumph Over Treatment Challenges.
Cureus. 2023;15:e50498.
Abstract
Related articles
Urease-powered nanobots for radionuclide bladder cancer therapy.
Nat Nanotechnol. 2024 Jan 15. doi: 10.1038/s41565-023-01577.
Abstract
Related articles
Determination of the Roles of Endothelial Nitric Oxide Synthase 4VNTR (4a/b),
G894T, T786C Gene Variations in the Bladder Cancer Development.
Indian J Clin Biochem. 2024;39:92-100.
Abstract
Related articles
Tislelizumab with gemcitabine and cisplatin as a neoadjuvant regimen for
muscle-invasive bladder cancer: case series.
Ann Med Surg (Lond). 2023;86:245-251.
Abstract
Related articles
Nadofaragene: a new era of precision medicine for bladder cancer.
Ann Med Surg (Lond). 2023;86:7-10.
Abstract
Related articles
Matched analysis of detailed peripheral blood and tumor immune microenvironment
profiles in bladder cancer.
Epigenomics. 2024;16:41-56.
Abstract
Related articles
Bladder Cancer and the Urinary Microbiome-New Insights and Future Directions: A
Review.
Clin Genitourin Cancer. 2024 Jan 9:S1558-7673(23)00281.
Abstract
Related articles
USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer.
Cell Death Dis. 2024;15:44.
Abstract
Related articles
Metabolic reprogramming based on RNA sequencing of gemcitabine-resistant cells
reveals the FASN gene as a therapeutic for bladder cancer.
J Transl Med. 2024;22:55.
Abstract
Related articles
Urease-Powered Black TiO(2) Micromotors for Photothermal Therapy of Bladder
Cancer.
ACS Appl Mater Interfaces. 2024 Jan 13. doi: 10.1021/acsami.3c11772.
Abstract
Related articles
Vesical fungal bezoars on post-TURBT scar tissue causing obstruction and
mimicking urothelial carcinoma.
BMJ Case Rep. 2024;17:e257132.
Abstract
Related articles
Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various
types of cancer.
BMC Endocr Disord. 2024;24:9.
Abstract
Related articles
Extraperitonealization of the ileal conduit decreases the risk of parastomal
hernia: A single-center, randomized clinical trial.
Cell Rep Med. 2024;5:101343.
Abstract
Related articles
Stentless florence robotic intracorporeal neobladder (FloRIN), a feasibility
prospective randomized clinical trial.
Eur J Surg Oncol. 2024;50:107259.
Abstract
Related articles
Cell fusion upregulates PD-L1 expression for evasion from immunosurveillance.
Cancer Gene Ther. 2024;31:158-173.
Abstract
Related articles
KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder
urothelial carcinoma cell proliferation and migration, inhibits apoptosis.
Mol Carcinog. 2024;63:286-300.
Abstract
Related articles
How Do Molecular Classifications Affect the Neoadjuvant Treatment of
Muscle-Invasive Urothelial Carcinoma?
Mol Diagn Ther. 2024;28:37-51.
Abstract
Related articles
The Double Antibody Drug Conjugate (DAD) phase I trial: sacituzumab govitecan
plus enfortumab vedotin for metastatic urothelial carcinoma.
Ann Oncol. 2024;35:91-97.
Abstract
Related articles
Erdafitinib versus pembrolizumab in pretreated patients with advanced or
metastatic urothelial cancer with select FGFR alterations: cohort 2 of the
randomized phase III THOR trial.
Ann Oncol. 2024;35:107-117.
Abstract
Related articles
Machine learning algorithms predicting bladder cancer associated with diabetes
and hypertension: NHANES 2009 to 2018.
Medicine (Baltimore). 2024;103:e36587.
Abstract
Related articles
Relevance of HOTAIR rs920778 and rs12826786 Genetic Variants in Bladder Cancer
Risk and Survival.
Cancers (Basel). 2024;16:434.
Abstract
Related articles
Immuno-Transcriptomic Profiling of Blood and Tumor Tissue Identifies Gene
Signatures Associated with Immunotherapy Response in Metastatic Bladder Cancer.
Cancers (Basel). 2024;16:433.
Abstract
Related articles
A comparative analysis of radical cystectomy with perioperative chemotherapy,
chemoradiation therapy, or systemic therapy in patients with clinically advanced
node-positive bladder cancer (cN2/N3).
Front Oncol. 2024;13:1157880.
Abstract
Related articles
Curcumin Inhibits Bladder Cancer by Inhibiting Invasion via AKT/MMP14 Pathway.
Discov Med. 2024;36:71-81.
Abstract
Related articles
Development and preliminary validation of a PROS scale for Chinese bladder cancer
patients with abdominal stoma.
Sci Rep. 2024;14:2187.
Abstract
Related articles
Multi-omics reveals the role of ENO1 in bladder cancer and constructs an
epithelial-related prognostic model to predict prognosis and efficacy.
Sci Rep. 2024;14:2189.
Abstract
Related articles
Patient experience and unmet needs in high-risk nonmuscle-invasive bladder
cancer: Insights from qualitative interviews and a cross-sectional survey.
Urol Oncol. 2024 Jan 24:S1078-1439(24)00015.
Abstract
Related articles
Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral
Resection (TUR) + Bacillus Calmette-Guerin (BCG) Versus Upfront Induction BCG
After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a
Randomized
Eur Urol Focus. 2024 Jan 24:S2405-4569(24)00005.
Abstract
Related articles
Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of
bladder cancer.
Cancer Lett. 2024 Jan 23:216606. doi: 10.1016/j.canlet.2023.216606.
Abstract
Related articles
Aging induces changes in cancer formation and microbial content in a murine model
of bladder cancer.
Geroscience. 2024 Jan 25. doi: 10.1007/s11357-024-01064.
Abstract
Related articles
Early port site and peritoneal metastasis following robot-assisted radical
cystectomy: a rare case report.
J Cancer Res Clin Oncol. 2024;150:32.
Abstract
Related articles
Preoperative CT-based deep learning radiomics model to predict lymph node
metastasis and patient prognosis in bladder cancer: a two-center study.
Insights Imaging. 2024;15:21.
Abstract
Related articles
Cigarette smoking combined with genetic variation regulates the m(6) A
methylation of CRNKL1 and is associated with bladder cancer risk.
Environ Toxicol. 2024 Jan 25. doi: 10.1002/tox.24138.
Abstract
Related articles
Urethral Recurrence After Cystectomy and Orthotopic Bladder Reconstruction: A
Rare Case of Recurrent Bladder Cancer After 12 Years and Review of the
Literature.
Clin Med Insights Case Rep. 2024;17:11795476231224188.
Abstract
Related articles
Glycocalyx analysis of bladder cancer: three-dimensional images in electron
microscopy and vicia villosa lectin as a marker for invasiveness in frozen
sections.
Front Cell Dev Biol. 2024;11:1308879.
Abstract
Related articles
RC48-ADC combined with tislelizumab as neoadjuvant treatment in patients with
HER2-positive locally advanced muscle-invasive urothelial bladder cancer: a
multi-center phase Ib/II study (HOPE-03).
Front Oncol. 2024;13:1233196.
Abstract
Related articles
Prediction of anticancer drug resistance using a 3D microfluidic bladder cancer
model combined with convolutional neural network-based image analysis.
Front Bioeng Biotechnol. 2024;11:1302983.
Abstract
Related articles
Metabolomic profiling of human bladder tissue extracts.
Metabolomics. 2024;20:14.
Abstract
Related articles
Assessing the Impact of Percutaneous Nephrostomy Presence on Neoadjuvant
Treatment Quality in Patients With Muscle Invasive Bladder Cancer.
Clin Genitourin Cancer. 2024 Jan 6:S1558-7673(24)00004.
Abstract
Related articles
Impact of variant histology on upstaging and survival in patients with nonmuscle
invasive bladder cancer undergoing radical cystectomy.
Urol Oncol. 2024 Jan 23:S1078-1439(23)00487.
Abstract
Related articles
Prognostic impact of variant histology in bladder cancer: Would early and
aggressive treatment shift the paradigm?
Urol Oncol. 2024 Jan 23:S1078-1439(24)00010.
Abstract
Related articles
Immunologic Crosstalk of Endoplasmic Reticulum Stress Signaling in Bladder
Cancer.
Curr Cancer Drug Targets. 2024 Jan 23. doi: 10.2174/0115680096272663231121100515
Abstract
Related articles
Immunohistochemical Expression of Vitamin D Receptor (VDR) in Urinary Bladder
Squamous Cell Carcinoma.
Turk Patoloji Derg. 2024;1.
Abstract
Related articles
Combination intravesical chemotherapy for non-muscle invasive bladder cancer
(NMIBC) as first-line or rescue therapy: where do we stand Now?
Expert Opin Pharmacother. 2024 Jan 24. doi: 10.1080/14656566.2024.2310073.
Abstract
Related articles
Corrigendum: Label-free LC-MS/MS proteomics analyses reveal CLIC1 as a predictive
biomarker for bladder cancer staging and prognosis.
Front Oncol. 2024;13:1216134.
Abstract
Related articles
Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle
invasive bladder cancer: a systematic review and meta-analysis.
Front Immunol. 2024;14:1332213.
Abstract
Related articles
[Retracted] microRNA?195 inhibits cell proliferation in bladder cancer via
inhibition of cell division control protein 42 homolog/signal transducer and
activator of transcription?3 signaling.
Exp Ther Med. 2023;27:78.
Abstract
Related articles
Predictive factors of bladder tumor recurrence after radical treatment of upper
urinary tract cancer.
Tunis Med. 2023;101:356-361.
Abstract
Related articles
Radiomics nomogram for predicting disease-free survival after partial resection
or radical cystectomy in patients with bladder cancer.
Br J Radiol. 2024;97:201-209.
Abstract
Related articles
Giant cell-rich solitary fibrous tumour of the urinary bladder: case report of an
unusual histological variant and literature review.
Diagn Pathol. 2024;19:20.
Abstract
Related articles
Bladder sparing by short-course radiotherapy combined with toripalimab in
high-risk/extremely high-risk non-muscle invasive bladder cancer (HOPE-04): study
protocol for a single-arm, prospective, phase II trial.
BMJ Open. 2024;14:e076663.
Abstract
Related articles
Dose-Escalated Radiation Therapy as Primary Treatment for Residual Bladder Cancer
After Transurethral Resection.
Adv Radiat Oncol. 2024;9:101302.
Abstract
Related articles
Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for
kidney and bladder cancer immunotherapy.
Front Immunol. 2024;14:1274781.
Abstract
Related articles
Role of Additional MRI-Based Morphologic Measurements on the Performance of
VI-RADS for Muscle-Invasive Bladder Cancer.
J Magn Reson Imaging. 2024 Jan 23. doi: 10.1002/jmri.29184.
Abstract
Related articles
Photodynamic Therapy: Current Trends and Potential Future Role in the Treatment
of Bladder Cancer.
Int J Mol Sci. 2024;25:960.
Abstract
Related articles
Molecular Targeting of the Fibroblast Growth Factor Receptor Pathway across
Various Cancers.
Int J Mol Sci. 2024;25:849.
Abstract
Related articles
Sialidase NEU3 Contributes to the Invasiveness of Bladder Cancer.
Biomedicines. 2024;12:192.
Abstract
Related articles
m6A Methylation-Mediated Stabilization of LINC01106 Suppresses Bladder Cancer
Progression by Regulating the miR-3148/DAB1 Axis.
Biomedicines. 2024;12:114.
Abstract
Related articles
Exploring the Relationship between CLPTM1L-MS2 Variants and Susceptibility to
Bladder Cancer.
Genes (Basel). 2023;15:50.
Abstract
Related articles
Urinary Microbiome Dysbiosis and Immune Dysregulations as Potential Diagnostic
Indicators of Bladder Cancer.
Cancers (Basel). 2024;16:394.
Abstract
Related articles
Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic
Targets in Bladder Cancer.
Cancers (Basel). 2024;16:246.
Abstract
Related articles
Evaluation of the Mechanisms Involved in the Development of Bladder Toxicity
following Exposure to Occupational Bladder Cancer Causative Chemicals Using DNA
Adductome Analysis.
Biomolecules. 2023;14:36.
Abstract
Related articles
The feasibility of an exercise intervention after robotic-assisted radical
cystectomy for urinary bladder cancer, prior to the CanMoRe trial.
Pilot Feasibility Stud. 2024;10:12.
Abstract
Related articles
The 15-year national trends of urinary cancers incidence among Iranian men and
women; 2005-2020.
Int J Equity Health. 2024;23:13.
Abstract
Related articles
Urinary DNA methylation-based risk stratification model to triage patients for
repeat transurethral resection of bladder tumours.
Clin Transl Med. 2024;14:e1549.
Abstract
Related articles
End-of-Life Care Preferences of Patients with Advanced Urological Malignancies:
An Explorative Survey Study at a Tertiary Referral Center.
Curr Oncol. 2024;31:462-471.
Abstract
Related articles
Novel integrated Omics based computational approach for drug repurposing for
non-muscle invasive bladder cancer (NMIBC).
J Biomol Struct Dyn. 2024 Jan 21:1-11. doi: 10.1080/07391102.2024.2302343.
Abstract
Related articles
[?. Urinary Liquid Biopsy in Bladder Cancer- Current Status and Issues].
Gan To Kagaku Ryoho. 2024;51:40-44.
Abstract
Related articles
[INFECTIOUS AORTITIS-RELATED MORTALITY AFTER ILEAL NEOBLADDER SUBSTITUTION IN A
PATIENT WITH DIABETES MELLITUS].
Nihon Hinyokika Gakkai Zasshi. 2023;114:26-29.
Abstract
Related articles
[NONRISING BLADDER PARAGANGLIOMA SUCCESSFULLY TREATED BY THE OPEN BLADDER
SURGERY: A CASE REPORT].
Nihon Hinyokika Gakkai Zasshi. 2023;114:16-20.
Abstract
Related articles
High and selective cytotoxicity of ex vivo expanded allogeneic human natural
killer cells from peripheral blood against bladder cancer: implications for
natural killer cell instillation after transurethral resection of bladder tumor.
J Exp Clin Cancer Res. 2024;43:24.
Abstract
Related articles
Development of a stemness-related prognostic index to provide therapeutic
strategies for bladder cancer.
NPJ Precis Oncol. 2024;8:14.
Abstract
Related articles
PRPF19 could serve as a prognostic biomarker for patients with bladder cancer: A
comprehensive analysis by integrating bulk and single-cell sequencing.
Asian J Surg. 2024 Jan 19:S1015-9584(24)00115.
Abstract
Related articles
Radiotherapy in metastatic bladder cancer.
World J Urol. 2024;42:47.
Abstract
Related articles
Single incision robotic cystectomy and urinary diversion.
World J Urol. 2024;42:45.
Abstract
Related articles
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing
treatment for muscle-invasive bladder cancer: a phase 2 trial.
Nat Med. 2024 Jan 19. doi: 10.1038/s41591-024-02814.
Abstract
Related articles
MRI for risk stratification of muscle invasion by upper tract urothelial
carcinoma: a feasibility study.
Eur Radiol Exp. 2024;8:9.
Abstract
Related articles
Exposure to disinfection by-products and risk of cancer: A systematic review and
dose-response meta-analysis.
Ecotoxicol Environ Saf. 2024;270:115925.
Abstract
Related articles
Clear cell urothelial carcinoma of bladder: Case report of a rare and aggressive
variant with review of literature.
Indian J Cancer. 2023;60:575-577.
Abstract
Related articles
Characteristics and survival of primary urothelial carcinoma of the prostate: A
multi-center retrospective study of 18 cases.
Neoplasia. 2024;47:100961.
Abstract
Related articles
TERT promoter mutations and the outcome of patients with advanced urothelial
carcinoma treated by platinum-based chemotherapy or pembrolizumab.
Pathol Res Pract. 2024;253:155008.
Abstract
Related articles
CD47 expression in urothelial carcinoma and its correlation with
histopathological findings.
Indian J Cancer. 2023;60:458-463.
Abstract
Related articles
Is there any robust evidence showing that SGLT2 inhibitor predisposes to cancer?
Eur J Clin Invest. 2024;54:e14131.
Abstract
Related articles
APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Neurol Res. 2023 Nov 26:1-16. doi: 10.1080/01616412.2023.2287340.
Abstract
Related articles
Postmarketing Safety of Sacituzumab Govitecan: A Pharmacovigilance Study Based on
the FDA Adverse Event Reporting System.
Clin Pharmacol Ther. 2024;115:256-268.
Abstract
Related articles
The Association between Dietary Inflammatory Potential and Urologic Cancers: A
Meta-analysis.
Adv Nutr. 2023 Nov 3:100124. doi: 10.1016/j.advnut.2023.
Abstract
Related articles
An accurate diagnostic approach for urothelial carcinomas based on novel dual
methylated DNA markers in small-volume urine.
Chin Med J (Engl). 2024;137:232-234.
Abstract
Related articles
Diffuse Carbonic Anhydrase 9 and GATA3 Expression in Fumarate Hydratase Deficient
Renal Cell Carcinoma - A Case Report and Immunoprofile Review.
Int J Surg Pathol. 2024;32:145-149.
Abstract
Related articles
Urinary Bladder "Melanosis": A Case Report and Review of the Literature.
Int J Surg Pathol. 2024;32:104-108.
Abstract
Related articles
Identification and preliminary analysis of hub genes associated with bladder
cancer progression by comprehensive bioinformatics analysis.
Sci Rep. 2024;14:2782.
Abstract
Related articles
Standardization of the evaluation and surveillance of patients with BCG
unresponsive high grade non-muscle invasive bladder cancer clinical trials.
Urol Oncol. 2024 Feb 1:S1078-1439(24)00020-6. doi: 10.1016/j.urolonc.2024.
Abstract
Related articles
A novel predict method for muscular invasion of bladder cancer based on 3D mp-MRI
feature fusion.
Phys Med Biol. 2024 Feb 2. doi: 10.1088/1361-6560.
Abstract
Related articles
A risk model based on lncRNA-miRNA-mRNA gene signature for predicting prognosis
of patients with bladder cancer.
Cancer Biomark. 2024 Jan 8. doi: 10.3233/CBM-230216.
Abstract
Related articles
Relationship Between Availability of Urologists and Primary Care Providers and
Stage of Diagnosis for Invasive Urinary Bladder Cancer.
Urol Pract. 2024 Jan 15:101097UPJ0000000000000503.
Abstract
Related articles
Genetic insights into bladder cancer: the impact of SIRT1 gene polymorphism.
Nucleosides Nucleotides Nucleic Acids. 2024.
Abstract
Related articles
Development and validation of a CT-based deep learning radiomics nomogram to
predict muscle invasion in bladder cancer.
Heliyon. 2024;10:e24878.
Abstract
Related articles
PRPF19 functions in DNA damage repair and gemcitabine sensitivity via regulating
DDB1 in bladder cancer cells.
Cytotechnology. 2024;76:85-96.
Abstract
Related articles
Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance
against cellular stress in bladder cancer.
Front Oncol. 2024;13:1334112.
Abstract
Related articles
The Evolving Role of PD-(L)1 Inhibition in Optimizing Outcomes for High-Risk
Non-Muscle-Invasive Bladder Cancer (NMIBC): A Podcast.
Adv Ther. 2024 Feb 2. doi: 10.1007/s12325-023-02763.
Abstract
Related articles
Association of Age with Non-muscle-invasive Bladder Cancer: Unearthing a
Biological Basis for Epidemiological Disparities?
Eur Urol Oncol. 2024 Jan 31:S2588-9311(24)00036.
Abstract
Related articles
Time to progression is the main predictor of survival in patients with high-risk
nonmuscle invasive bladder cancer: Results from a machine learning-based analysis
of a large multi-institutional database.
Urol Oncol. 2024 Jan 31:S1078-1439(24)00003.
Abstract
Related articles
The clinical validity of urinary pellet DNA monitoring for the diagnosis of
recurrent bladder cancer.
J Mol Diagn. 2024 Jan 30:S1525-1578(24)00012.
Abstract
Related articles
Integration of multi-omics and clinical treatment data reveals bladder cancer
therapeutic vulnerability gene combinations and prognostic risks.
Front Immunol. 2024;14:1301157.
Abstract
Related articles
Prognostic biomarker DARS2 correlated with immune infiltrates in bladder tumor.
Front Immunol. 2024;14:1301945.
Abstract
Related articles
Retracted: Preoperative Nutritional Risk Assessment for Predicting Complications
after Radical Cystectomy plus Urinary Diversion for Bladder Cancer.
Emerg Med Int. 2024;2024:9849523.
Abstract
Related articles
Microbiome Profiling in Bladder Cancer Patients Using the First-morning Urine
Sample.
Eur Urol Open Sci. 2023;59:18-26.
Abstract
Related articles
Is switching intravesical chemotherapeutic agents beneficial in short-term
recurrent high-risk non-muscle-invasive bladder tumors? A 5-year retrospective
study.
BMC Urol. 2024;24:25.
Abstract
Related articles
Management of patients with muscle-invasive bladder cancer with clinical evidence
of pelvic lymph node metastases.
Nat Rev Urol. 2024 Jan 31. doi: 10.1038/s41585-023-00842.
Abstract
Related articles
Achieving Benchmarks for National Quality Indicators Reduces Recurrence and
Progression in Non-muscle-invasive Bladder Cancer.
Eur Urol Oncol. 2024 Jan 30:S2588-9311(24)00037.
Abstract
Related articles
Definition of the prognosis value of urine extracellular vesicles ZNF540 in
bladder cancer based on GEO database.
Asian J Surg. 2024 Jan 30:S1015-9584(24)00109.
Abstract
Related articles
Single-cell transcriptome analysis reveals the association between histone
lactylation and cisplatin resistance in bladder cancer.
Drug Resist Updat. 2024;73:101059.
Abstract
Related articles
PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in
bladder cancer.
Environ Toxicol. 2024 Jan 31. doi: 10.1002/tox.24153.
Abstract
Related articles
[RBMX overexpression inhibits proliferation, migration, invasion and glycolysis
of human bladder cancer cells by downregulating PKM2].
Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:9-16.
Abstract
Related articles
Tumour tissue-derived small extracellular vesicles reflect molecular subtypes of
bladder cancer.
J Extracell Vesicles. 2024;13:e12402.
Abstract
Related articles
Integrated bioinformatics analysis identifies a Ferroptosis-related gene
signature as prognosis model and potential therapeutic target of bladder cancer.
Toxicol Res (Camb). 2024;13:tfae010.
Abstract
Related articles
circCD2AP promotes epithelial mesenchymal transition and stemness in bladder
cancer by regulating FOXQ1/USP21 axis.
iScience. 2023;27:108447.
Abstract
Related articles
A prospective evaluation of quality of life, psychosocial distress, and
functional outcomes two years after radical cystectomy and urinary diversion in
842 German bladder cancer patients.
J Cancer Surviv. 2024 Jan 30. doi: 10.1007/s11764-024-01535.
Abstract
Related articles
Artificial intelligence assisted patient blood and urine droplet pattern analysis
for non-invasive and accurate diagnosis of bladder cancer.
Sci Rep. 2024;14:2488.
Abstract
Related articles
Proton pump inhibitors and potassium competitive acid blockers decrease
pembrolizumab efficacy in patients with metastatic urothelial carcinoma.
Sci Rep. 2024;14:2520.
Abstract
Related articles
Prostate Cancer among Patients Undergoing Radical Cystoprostatectomy for Bladder
Cancer in the Department of Urology in a Tertiary Care Centre.
JNMA J Nepal Med Assoc. 2023;61:782-786.
Abstract
Related articles
Electrocardiographic characteristics of bladder cancer patients receiving
preoperative chemotherapy combined with immunotherapy.
Ann Noninvasive Electrocardiol. 2024;29:e13107.
Abstract
Related articles
Author Correction: Duality of the SVIL expression in bladder cancer and its
correlation with immune infiltration.
Sci Rep. 2024;14:2369.
Abstract
Related articles
Sexual dimorphism in bladder cancer: a review of etiology, biology, diagnosis,
and outcomes.
Front Pharmacol. 2024;14:1326627.
Abstract
Related articles
Type 2 innate lymphoid cells are not involved in mouse bladder tumor development.
Front Immunol. 2024;14:1335326.
Abstract
Related articles
Unveiling Anoikis-related genes: A breakthrough in the prognosis of bladder
cancer.
J Gene Med. 2024;26:e3651.
Abstract
Related articles
Exploration of the prognostic effect of costimulatory genes in bladder cancer.
J Gene Med. 2024;26:e3655.
Abstract
Related articles
[Mesonephric-like adenocarcinoma of the female urinary bladder associated with
endometriosis: report of a case].
Zhonghua Bing Li Xue Za Zhi. 2024;53:201-203.
Abstract
Related articles
Squalene monooxygenase facilitates bladder cancer development in part by
regulating PCNA.
Biochim Biophys Acta Mol Cell Res. 2024;1871:119681.
Abstract
Related articles
Evaluation of a New Cystoscopic Cryocatheter and Method for the In Situ
Destruction of Bladder Cancer: Preliminary In vivo Study.
J Endourol. 2024 Jan 27. doi: 10.1089/end.2023.0635.
Abstract
Related articles
The relationship between the expression of lncRNA MALAT1 and clinical features
and prognosis in bladder cancer: A meta-analysis.
Cell Mol Biol (Noisy-le-grand). 2023;69:166-171.
Abstract
Related articles
Combinatorial Gene Expression Profiling of Serum HULC, HOTAIR, and UCA1 lncRNAs
to Differentiate Hepatocellular Carcinoma from Liver Diseases: A Systematic
Review and Meta-Analysis.
Int J Mol Sci. 2024;25:1258.
Abstract
Related articles
Plasma-Activated Media Produced by a Microwave-Excited Atmospheric Pressure
Plasma Jet Is Effective against Cisplatin-Resistant Human Bladder Cancer Cells In
Vitro.
Int J Mol Sci. 2024;25:1249.
Abstract
Related articles
Prognostic significance of lncRNA AL354919.2 in bladder cancer.
Asian J Surg. 2024 Jan 25:S1015-9584(24)00099.
Abstract
Related articles
Re: Christopher D. Gaffney, Andrew Katims, Neeta D'Souza, Marc A. Bjurlin,
Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk
Reduction. Eur Urol Focus 2023;9:575-8.
Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00006.
Abstract
Related articles
Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia
and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza,
Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus
Calmette-Guerin (BCG)
Eur Urol Focus. 2024 Jan 25:S2405-4569(24)00004.
Abstract
Related articles
Application of contrast-enhanced ultrasound in diagnosis and grading of bladder
urothelial carcinoma.
BMC Med Imaging. 2024;24:26.
Abstract
Related articles
Latin American Consensus for the Evaluation and Treatment of Patients With
Metastatic/Locally Advanced Urothelial Carcinoma.
JCO Glob Oncol. 2024;10:e2300244.
Abstract
Related articles
Nanoreactor based on single-atom nanoenzymes promotes ferroptosis for cancer
immunotherapy.
Biomater Adv. 2024;157:213758.
Abstract
Related articles
An iodine?labelled Antibody-drug conjugate PET probe for noninvasive monitoring
of Nectin-4 expression in urothelial carcinoma.
Int J Pharm. 2024;651:123756.
Abstract
Related articles
MicroRNA-299-3p inhibits cell proliferation, motility, invasion and angiogenesis
via VEGFA in upper tract urothelial carcinoma.
J Gene Med. 2024;26:e3616.
Abstract
Related articles
Quantitative image analysis of intracellular protein translocation in
3-dimensional tissues for pharmacodynamic studies of immunogenic cell death.
J Control Release. 2024;365:89-100.
Abstract
Related articles
Combination neoadjuvant therapies are paving the way for bladder preservation to
become the standard for selected patients.
Nat Rev Clin Oncol. 2024;21:87-88.
Abstract
Related articles
Cardiac metastasis from urothelial carcinoma: a stealthy precursor.
Eur Heart J Cardiovasc Imaging. 2024;25:e92.
Abstract
Related articles
Comparison of DNA methylation and cytology tests in urine to detect upper tract
urothelial carcinoma: A paired-design diagnostic study.
Am J Clin Pathol. 2024;161:115-121.
Abstract
Related articles
Reactive arthritis as a rare complication of intravesical bacillus
Calmette-Guerin treatment: Report of two cases.
Int J Rheum Dis. 2024;27:e14862.
Abstract
Related articles
Noninvasive Papillary Urothelial Carcinoma of the Bladder: An Institutional
Experience Focusing on Tumors With Borderline Features.
Arch Pathol Lab Med. 2024;148:223-229.
Abstract
Related articles
The prognostic significance and clinical relevance of stem cell characteristic in
bladder cancer.
Heliyon. 2024;10:e24858.
Abstract
Related articles
A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target
for bladder cancer.
Sci Rep. 2024;14:3198.
Abstract
Related articles
Bibliometric analysis of immunotherapy for bladder cancer: A correspondence.
Hum Vaccin Immunother. 2024;20:2313287.
Abstract
Related articles
Drug-Loaded Bacillus Calmette-Guerin Bacteria for Immuno-Chemo Combo Therapy in
Bladder Cancer.
Adv Mater. 2024 Feb 8:e2310735. doi: 10.1002/adma.202310735.
Abstract
Related articles
[6]-Shogaol Induces Apoptosis of Murine Bladder Cancer Cells.
Cell Physiol Biochem. 2024;58:49-62.
Abstract
Related articles
Re: Clinical impact of detrusor muscle in en bloc resection for T1 bladder
cancer. Yanagisawa T, Sato S, Hayashida Y, Okada Y, Fukuokaya W, Iwatani K, et
al. J Urol Oncol. 2023;41(12):484.e7-484.e15.
Urol Oncol. 2024 Feb 6:S1078-1439(24)00018-8. doi: 10.1016/j.urolonc.2024.
Abstract
Related articles
Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer
Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse
Probability Treatment Weighted Analysis.
Eur Urol Oncol. 2024 Feb 6:S2588-9311(24)00040-3. doi: 10.1016/j.euo.2024.
Abstract
Related articles
Population Estimates of Ovarian Cancer Risk in a Cohort of Patients with Bladder
Cancer.
Eur Urol Focus. 2024 Feb 6:S2405-4569(24)00015-4. doi: 10.1016/j.euf.2024.
Abstract
Related articles
Glandular Lesions of the Urinary Bladder: Diagnostic and Molecular Updates.
Adv Anat Pathol. 2024;31:88-95.
Abstract
Related articles
Erratum: A CRISPR Interference of CBP and p300 Selectively Induced Synthetic
Lethality in Bladder Cancer Cells In Vitro: Erratum.
Int J Biol Sci. 2024;20:1088-1089.
Abstract
Related articles
[Guillain-Barre syndrome caused by intravesical instillation of Bacillus
Calmette-Guerin].
Ideggyogy Sz. 2024;77.
Abstract
Related articles
Clinical significance of KRT7 in bladder cancer prognosis.
Int J Biol Markers. 2024 Feb 6:3936155231224798. doi: 10.1177/03936155231224798.
Abstract
Related articles
Molecular profile of bladder cancer progression to clinically aggressive
subtypes.
Nat Rev Urol. 2024 Feb 6. doi: 10.1038/s41585-023-00847.
Abstract
Related articles
Teaching NeuroImage: Metastatic Urachal Carcinoma in the Extraocular Muscles
Mimicking Oculomotor Paralysis.
Neurology. 2024;102:e209191.
Abstract
Related articles
Construction of a necroptosis-related lncRNA signature for predicting prognosis
and revealing the immune microenvironment in bladder cancer.
Aging (Albany NY). 2024;16.
Abstract
Related articles
Elafibranor emerged as a potential chemotherapeutic drug for non-muscle invasive
bladder cancer.
Cell Insight. 2024;3:100149.
Abstract
Related articles
Characterization and verification of CAF-relevant prognostic gene signature to
aid therapy in bladder cancer.
Heliyon. 2024;10:e23873.
Abstract
Related articles
Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer.
Nat Rev Urol. 2024 Feb 5. doi: 10.1038/s41585-024-00859.
Abstract
Related articles
FATP2 activates PI3K/Akt/mTOR pathway by inhibiting ATF3 and promotes the
occurrence and development of bladder cancer.
Cell Signal. 2024;117:111087.
Abstract
Related articles
Prevalence of Bladder Cancers Incidentally Detected During Multiparametric MRI
Scans of the Prostate Gland and the Clinical Significance of Scoring Them
According to VI-RADS: A Pictorial Single-Centre Study.
J Belg Soc Radiol. 2024;108:7.
Abstract
Related articles
Toward standardization in bladder cancer clinical trials: Guidance from the
SITC-IBCG expert panel.
J Immunother Cancer. 2024;12:e008508.
Abstract
Related articles
Unusual case of retroperitoneal hematoma and duodenal ulcerative bleeding after
nephrectomy: Case report.
Medicine (Baltimore). 2024;103:e33765.
Abstract
Related articles
[A Case Report of Metachronous Multiple Cancers Including Triple Lung Cancers,
Gastric Cancer, and Double Urothelial Cancers].
Gan To Kagaku Ryoho. 2023;50:1656-1658.
Abstract
Related articles
Emerging strategy for the treatment of urothelial carcinoma: Advances in
antibody-drug conjugates combination therapy.
Biomed Pharmacother. 2024;171:116152.
Abstract
Related articles
Initial Experience with (68)Ga-FAP-2286 PET Imaging in Patients with Urothelial
Cancer.
J Nucl Med. 2024 Jan 11:jnumed.123.266390. doi: 10.2967/jnumed.123.266390.
Abstract
Related articles
Predictors of response to neoadjuvant therapy in urothelial cancer.
Crit Rev Oncol Hematol. 2024;194:104236.
Abstract
Related articles
lncRNA UCA1 promotes tumor progression by targeting SMARCD3 in cervical cancer.
Mol Carcinog. 2023 Dec 20. doi: 10.1002/mc.23659.
Abstract
Related articles
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial,
testicular and penile carcinoma - Today's impact, tomorrow's potential.
Expert Rev Med Devices. 2024;21.
Abstract
Related articles
Contemporary Issues in Urothelial Carcinoma of Upper Urinary Tract.
Adv Anat Pathol. 2024;31:80-87.
Abstract
Related articles
Squamous cell carcinoma of the bladder: Demographics and outcomes associated with
surgery and radiotherapy.
J Surg Oncol. 2024;129:649-658.
Abstract
Related articles
Investigation of eligibility for adjuvant therapy from real-world data of
patients with urothelial carcinoma undergoing radical cystectomy and radical
nephroureterectomy.
Jpn J Clin Oncol. 2024;54:182-191.
Abstract
Related articles
Urinary tract cytology showing variant morphology and divergent differentiation.
Cytopathology. 2024;35:199-212.
Abstract
Related articles
Cytologic evaluation of upper urinary tract specimens: An institutional
retrospective study using The Paris System for Reporting Urine Cytology second
edition with histopathologic follow-up.
Cytopathology. 2024;35:235-241.
Abstract
Related articles
Trend in overall survival from the start of first-line chemotherapy in patients
with metastatic urothelial carcinoma.
Jpn J Clin Oncol. 2024;54:221-224.
Abstract
Related articles
Presence, Subtypes, and Prognostic Significance of Tertiary Lymphoid Structures
in Urothelial Carcinoma of the Bladder.
Oncologist. 2024;29:e248-e258.
Abstract
Related articles
Intraoperative hypertensive crisis in a dog with functional paraganglioma of the
gall bladder.
J Small Anim Pract. 2024;65:144-148.
Abstract
Related articles
A systematic review and meta-analysis for human epidermal growth factor receptor
2 on upper tract urothelial carcinoma patients.
Tumori. 2024;110:25-33.
Abstract
Related articles
An Interleukin-15 Superagonist with BCG - A Major Therapeutic Advancement or Just
a Small Step in the Right Direction?
NEJM Evid. 2023;2:EVIDe2200264.
Abstract
Related articles
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.
NEJM Evid. 2023;2:EVIDoa2200167.
Abstract
Related articles
Adjuvant Intravesical Chemotherapy Versus Immunotherapy for All Risk Groups of
Patients With Non-muscle Invasive Bladder Cancer.
Med Arch. 2023;77:460-464.
Abstract
Related articles
A systematic review and meta-analysis of intraarterial chemotherapy for non
muscle invasive bladder cancer: Promising alternative therapy in high
tuberculosis burden countries.
Arch Ital Urol Androl. 2024 Feb 16. doi: 10.4081/aiua.2024.12154.
Abstract
Related articles
Quality of bladder cancer treatment information on YouTube: May the user's
profile affect the quality of results?
Arch Ital Urol Androl. 2024 Feb 16. doi: 10.4081/aiua.2024.12179.
Abstract
Related articles
Light-Activatable Photocaged UNC2025 for Triggering TAM Kinase Inhibition in
Bladder Cancer.
Chembiochem. 2024 Feb 16:e202300855. doi: 10.1002/cbic.202300855.
Abstract
Related articles
Prevention of Bladder Cancer Recurrence With the Botanical Formula LCS103: A Case
Series Study.
Integr Cancer Ther. 2024;23:15347354241233233.
Abstract
Related articles
Vesical Imaging-Reporting and Data System (VI-RADS) as a grouping imaging
biomarker combined with a decision-tree mode to preoperatively predict the
pathological grade of bladder cancer.
Clin Radiol. 2024 Feb 9:S0009-9260(24)00082-5. doi: 10.1016/j.crad.2024.
Abstract
Related articles
Response to 2 Induction Courses of Bacillus Calmette-Guerin Therapy Among
Patients With High-Risk Non-Muscle-Invasive Bladder Cancer: 5-year Follow-Up of a
Phase 2 Clinical Trial.
JAMA Oncol. 2024 Feb 15. doi: 10.1001/jamaoncol.2023.6804.
Abstract
Related articles
Plasmacytoid urothelial carcinoma with duodenal metastasis-A rare tumor with
unusual site of metastasis with grim outcome.
Indian J Pathol Microbiol. 2024;67:175-177.
Abstract
Related articles
Papillary urothelial neoplasm of low malignant potential with osseous metaplasia
in a 19-year-old chronic smoker: A case report with review of literature.
Indian J Pathol Microbiol. 2024;67:159-161.
Abstract
Related articles
Hesperetin Inhibits Bladder Cancer Cell Proliferation and Promotes Apoptosis and
Cycle Arrest by PI3K/AKT/FoxO3a and ER Stress-mitochondria Pathways.
Curr Med Chem. 2024 Feb 13. doi: 10.2174/0109298673283888231217174702.
Abstract
Related articles
Disulfidptosis characterizes the tumor microenvironment and predicts
immunotherapy sensitivity and prognosis in bladder cancer.
Heliyon. 2024;10:e25573.
Abstract
Related articles
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response
to immune checkpoint inhibitors in urothelial cancer.
Nat Commun. 2024;15:1349.
Abstract
Related articles
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in
SMARCB1-deficient bladder cancer.
Nat Commun. 2024;15:1373.
Abstract
Related articles
Low rate of severe-end-stage kidney disease after SABR for localised primary
kidney cancer.
Radiat Oncol. 2024;19:23.
Abstract
Related articles
Surgical proficiency in laparoscopic radical cystectomy with extracorporeal
urinary diversion and its adequacy for the execution of robot-assisted radical
cystectomy with intracorporeal urinary diversion.
Asian J Endosc Surg. 2024;17:e13289.
Abstract
Related articles
A Machine Learning Computational Framework Develops a Multiple Programmed Cell
Death Index for Improving Clinical Outcomes in Bladder Cancer.
Biochem Genet. 2024 Feb 14. doi: 10.1007/s10528-024-10683.
Abstract
Related articles
Experts' recommendations in laser use for the treatment of bladder cancer: a
comprehensive guide by the European Section of Uro-Technology (ESUT) and Training
and Research in Urological Surgery and Technology (TRUST)-Group.
World J Urol. 2024;42:79.
Abstract
Related articles
Homogeneous Polyporus polysaccharide exerts anti-bladder cancer effects via
autophagy induction.
Pharm Biol. 2024;62:214-221.
Abstract
Related articles
Laparoscopic vs. open surgical access radical cystectomy with subsequent
orthotopic reconstruction in the treatment of invasive urothelial carcinoma of
the bladder.
Folia Med (Plovdiv). 2023;65:894-901.
Abstract
Related articles
Polymorphisms in drug-metabolizing genes and urinary bladder cancer
susceptibility and prognosis: Possible impacts and future management.
Gene. 2024;907:148252.
Abstract
Related articles
A CT-based deep learning model predicts overall survival in patients with muscle
invasive bladder cancer after radical cystectomy: a multicenter retrospective
cohort study.
Int J Surg. 2024 Feb 13. doi: 10.1097/JS9.0000000000001194.
Abstract
Related articles
Analysis of progression after elective distal ureterectomy and effects of salvage
radical nephroureterectomy in patients with distal ureteral urothelial carcinoma.
Sci Rep. 2024;14:3497.
Abstract
Related articles
Validation of hyperthermia as an enhancer of chemotherapeutic efficacy: insights
from a bladder cancer organoid model.
Int J Hyperthermia. 2024;41:2316085.
Abstract
Related articles
Advances in diagnosis and treatment of bladder cancer.
BMJ. 2024;384:e076743.
Abstract
Related articles
Network pharmacology and in vitro experiments reveal sophoridine-induced
apoptosis and G(1) phase arrest via ROS-dependent PI3K/Akt/FoxO3a pathway
activation in human bladder cancer cells.
Chem Biol Drug Des. 2024;103:e14476.
Abstract
Related articles
[Radical cystectomy for bladder cancer is a complex procedure].
Lakartidningen. 2024;121:23132.
Abstract
Related articles
Comparison of Monopolar Versus Bipolar Repeat Transurethral Resection of
Bladder Tumours.
J Coll Physicians Surg Pak. 2024;34:230-234.
Abstract
Related articles
Multi-cohort validation of Ascore: an anoikis-based prognostic signature for
predicting disease progression and immunotherapy response in bladder cancer.
Mol Cancer. 2024;23:30.
Abstract
Related articles
Gemcitabine with cisplatin and nivolumab: Redefining standard of care for
first-line metastatic urothelial carcinoma?
Med. 2024;5:109-111.
Abstract
Related articles
Small Cajal Body-Specific RNA12 Promotes Carcinogenesis through Modulating
Extracellular Matrix Signaling in Bladder Cancer.
Cancers (Basel). 2024;16:483.
Abstract
Related articles
Transcriptome Analysis Reveals Anti-Cancer Effects of Isorhapontigenin (ISO) on
Highly Invasive Human T24 Bladder Cancer Cells.
Int J Mol Sci. 2024;25:1783.
Abstract
Related articles
The Urinary Microbiome in Health and Disease: Relevance for Bladder Cancer.
Int J Mol Sci. 2024;25:1732.
Abstract
Related articles
Mini-Review: Current Bladder Cancer Treatment-The Need for Improvement.
Int J Mol Sci. 2024;25:1557.
Abstract
Related articles
Inpatient Outcomes of Patients Undergoing Robot-Assisted versus Laparoscopic
Radical Cystectomy for Bladder Cancer: A National Inpatient Sample Database
Study.
J Clin Med. 2024;13:772.
Abstract
Related articles
TFRC, associated with hypoxia and immune, is a prognostic factor and potential
therapeutic target for bladder cancer.
Eur J Med Res. 2024;29:112.
Abstract
Related articles
The role of URO17(R) in diagnosis and follow up of bladder cancer patients.
BMC Urol. 2024;24:34.
Abstract
Related articles
The Prognostic Value of Tumor Infiltrating Lymphocytes After Radical Cystectomy
for Bladder Cancer: A Systematic Review and Meta-Analysis.
Clin Genitourin Cancer. 2024 Jan 17:S1558-7673(24)00009.
Abstract
Related articles
The impact of body mass index on survival endpoints among patients with
metastatic urothelial carcinoma undergoing treatment with immune checkpoint
inhibitors: A real-world multicenter analysis.
Cancer Med. 2024;13:e7008.
Abstract
Related articles
[Not Available].
Aktuelle Urol. 2024;55:24-25.
Abstract
Related articles
[Not Available].
Aktuelle Urol. 2024;55:22-23.
Abstract
Related articles
[Not Available].
Aktuelle Urol. 2024;55:18-20.
Abstract
Related articles
Aggressive prostatic adenocarcinoma with urothelial-like morphology, with
frequent CK7/CK20/HMWK expression and occasional diffuse neuroendocrine features:
A clinicopathologic study of 12 cases.
Pathol Res Pract. 2024;254:155105.
Abstract
Related articles
Is my patient with urothelial cancer (in)eligible for platinum?
Urol Oncol. 2024;42:27.
Abstract
Related articles
Enfortumab vedotin and pembrolizumab as new first-line standard for metastatic
urothelial cancer.
Med. 2024;5:106-108.
Abstract
Related articles
Brain metastasis of a urothelial neuroendocrine carcinoma: A double pitfall for
neuropathologists and DNA-methylation profiling.
Neuropathol Appl Neurobiol. 2024;50:e12951.
Abstract
Related articles
Postoperative recurrence detection using individualized circulating tumor DNA in
upper tract urothelial carcinoma.
Cancer Sci. 2024;115:529-539.
Abstract
Related articles
Preoperative C-reactive protein to albumin ratio as a novel prognostic biomarker
for the oncological outcomes of radical nephroureterectomy.
Urol Oncol. 2024;42:30.
Abstract
Related articles
Do Urine Cytology and FISH Analysis Have a Role in the Follow-Up Protocol of
Upper Tract Urothelial Carcinoma?
Clin Genitourin Cancer. 2024;22:98-105.
Abstract
Related articles
NECTIN-4 targeted theranostics for urothelial cancer: getting ready for
primetime?
Expert Rev Anticancer Ther. 2024;24.
Abstract
Related articles
Unlocking precision oncology with FGFR inhibition in urothelial carcinoma.
Ann Oncol. 2024;35:150-153.
Abstract
Related articles
Pemigatinib for metastatic or surgically unresectable urothelial carcinoma with
FGF/FGFR genomic alterations: final results from FIGHT-201.
Ann Oncol. 2024;35:200-210.
Abstract
Related articles
Novel MSH2 and TSC2 variants in a Chinese family with Lynch syndrome and their
synergistic impact in urothelial carcinoma.
Transl Res. 2024;265:26-35.
Abstract
Related articles
Quantitatively Lighting up the Spatial Organization of CD47/SIRPalpha Immune
Checkpoints on the Cellular Membrane with Single-Molecule Localization
Microscopy.
ACS Nano. 2023;17:21626-21638.
Abstract
Related articles
[Paraganglioma of the urinary bladder-a rare, but relevant differential
diagnosis].
Urologie. 2024;63:168-170.
Abstract
Related articles
Intra-arterial chemotherapy plus BCG, a promising combination adjuvant treatment
for high-risk NMIBC.
Urol Oncol. 2024;42:30.
Abstract
Related articles
Does neo-adjuvant chemotherapy improve the negative effect of lymphovascular
invasion in survival after radical cystectomy?
Urol Oncol. 2024;42:30.
Abstract
Related articles
Clinical Presentation and Targeted Interventions in Urachal Adenocarcinoma: A
Single-Institution Case Series and Review of Emerging Therapies.
Clin Genitourin Cancer. 2024;22:67-75.
Abstract
Related articles
Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence
and identifies responders to intravesical therapy.
Mol Oncol. 2024;18:291-304.
Abstract
Related articles
Systemic treatment of advanced and metastatic urothelial cancer: The landscape in
Australia.
Asia Pac J Clin Oncol. 2023;19:585-595.
Abstract
Related articles
Immunotherapy in the Treatment of Localized Genitourinary Cancers.
JAMA Oncol. 2023;9:1447-1454.
Abstract
Related articles
Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from
a single institution.
Clin Transl Oncol. 2024;26:682-688.
Abstract
Related articles
A SEER-Medicare Based Quality Score for Patients With Metastatic Upper Tract
Urothelial Carcinoma.
Clin Genitourin Cancer. 2024;22:14-22.
Abstract
Related articles
Phase II study of neoadjuvant chemotherapy with four cycles of dose-dense MVAC
followed by radical cystectomy in Korean patients with muscle-invasive or locally
advanced urothelial carcinoma of bladder.
Asia Pac J Clin Oncol. 2023;19:739-746.
Abstract
Related articles
Fremantle protocol: Multicenter clinical outcomes for a pragmatic protocol for
intravesical bacillus Calmette-Guerin.
Asia Pac J Clin Oncol. 2023;19:697-705.
Abstract
Related articles
Impact of bladder cancer family history on the prognosis of patients with
Non-Muscle Invasive bladder cancer Treated with Bacillus Calmette-Guerin (BCG).
Expert Opin Pharmacother. 2024 Feb 23. doi: 10.1080/14656566.2024.2323609.
Abstract
Related articles
Impacts of Neoadjuvant Chemotherapy on Perioperative Outcomes in Patients with
Bladder Cancer Treated with Radical Cystectomy: A Single High-Volume Center
Experience.
J Pers Med. 2024;14:212.
Abstract
Related articles
BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder
Cancer.
Curr Oncol. 2024;31:1063-1078.
Abstract
Related articles
Diagnostic Accuracy of Contrast-Enhanced Ultrasound (CEUS) in the Detection of
Muscle-Invasive Bladder Cancer: A Systematic Review and Diagnostic Meta-Analysis.
Curr Oncol. 2024;31:818-827.
Abstract
Related articles
Immune Cell Infiltration Types as Biomarkers for the Recurrence Diagnosis and
Prognosis of Bladder Cancer.
Cancer Invest. 2024 Feb 23:1-13. doi: 10.1080/07357907.2024.2308161.
Abstract
Related articles
The Added-value of Staging (18)F-FDG PET/CT in the Prediction of Overall Survival
in the Patients with Bladder Cancer.
Mol Imaging Radionucl Ther. 2024;33:11-18.
Abstract
Related articles
Reply to Shun-Fa Hung's Letter to the editor regarding the article "Clinical
impact of detrusor muscle in en bloc resection for T1 bladder cancer".
Urol Oncol. 2024 Feb 21:S1078-1439(24)00021.
Abstract
Related articles
Smoking characteristics and years since quitting smoking of US adults diagnosed
with lung and bladder cancer: A national health and nutrition examination survey
analysis.
Int Braz J Urol. 2024;50:199-208.
Abstract
Related articles
Urinary exosomal mRNA as a biomarker for the diagnosis of bladder cancer.
Anticancer Drugs. 2024 Feb 23. doi: 10.1097/CAD.0000000000001571.
Abstract
Related articles
METTL16 suppressed the proliferation and cisplatin-chemoresistance of bladder
cancer by degrading PMEPA1 mRNA in a m6A manner through autophagy pathway.
Int J Biol Sci. 2024;20:1471-1491.
Abstract
Related articles
UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT.
Int J Biol Sci. 2024;20:1389-1409.
Abstract
Related articles
A rare case of muscle invasive bladder cancer in a Vescical inguinal hernia.
Urol Case Rep. 2024;53:102673.
Abstract
Related articles
Pembrolizumab-induced myocarditis with complete atrioventricular block and
concomitant myositis in a metastatic bladder cancer patient: a case report and
review of the literature.
J Med Case Rep. 2024;18:107.
Abstract
Related articles
Urinary Exosomal miR-17-5p Accelerates Bladder Cancer Invasion by Repressing its
Target Gene ARID4B and Regulating the Immune Microenvironment.
Clin Genitourin Cancer. 2024 Jan 22:S1558-7673(24)00012.
Abstract
Related articles
Research progress of ICIS in the treatment of bladder cancer.
Panminerva Med. 2024 Feb 21. doi: 10.23736/S0031-0808.24.05102.
Abstract
Related articles
Independent prognostic value of CLDN6 in bladder cancer based on M2 macrophages
related signature.
iScience. 2024;27:109138.
Abstract
Related articles
Comparative survival analysis of bladder preservation therapy versus radical
cystectomy in muscle-invasive bladder cancer.
Cancer Med. 2024;13:e6972.
Abstract
Related articles
Vasohibin-1 Expression Can Predict Pathological Complete Remission of Advanced
Bladder Cancer with Neoadjuvant Chemotherapy.
Ann Surg Oncol. 2024 Feb 20. doi: 10.1245/s10434-024-15009.
Abstract
Related articles
Current Trends and Challenges of Microbiome Research in Bladder Cancer.
Curr Oncol Rep. 2024 Feb 20. doi: 10.1007/s11912-024-01508.
Abstract
Related articles
Clinical significance of blocking novel immune checkpoint B7-H4 in urothelial
carcinoma of bladder as a potential therapeutic target.
Med Oncol. 2024;41:74.
Abstract
Related articles
Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and
DNA Damage.
Anticancer Agents Med Chem. 2024;24:348-357.
Abstract
Related articles
Caregiver experiences of caring for family members with urostomy: a qualitative
study.
Support Care Cancer. 2024;32:167.
Abstract
Related articles
Targeting histone modifiers in bladder cancer therapy - preclinical and clinical
evidence.
Nat Rev Urol. 2024 Feb 19. doi: 10.1038/s41585-024-00857.
Abstract
Related articles
Prospective learning curve analysis of en bloc resection of bladder tumor using
an ex vivo porcine model.
BMC Surg. 2024;24:65.
Abstract
Related articles
HER2 Affects the Biological Behaviours of Bladder Cancer Cells and is Closely
Associated with the Progression and Prognosis of Bladder Cancer.
Arch Esp Urol. 2024;77:79-91.
Abstract
Related articles
Relationship between Changes of Serum Vascular Endothelial Growth Factor and
Folate Receptor-alpha Levels and Clinical Efficacy of Toripalimab in Patients with
Bladder Cancer.
Arch Esp Urol. 2024;77:31-37.
Abstract
Related articles
Current look at the most promising proteomic and glycomic biomarkers of bladder
cancer.
J Cancer Res Clin Oncol. 2024;150:96.
Abstract
Related articles
Comparison of narrow band imaging versus white light imaging in detecting non
muscle invasive bladder cancer.
Urologia. 2024 Feb 19:3915603241232115. doi: 10.1177/03915603241232115.
Abstract
Related articles
Shortened time to diagnosis for patients suspected of urinary bladder cancer
managed in a standardized care pathway was associated with an improvement in
tumour characteristics.
BJUI Compass. 2023;5:261-268.
Abstract
Related articles
Validation of non-muscle-invasive bladder cancer risk stratification updated in
the 2021 European Association of Urology guidelines.
BJUI Compass. 2023;5:269-280.
Abstract
Related articles
Exosome-mediated delivery of artificial circular RNAs for gene therapy of bladder
cancer.
J Cancer. 2024;15:1770-1778.
Abstract
Related articles
Prognostic and chemotherapeutic response prediction by proliferation essential
gene signature: Investigating POLE2 in bladder cancer progression and cisplatin
resistance.
J Cancer. 2024;15:1734-1749.
Abstract
Related articles
HES4 is a potential biomarker for bladder cancer: a Mendelian randomization
study.
J Cancer. 2024;15:1624-1641.
Abstract
Related articles
Feasibility analysis of arterial CT radiomics model to predict the risk of local
and metastatic recurrence after radical cystectomy for bladder cancer.
Discov Oncol. 2024;15:40.
Abstract
Related articles
Oridonin inhibits bladder cancer survival and immune escape by covalently
targeting HK1.
Phytomedicine. 2024;126:155426.
Abstract
Related articles
Occupational exposure to organic solvents and risk of bladder cancer.
J Expo Sci Environ Epidemiol. 2024 Feb 16. doi: 10.1038/s41370-024-00651.
Abstract
Related articles
Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN
protein degradation resulting from SNHG1 upregulation.
J Exp Clin Cancer Res. 2024;43:50.
Abstract
Related articles
Prediction of future research trends in bladder urothelial carcinoma:
Bibliometric analysis.
Medicine (Baltimore). 2024;103:e37176.
Abstract
Related articles
Targeting cancer-derived extracellular vesicles by combining CD147 inhibition
with tissue factor pathway inhibitor for the management of urothelial cancer
cells.
Cell Commun Signal. 2024;22:129.
Abstract
Related articles
Changes in the Perioperative Management and Outcomes of Patients With Upper Tract
Urothelial Carcinoma Undergoing Radical Nephroureterectomy at Memorial Sloan
Kettering Cancer Center: Over 20 Years of Experience.
Urol Pract. 2024;11:356-366.
Abstract
Related articles
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract.
Curr Treat Options Oncol. 2024;25:206-219.
Abstract
Related articles
Prognostic model development and molecular subtypes identification in bladder
urothelial cancer by oxidative stress signatures.
Aging (Albany NY). 2024;16:2591-2616.
Abstract
Related articles
Immunomodulatory effects and improved outcomes with cisplatin- versus
carboplatin-based chemotherapy plus atezolizumab in urothelial cancer.
Cell Rep Med. 2024;5:101393.
Abstract
Related articles
PD-L1 immunohistochemical expression in bladder urothelial cancer with SP263,
SP142 and 22C3 antibodies: A comparative study.
Ann Diagn Pathol. 2024;69:152267.
Abstract
Related articles
Untargeted metabolomics of bladder tissue using liquid chromatography and
quadrupole time-of-flight mass spectrometry for cancer biomarker detection.
J Pharm Biomed Anal. 2024;240:115966.
Abstract
Related articles
Effects of an intraoperative intravenous Bolus Dose of Dexmedetomidine on
postoperative catheter-related bladder discomfort in male patients undergoing
transurethral resection of bladder tumors: a randomized, double-blind, controlled
trial.
Eur J Clin Pharmacol. 2024;80:465-474.
Abstract
Related articles
Hybrid technique has lower stricture rates than Wallace and Bricker.
Surg Oncol. 2024;52:102036.
Abstract
Related articles
Screening DNA Damage in the Rat Kidney and Liver by Untargeted DNA Adductomics.
Chem Res Toxicol. 2024;37:340-360.
Abstract
Related articles
Early-Onset Asymptomatic Polypoid Cystitis in Two Adolescent Male Beagle Dogs.
Toxicol Pathol. 2023;51:357-360.
Abstract
Related articles
Glomerular filtration rate measurement during platinum treatment for urothelial
carcinoma: optimal methods for clinical practice.
Int J Clin Oncol. 2024;29:309-317.
Abstract
Related articles
Characterization of Cystoscopy Performance and Reporting Practices at Academic
Urology Centers.
Urol Pract. 2024;11:249-253.
Abstract
Related articles
Cancer mortality and premature deaths among hairdressers in Brazil.
Environ Res. 2024;244:117942.
Abstract
Related articles
Letter to the editor: Long-term survival after female pelvic organ-sparing
radical cystectomy versus standard radical cystectomy: a multi-institutional
propensity score-matched analysis.
Int J Surg. 2024;110:1289-1290.
Abstract
Related articles
MRI-based automated machine learning model for preoperative identification of
variant histology in muscle-invasive bladder carcinoma.
Eur Radiol. 2024;34:1804-1815.
Abstract
Related articles
Inhibition of TNF-alpha Oncogene Expression by Artemisia Annua L. Extract Against
Pioglitazone Side Effects in Male Albino Mice.
Mol Biotechnol. 2024;66:432-441.
Abstract
Related articles
Delayed diagnosis of bladder cancer in a patient with autosomal dominant
polycystic kidney disease.
J Cancer Res Ther. 2023;19.
Abstract
Related articles
Prognostic importance of PD-L1 expression in bladder cancer patients.
J Cancer Res Ther. 2023;19.
Abstract
Related articles
[Retracted] Human HLA?F adjacent transcript 10 promotes the formation of cancer
initiating cells and cisplatin resistance in bladder cancer.
Mol Med Rep. 2024;29:63.
Abstract
Related articles
Hydrogel: a new material for intravesical drug delivery after bladder cancer
surgery.
J Mater Chem B. 2024 Mar 1. doi: 10.1039/d3tb02837.
Abstract
Related articles
Inducing mitochondriopathy-like damages by transformable nucleopeptide
nanoparticles for targeted therapy of bladder cancer.
Natl Sci Rev. 2024;11:nwae028.
Abstract
Related articles
Comparative analysis of wound healing techniques in postoperative bladder cancer
patients.
Int Wound J. 2024;21:e14820.
Abstract
Related articles
Impact of sarcopenia on outcomes of bladder cancer undergoing radical cystectomy:
A systematic review and meta-analysis.
Scott Med J. 2024 Feb 29:369330241234690. doi: 10.1177/00369330241234690.
Abstract
Related articles
Excavatolide C/cisplatin combination induces antiproliferation and drives
apoptosis and DNA damage in bladder cancer cells.
Arch Toxicol. 2024 Feb 29. doi: 10.1007/s00204-024-03699.
Abstract
Related articles
Parkin inhibits proliferation and migration of bladder cancer via ubiquitinating
Catalase.
Commun Biol. 2024;7:245.
Abstract
Related articles
Development and experimental validation of an M2 macrophage and
platelet-associated gene signature to predict prognosis and immunotherapy
sensitivity in bladder cancer.
Cancer Sci. 2024 Feb 29. doi: 10.1111/cas.16113.
Abstract
Related articles
Neoadjuvant combination therapy (immunotherapy and chemotherapy) and
treatment-related biomarkers in upper tract urothelial carcinoma.
World J Urol. 2024;42:110.
Abstract
Related articles
Improvements in urinary symptoms, health-related quality of life, and
psychosocial distress in the early recovery period after radical cystectomy and
urinary diversion in 842 German bladder cancer patients: data from
uro-oncological rehabilitation.
World J Urol. 2024;42:111.
Abstract
Related articles
PPP3CB Inhibits Cell Proliferation and the Warburg Effect in Bladder Cancer by
Blocking PDHK1.
Front Biosci (Landmark Ed). 2024;29:48.
Abstract
Related articles
Ogilvie's Syndrome in a Male With Bladder Cancer.
Cureus. 2024;16:e55097.
Abstract
Related articles
Immune regulation and the tumor microenvironment in anti-PD-1/PDL-1 and
anti-CTLA-4 therapies for cancer immune evasion: A bibliometric analysis.
Hum Vaccin Immunother. 2024;20:2318815.
Abstract
Related articles
Prostate Biopsy May Not Be Indicated Early after Bacillus Calmette Guerin
Treatment.
Acta Med Okayama. 2024;78:9-13.
Abstract
Related articles
Survivin as a potential biomarker in the diagnosis of bladder cancer: A
systematic review and meta-analysis.
Urol Oncol. 2024 Feb 27:S1078-1439(24)00019.
Abstract
Related articles
Efficacy of Platinum-based Chemotherapy in Patients With Metastatic Urothelial
Carcinoma With Variant Histology.
In Vivo. 2024;38:873-880.
Abstract
Related articles
Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer.
Biomed Pharmacother. 2024;173:116312.
Abstract
Related articles
Unraveling the Dietary Puzzle: Exploring the Influence of Diet, Nutraceuticals,
and Supplements on Bladder Cancer Risk, Outcomes, and Immunotherapy Efficacy:
Insights from the BLOSSOM Study and Beyond.
Oncol Ther. 2024 Feb 28. doi: 10.1007/s40487-024-00266.
Abstract
Related articles
Immunohistochemical Expression of Claudin-1 and Claudin-4 in Urothelial Carcinoma
of the Urinary Bladder.
Asian Pac J Cancer Prev. 2024;25:637-646.
Abstract
Related articles
LncRNA HCP5 Promotes Cell Invasion and Migration by Sponging miR-29b-3p in Human
Bladder Cancer [Retraction].
Onco Targets Ther. 2024;17:159-160.
Abstract
Related articles
Systematic review comparing uretero-enteric stricture rates between open
cystectomy with ileal conduit, robotic cystectomy with extra-corporeal ileal
conduit and robotic cystectomy with intra corporeal ileal conduit formation.
J Robot Surg. 2024;18:100.
Abstract
Related articles
Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or
advanced urothelial carcinoma.
Clin Transl Sci. 2024;17:e13730.
Abstract
Related articles
Exploration of potential biomarkers for early bladder cancer based on urine
proteomics.
Front Oncol. 2024;14:1309842.
Abstract
Related articles
Comprehensive analysis of mitochondria-related genes indicates that PPP2R2B is a
novel biomarker and promotes the progression of bladder cancer via Wnt signaling
pathway.
Biol Direct. 2024;19:17.
Abstract
Related articles
Vagococcus fluvialis isolation from the urine of a bladder cancer patient: a case
report.
BMC Infect Dis. 2024;24:261.
Abstract
Related articles
Outcomes of a Dietary Intervention to Reduce Bladder Cancer Recurrence and
Progression in Survivors of Non-Muscle-Invasive Bladder Cancer.
J Natl Compr Canc Netw. 2024 Feb 26:1-9. doi: 10.6004/jnccn.2023.7086.
Abstract
Related articles
Letter to the editor for the article "Prognostic factors of intravesical
recurrence after radical nephroureterectomy for upper tract urothelial
carcinoma".
World J Urol. 2024;42:101.
Abstract
Related articles
DaBlaCa-17: nationwide observational study in Denmark on survival before and
after implementation of neoadjuvant chemotherapy prior to cystectomy for
muscle-invasive bladder cancer.
Scand J Urol. 2024;59:39-46.
Abstract
Related articles
Simulation of the effects of molecular urine markers in follow-up of patients
with high-risk non-muscle invasive bladder cancer.
Urol Oncol. 2024 Feb 24:S1078-1439(24)00041.
Abstract
Related articles
Integration of CD4(+) T cells and molecular subtype predicts benefit from PD-L1
blockade in muscle-invasive bladder cancer.
Cancer Sci. 2024 Feb 25. doi: 10.1111/cas.16119.
Abstract
Related articles
JAM3 is a potential risk biomarker for predicting prognosis and immune cell
infiltration by regulating epithelial-mesenchymal transition in bladder cancer.
Biomol Biomed. 2024 Feb 23. doi: 10.17305/bb.2024.9979.
Abstract
Related articles
Bladder Cancer: Immunotherapy and Pelvic Lymph Node Dissection.
Vaccines (Basel). 2024;12:150.
Abstract
Related articles
Complications Subsequent to Urinary Tract Stent Placement: An Overview Focusing
on the Imaging of Cancer Patients.
Medicina (Kaunas). 2024;60:338.
Abstract
Related articles
New Perspectives on the Role of Liquid Biopsy in Bladder Cancer: Applicability to
Precision Medicine.
Cancers (Basel). 2024;16:803.
Abstract
Related articles
Urine-Based Biomarker Test Uromonitor((R)) in the Detection and Disease Monitoring
of Non-Muscle-Invasive Bladder Cancer-A Systematic Review and Meta-Analysis of
Diagnostic Test Performance.
Cancers (Basel). 2024;16:753.
Abstract
Related articles
Interleukin-1beta/Interleukin (IL)-1-Receptor-Antagonist (IL1-RA) Axis in Invasive
Bladder Cancer-An Exploratory Analysis of Clinical and Tumor Biological
Significance.
Int J Mol Sci. 2024;25:2447.
Abstract
Related articles
The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical
Outcomes in Bladder Cancer.
Int J Mol Sci. 2024;25:2178.
Abstract
Related articles
Progress of Multiparameter Magnetic Resonance Imaging in Bladder Cancer: A
Comprehensive Literature Review.
Diagnostics (Basel). 2024;14:442.
Abstract
Related articles
N(6)-methyladenosine-modified circ_104797 sustains cisplatin resistance in
bladder cancer through acting as RNA sponges.
Cell Mol Biol Lett. 2024;29:28.
Abstract
Related articles
Pan-cancer analysis reveals potential immunological and prognostic roles of COA6
in human cancers and preliminary exploration of COA6 in bladder cancer.
Cell Signal. 2024;117:111111.
Abstract
Related articles
Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients
with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A
Multicenter Retrospective Study.
Curr Oncol. 2024;31:862-871.
Abstract
Related articles
Real-World Insights into Efficacy and Safety of Enfortumab Vedotin in Japanese
Patients with Metastatic Urothelial Carcinoma: Findings, Considerations, and
Future Directions.
Curr Oncol. 2024;31:759-768.
Abstract
Related articles
A Real-World Retrospective Analysis of the Management of Advanced Urothelial
Carcinoma in Canada.
Curr Oncol. 2024;31:704-722.
Abstract
Related articles
Sacituzumab govitecan plus platinum-based chemotherapy mediates significant
antitumor effects in triple-negative breast, urinary bladder, and small-cell lung
carcinomas.
Oncotarget. 2024;15:144-158.
Abstract
Related articles
Applicability and feasibility of robot-assisted cystectomy and intracorporeal
urinary diversion in a patient with right renal pelvic ectopia.
Int Braz J Urol. 2024;50:227-228.
Abstract
Related articles
Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic
Responses in Platinum-refractory Urothelial Carcinoma.
Cancer Res Commun. 2024;4:530-539.
Abstract
Related articles
[Histomolecular classification of urothelial carcinoma of the urinary bladder :
From histological phenotype to genotype and back].
Pathologie (Heidelb). 2024;45:106-114.
Abstract
Related articles
PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract
Cancers.
PET Clin. 2024;19:197-206.
Abstract
Related articles
The JAVELIN Bladder Medley trial: avelumab-based combinations as first-line
maintenance in advanced urothelial carcinoma.
Future Oncol. 2024;20:179-190.
Abstract
Related articles
POLQ identifies a better response subset to immunotherapy in muscle-invasive
bladder cancer with high PD-L1.
Cancer Med. 2024;13:e6962.
Abstract
Related articles
Mineralocorticoid receptor signaling inhibits bladder cancer progression.
Am J Cancer Res. 2024;14:696-708.
Abstract
Related articles
TM9SF1 promotes bladder cancer cell growth and infiltration.
World J Clin Oncol. 2024;15:302-316.
Abstract
Related articles
TM9SF1 is implicated in promoting the proliferation and invasion of bladder
cancer cells.
World J Clin Oncol. 2024;15:175-177.
Abstract
Related articles
The role of microbiota in tumorigenesis, progression and treatment of bladder
cancer.
Microbiome Res Rep. 2023;3:5.
Abstract
Related articles
The relationship between income, health insurance, and employment status as
prognostic indicators of bladder cancer: a survival analysis.
Arch Ital Urol Androl. 2024 Mar 7:12305. doi: 10.4081/aiua.2024.12305.
Abstract
Related articles
Prospective evaluation of sexual health following radical cystectomy due to
bladder cancer.
Sex Med. 2024;12:qfae005.
Abstract
Related articles
[Bladder Cancer Detected Incidentally by Cystoscopy before Radical
Prostatectomy].
Hinyokika Kiyo. 2024;70:39-43.
Abstract
Related articles
Enfortumab Vedotin and Pembrolizumab - A New Perspective on Urothelial Cancer.
N Engl J Med. 2024;390:944-946.
Abstract
Related articles
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
N Engl J Med. 2024;390:875-888.
Abstract
Related articles
Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune
Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
JAMA Netw Open. 2024;7:e241215.
Abstract
Related articles
LncRNA XIST promotes bladder cancer progression by modulating miR-129-5p/TNFSF10
axis.
Discov Oncol. 2024;15:65.
Abstract
Related articles
A bibliometric insight into neoadjuvant chemotherapy in bladder cancer: trends,
collaborations, and future avenues.
Front Immunol. 2024;15:1297542.
Abstract
Related articles
The potential mechanism of ursolic acid in the treatment of bladder cancer based
on network pharmacology and molecular docking.
J Int Med Res. 2024;52:3000605241234006.
Abstract
Related articles
Taraxasterol enhanced bladder cancer cells radiosensitivity via inhibiting the
COX-2/PGE2/JAK2/STAT3/MMP pathway.
Int J Radiat Biol. 2024 Mar 5:1-11. doi: 10.1080/09553002.2024.2324475.
Abstract
Related articles
Tectoridin inhibits the growth of bladder cancer by regulating PI3K/MAPK pathway
through RAB27B.
Mol Carcinog. 2024 Mar 5. doi: 10.1002/mc.23712.
Abstract
Related articles
Metastatic small cell bladder cancer treated with sequential systemic therapy
including pembrolizumab and amrubicin: A case report.
IJU Case Rep. 2023;7:127-130.
Abstract
Related articles
An Atlas of Dietary Intakes and Medication Uses on Risk of Bladder Cancer: A
Wide-Angle Mendelian Randomization Analysis.
Nutr Cancer. 2024 Mar 5:1-10. doi: 10.1080/01635581.2024.2324504.
Abstract
Related articles
Intravesical sequential gemcitabine/docetaxel for non-muscle invasive bladder
cancer: tips and tricks for better efficacy and tolerability.
J Chemother. 2024 Mar 4:1-4. doi: 10.1080/1120009X.2024.2325765.
Abstract
Related articles
Bioinformatics analysis and experimental validation reveal that CDC20
overexpression promotes bladder cancer progression and potential underlying
mechanisms.
Genes Genomics. 2024 Mar 4. doi: 10.1007/s13258-024-01505.
Abstract
Related articles
A phase 2 pilot study of water irrigation after transurethral resection of
bladder tumor (WATIP) demonstrating safety, feasibility and activity.
World J Urol. 2024;42:115.
Abstract
Related articles
Establishment of bladder cancer spheroids and cultured in microfluidic platform
for predicting drug response.
Bioeng Transl Med. 2023;9:e10624.
Abstract
Related articles
Causal association of smoking, blood lipids, and bladder cancer: Insights from a
multivariable and mediation mendelian randomization investigation.
J Cancer. 2024;15:1929-1939.
Abstract
Related articles
Discovery of anticancer function of Febrifugine: Inhibition of cell
proliferation, induction of apoptosis and suppression steroid synthesis in
bladder cancer cells.
Toxicol Appl Pharmacol. 2024;484:116878.
Abstract
Related articles
Recurrent Bacteriuria as a Prognosis Marker in the Adjuvant Treatment of
Non-Muscle Invasive Bladder Cancer.
Clin Genitourin Cancer. 2024;22:102048.
Abstract
Related articles
Development of a prognostic model for muscle-invasive bladder cancer using
glutamine metabolism.
Comput Biol Med. 2024;171:108223.
Abstract
Related articles
Integrating molecular subtype and CD8(+) T cells infiltration to predict
treatment response and survival in muscle-invasive bladder cancer.
Cancer Immunol Immunother. 2024;73:66.
Abstract
Related articles
Construction of endothelial cell signatures for predicting the diagnosis,
prognosis and immunotherapy response of bladder cancer via machine learning.
J Cell Mol Med. 2024;28:e18155.
Abstract
Related articles
A Bayesian Bernoulli-Exponential joint model for binary longitudinal outcomes and
informative time with applications to bladder cancer recurrence data.
BMC Med Res Methodol. 2024;24:54.
Abstract
Related articles
The role of neoadjuvant chemotherapy for patients with variant histology muscle
invasive bladder cancer undergoing robotic cystectomy: Data from the
International Robotic Cystectomy Consortium.
Urol Oncol. 2024 Feb 29:S1078-1439(24)00002.
Abstract
Related articles
Nicotinamide phosphoribosyltransferase modulates PD-L1 in bladder cancer and
enhances immunotherapeutic sensitivity.
Biochim Biophys Acta Mol Basis Dis. 2024 Feb 28:167106.
Abstract
Related articles
Mild magnetic hyperthermia-activated immuno-responses for primary bladder cancer
therapy.
Biomaterials. 2024;307:122514.
Abstract
Related articles
Oncologic surveillance intensity after endoscopic treatment of upper tract
urothelial carcinoma.
Minerva Urol Nephrol. 2024;76:88-96.
Abstract
Related articles
Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract
Urothelial Carcinoma.
Cancer Genomics Proteomics. 2024;21:137-143.
Abstract
Related articles
Practical Guide to VI-RADS: MRI Protocols, Lesion Characterization, and Pitfalls.
Radiographics. 2024;44:e230149.
Abstract
Related articles
Invited Commentary: VI-RADS and Routing Patient Care at the Muscularis Propria.
Radiographics. 2024;44:e230234.
Abstract
Related articles
Diminution of Primary Cilia in the Stromal Cells at the Tumor-stromal Interface
Correlates With an Aggressive Tumor Biology in the Urothelial Carcinoma of the
Urinary Bladder.
Appl Immunohistochem Mol Morphol. 2024;32:130-136.
Abstract
Related articles
Secondary bladder and colorectal cancer after treatments for prostate cancer: A
population based study.
Cancer Med. 2024;13:e6922.
Abstract
Related articles
Intragenic Rearrangement Burden Associates with Immune Cell Infiltration and
Response to Immune Checkpoint Blockade in Cancer.
Cancer Immunol Res. 2024;12:287-295.
Abstract
Related articles
Urine cytology in the detection of renal cell carcinomas - a territory-wide
multi-institutional retrospective review of more than 2 decades.
Cancer Cytopathol. 2024;132:186-192.
Abstract
Related articles
Paradigm Shifting Research: Key Studies in Urologic Oncology.
Ann Surg Oncol. 2024;31:2529-2537.
Abstract
Related articles
Landscape and Saturation Analysis of Mutations Associated With Race in Cancer
Genomes by Clinical Sequencing.
Oncologist. 2024;29:219-226.
Abstract
Related articles
Prognostic Impact of Preoperative Thrombocytosis on Recurrence-Free Survival in
Patients with Upper Tract Urothelial Carcinoma.
Ann Surg Oncol. 2024;31:2538-2544.
Abstract
Related articles
A comparison between conventional and the Paris systems of reporting urinary
cytopathology with a literature update.
Diagn Cytopathol. 2024;52:187-199.
Abstract
Related articles
Label-free screening of common urinary system tumors from blood plasma based on
surface-enhanced Raman spectroscopy.
Photodiagnosis Photodyn Ther. 2024;45:103900.
Abstract
Related articles
Sensitivity of urine cytology in detecting high-grade urothelial carcinoma in
patients with neoplastic urinary bladder diverticula: A major cancer center
experience.
Cancer Cytopathol. 2024;132:144-151.
Abstract
Related articles
Plain language summary of erdafitinib in locally advanced or metastatic
urothelial carcinoma: a phase 2 study with long-term follow-up.
Future Oncol. 2024;20:231-243.
Abstract
Related articles
Evaluating Oncologists' Practice Patterns and Decision-Making in Locally Advanced
or Metastatic Urothelial Carcinoma: The US Physician PARADIGM Study.
Oncologist. 2024;29:244-253.
Abstract
Related articles
BCGitis with aortoiliac aneurysm involvement: Report of two cases and review of
the literature.
Enferm Infecc Microbiol Clin (Engl Ed). 2024;42:152-157.
Abstract
Related articles
A prognostic risk prediction model based on ferroptosis-related long non-coding
RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation:
Erratum.
Medicine (Baltimore). 2024;103:e37547.
Abstract
Related articles
Effectiveness of integrated nursing interventions in enhancing patient outcomes
during postoperative intravesical instillation for non-muscle invasive bladder
cancer: A comparative study.
Medicine (Baltimore). 2024;103:e36871.
Abstract
Related articles
Establishment and validation of nomograms to predict the overall survival and
cancer-specific survival for non-metastatic bladder cancer patients: A large
population-based cohort study and external validation.
Medicine (Baltimore). 2024;103:e37492.
Abstract
Related articles
Securinine inhibits the tumor growth of human bladder cancer cells by suppressing
Wnt/beta-catenin signaling pathway and activating p38 and JNK signaling pathways.
Biochem Pharmacol. 2024 Mar 12:116125. doi: 10.1016/j.bcp.2024.116125.
Abstract
Related articles
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder
urothelial carcinoma.
Pathologica. 2024;116:55-61.
Abstract
Related articles
Identification and verification of anoikis-related gene markers to predict the
prognosis of patients with bladder cancer and assist in the diagnosis and
treatment of bladder cancer.
Transl Cancer Res. 2024;13:579-593.
Abstract
Related articles
Transcriptome-wide 1-methyladenosine functional profiling of messenger RNA and
long non-coding RNA in bladder cancer.
Front Genet. 2024;15:1333931.
Abstract
Related articles
Prediction of Ki-67 expression in bladder cancer based on CT radiomics nomogram.
Front Oncol. 2024;14:1276526.
Abstract
Related articles
Reliable prognostic definition and immunotherapy response prediction in bladder
cancer, based on a novel aging-associated 5-gene signature model.
Transl Androl Urol. 2024;13:193-208.
Abstract
Related articles
Understanding bladder cancer by genome-wide association studies.
Transl Androl Urol. 2024;13:363-365.
Abstract
Related articles
A narrative review of management of muscle-invasive bladder cancer perioperative
period: will continuous and combined treatment be the new trend?
Transl Androl Urol. 2024;13:293-307.
Abstract
Related articles
Patient experience of bladder cancer: A data linkage study.
BJUI Compass. 2024;5:382-388.
Abstract
Related articles
The mechanism of PFK-1 in the occurrence and development of bladder cancer by
regulating ZEB1 lactylation.
BMC Urol. 2024;24:59.
Abstract
Related articles
Alignment of molecular subtypes across multiple bladder cancer subtyping
classifiers.
Urol Oncol. 2024 Mar 12:S1078-1439(24)00043.
Abstract
Related articles
Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder
cancer based on site and number of metastases.
Urol Oncol. 2024 Mar 12:S1078-1439(24)00337.
Abstract
Related articles
Amplification-Free Analysis of Bladder Cancer MicroRNAs on Wrinkled Silica
Nanoparticles with DNA-Functionalized Quantum Dots.
Anal Chem. 2024 Mar 13. doi: 10.1021/acs.analchem.3c05204.
Abstract
Related articles
Perioperative chemotherapy in bladder cancer: the more cisplatin, the best
survival?
World J Urol. 2024;42:140.
Abstract
Related articles
Prognostic value of micrometric substaging in pT1 bladder cancer patients treated
with en-bloc transurethral resection.
Histopathology. 2024 Mar 13. doi: 10.1111/his.15177.
Abstract
Related articles
Serum EZH2 is a novel biomarker for bladder cancer diagnosis and prognosis.
Front Oncol. 2024;14:1303918.
Abstract
Related articles
Sulforaphane Inhibits Adhesion and Migration of Cisplatin- and
Gemcitabine-Resistant Bladder Cancer Cells In Vitro.
Nutrients. 2024;16:623.
Abstract
Related articles
Circular STAG2 RNA Modulates Bladder Cancer Progression via miR-145-5p/TAGLN2 and
Is Considered as a Biomarker for Recurrence.
Cancers (Basel). 2024;16:978.
Abstract
Related articles
Tumor Predisposing Post-Zygotic Chromosomal Alterations in Bladder
Cancer-Insights from Histologically Normal Urothelium.
Cancers (Basel). 2024;16:961.
Abstract
Related articles
Effect of Clinical Complete Remission Following Neoadjuvant Pembrolizumab or
Chemotherapy in Bladder-Preservation Strategy in Patients with Muscle-Invasive
Bladder Cancer Declining Definitive Local Therapy.
Cancers (Basel). 2024;16:894.
Abstract
Related articles
Hypermethylation Loci of ZNF671, IRF8, and OTX1 as Potential Urine-Based
Predictive Biomarkers for Bladder Cancer.
Diagnostics (Basel). 2024;14:468.
Abstract
Related articles
Bladder-sparing treatment using tislelizumab combined with gemcitabine/cisplatin
in selected patients with muscle-invasive bladder cancer: a real-world study.
Clin Transl Oncol. 2024 Mar 12. doi: 10.1007/s12094-024-03400.
Abstract
Related articles
Identification of RNA methylation-related lncRNAs for prognostic assessment and
immunotherapy in bladder cancer-based on single cell/Bulk RNA sequencing data.
Funct Integr Genomics. 2024;24:56.
Abstract
Related articles
Oncopig bladder cancer cells recapitulate human bladder cancer treatment
responses in vitro.
Front Oncol. 2024;14:1323422.
Abstract
Related articles
The mechanism of resistance to CDK4/6 inhibition and novel combination therapy
with RNR inhibition for chemo-resistant bladder cancer.
Cancer Commun (Lond). 2024 Mar 11. doi: 10.1002/cac2.12532.
Abstract
Related articles
Survival and clinicopathological significance of B7-H3 in bladder cancer: a
systematic review and meta-analysis.
BMC Urol. 2024;24:57.
Abstract
Related articles
A first-in-class TIMM44 blocker inhibits bladder cancer cell growth.
Cell Death Dis. 2024;15:204.
Abstract
Related articles
Efficacy and tolerability of bacillus Calmette-Guerin strain Russia for the
treatment of non-muscle-invasive bladder cancer: Analysis of a prospective
registry.
Can Urol Assoc J. 2024 Mar 1. doi: 10.5489/cuaj.8552.
Abstract
Related articles
Long-term survival after volatile or propofol general anesthesia for bladder
cancer surgery: a retrospective national registry cohort study.
Anesthesiology. 2024 Mar 11. doi: 10.1097/ALN.0000000000004969.
Abstract
Related articles
Targeted Delivery of Catalase and Photosensitizer Ce6 by a Tumor-Specific Aptamer
Is Effective against Bladder Cancer In Vivo.
Mol Pharm. 2024 Mar 11. doi: 10.1021/acs.molpharmaceut.3c01047.
Abstract
Related articles
Comprehensive analysis indicated that NDE1 is a potential biomarker for
pan-cancer and promotes bladder cancer progression.
Cancer Med. 2024;13:e6931.
Abstract
Related articles
Urinary mutagenicity and bladder cancer risk in northern New England.
Environ Mol Mutagen. 2024 Mar 11. doi: 10.1002/em.22588.
Abstract
Related articles
Hyperoside induces cell cycle arrest and suppresses tumorigenesis in bladder
cancer through the interaction of EGFR-Ras and Fas signaling pathways.
Int J Med Sci. 2024;21:690-702.
Abstract
Related articles
Membrane-associated RING-CH 7 inhibits stem-like capacities of bladder cancer
cells by interacting with nucleotide-binding oligomerization domain containing 1.
Cell Biosci. 2024;14:32.
Abstract
Related articles
LRP1 induces anti-PD-1 resistance by modulating the DLL4-NOTCH2-CCL2 axis and
redirecting M2-like macrophage polarisation in bladder cancer.
Cancer Lett. 2024 Mar 8:216807. doi: 10.1016/j.canlet.2024.216807.
Abstract
Related articles
A first-in-class beta-glucuronidase responsive conjugate for selective dual targeted
and photodynamic therapy of bladder cancer.
Eur J Med Chem. 2024;269:116283.
Abstract
Related articles
Bladder-cancer-derived exosomal circRNA_0013936 promotes suppressive immunity by
up-regulating fatty acid transporter protein 2 and down-regulating
receptor-interacting protein kinase 3 in PMN-MDSCs.
Mol Cancer. 2024;23:52.
Abstract
Related articles
FGFR inhibitors in urothelial cancer: Contextualizing THOR within the new
treatment landscape.
Med. 2024;5:176-178.
Abstract
Related articles
[Multiple Pulmonary Metastases Seven Years After Transurethral Bladder Tumor
Resection for Non-muscle Invasion Bladder Cancer:Report of a Case].
Kyobu Geka. 2024;77:155-159.
Abstract
Related articles
The Role of Radical Cystectomy in Clinically Node Positive Bladder Cancer: A US
Veterans Health Administration Study.
Clin Genitourin Cancer. 2024 Feb 15:102055. doi: 10.1016/j.clgc.2024.
Abstract
Related articles
Development of a prognostic model for long-term survival of young patients with
bladder cancer: a retrospective analysis of the SEER Database.
BMJ Open. 2024;14:e080092.
Abstract
Related articles
SRT1720 inhibits bladder cancer cell progression by impairing autophagic flux.
Biochem Pharmacol. 2024;222:116111.
Abstract
Related articles
Unraveling a hidden player in lymphovascular invasion in bladder cancer.
Cancer Cell. 2024 Mar 6:S1535-6108(24)00051-5. doi: 10.1016/j.ccell.2024.
Abstract
Related articles
Reconstruction of a large scalp defect secondary to a rare cutaneous metastasis
from urothelial bladder carcinoma using intact fish skin xenografts.
J Wound Care. 2024;33.
Abstract
Related articles
Dysregulation and antimetastatic function of circLRIG1 modulated by
miR-214-3p/LRIG1 axis in bladder carcinoma.
Biol Direct. 2024;19:20.
Abstract
Related articles
Shame in patients undergoing ureterostomy: A cross-sectional survey.
Int Wound J. 2024;21:e14793.
Abstract
Related articles
A systematic review and meta-analysis of the anti-tumor effects of Paeoniae Radix
Rubra in animal models.
J Ethnopharmacol. 2024;326:117987.
Abstract
Related articles
Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic
biomarker.
Cell Signal. 2024;117:111107.
Abstract
Related articles
Mortality and cancer incidence in perfluorooctanesulfonyl fluoride production
workers.
Am J Ind Med. 2024;67:321-333.
Abstract
Related articles
Utility of The Paris System (TPS) for upper urinary tract cytopathology:
correlation with histology follow-up and UroVysion fluorescence in situ
hybridization (FISH) analysis.
J Am Soc Cytopathol. 2024;13:149-155.
Abstract
Related articles
Reply to Khurshid R. Ghani's letter to editor regarding the article "Early
experience with UGN-101 for the treatment of upper tract urothelial cancer: a
multicenter evaluation of practice patterns and outcomes".
Urol Oncol. 2024;42:36.
Abstract
Related articles
Reason for euthanasia in dogs with urothelial carcinoma treated with chemotherapy
or radiation therapy or both: A retrospective observational study.
J Vet Intern Med. 2024;38:1127-1134.
Abstract
Related articles
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With
Metastatic Urothelial Carcinoma Requiring Treatment Interruption or
Discontinuation Due to Immune-Related Adverse Events.
Clin Genitourin Cancer. 2024;22:368-379.
Abstract
Related articles
Prognostic Significance of Lymph Node Density in Pathological Node Positive
Urothelial Carcinoma of the Bladder -Upfront Surgery and Post Neoadjuvant
Chemotherapy Cohorts.
Clin Genitourin Cancer. 2024;22:385-393.
Abstract
Related articles
Bladder-Preserving Trimodality Therapy With Capecitabine.
Clin Genitourin Cancer. 2024;22:476-482.
Abstract
Related articles
Management of Metastatic Urothelial Carcinoma in Emerging Markets (EM): An Expert
Opinion.
Clin Genitourin Cancer. 2024;22:467-475.
Abstract
Related articles
Comprehensive Evaluation of the Ability of Comorbidity and Health Status Indices
to Improve the Prediction of Perioperative Morbidity and Long-Term Survival
Outcomes After Radical Cystectomy.
Clin Genitourin Cancer. 2024;22:336-346.
Abstract
Related articles
Circulating Basophils as a Prognostic Marker for Response to Bacillus
Calmette-Guerin.
Clin Genitourin Cancer. 2024;22:354-359.
Abstract
Related articles
TGFB1I1 promotes cell proliferation and migration in urothelial carcinoma.
Kaohsiung J Med Sci. 2024;40:269-279.
Abstract
Related articles
First-line Management of Metastatic Urothelial Cancer: Current and Future
Perspectives After the EV-302 and CheckMate-901 Studies.
Clin Genitourin Cancer. 2024;22:330-335.
Abstract
Related articles
Efficacy of the Addition of Robot-assisted Radical Cystectomy with Extracorporeal
Urinary Diversion after an Enhanced Recovery Protocol.
Urol J. 2024;21:40-46.
Abstract
Related articles
Survival impact of variant histology in patients with upper tract urothelial
carcinoma after radical nephroureterectomy.
Urol Oncol. 2024;42:69.
Abstract
Related articles
RAS Family Gene Mutations, Clinicopathological Features, and Spread Patterns of
Inverted Urothelial Papilloma of the Bladder.
Am J Surg Pathol. 2024;48:458-464.
Abstract
Related articles
Prognostic impact of radiological tumor burden in patients with metastatic
urothelial carcinoma treated with pembrolizumab.
Urol Oncol. 2024;42:70.
Abstract
Related articles
Central Nervous System Disease Progression Among Patients With Metastatic
Urothelial Carcinoma Treated With Enfortumab Vedotin: A Case Series.
Clin Genitourin Cancer. 2024;22:315-321.
Abstract
Related articles
Latest evidence on clinical outcomes and prognostic factors of advanced
urothelial carcinoma in the era of immune checkpoint inhibitors: a narrative
review.
Jpn J Clin Oncol. 2024;54:254-264.
Abstract
Related articles
Prognostic Impact of the Modified 5-Item Frailty Index After Radical
Nephroureterectomy in Patients With Upper Tract Urothelial Carcinoma: A
Multicenter Retrospective Study.
Clin Genitourin Cancer. 2024;22:322-329.
Abstract
Related articles
Clinical analysis of small-cell carcinoma of the urinary bladder: A case report
and review of literature.
Asian J Surg. 2024;47:1602-1603.
Abstract
Related articles
Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint
inhibitors for advanced urothelial carcinoma: response, survival and safety
analysis from a multicentre real-world Japanese cohort.
Jpn J Clin Oncol. 2024;54:329-338.
Abstract
Related articles
Sex Does Not Affect Survival: A Propensity Score-Matched Comparison in a
Homogenous Contemporary Radical Cystectomy Cohort.
Clin Genitourin Cancer. 2024;22:171-180.
Abstract
Related articles
Impact of Neoadjuvant Chemotherapy on Pathologic Downstaging in Patients With
Variant Histology Undergoing Radical Cystectomy.
Clin Genitourin Cancer. 2024;22:157-163.
Abstract
Related articles
A plain language summary exploring a new treatment combination for untreated
locally advanced or metastatic urothelial cancer: enfortumab vedotin plus
pembrolizumab.
Future Oncol. 2024;20:351-360.
Abstract
Related articles
Literature analysis of cutaneous adverse reactions induced by tislelizumab.
Cutan Ocul Toxicol. 2024;43:52-57.
Abstract
Related articles
Advanced Age Impacts Survival After Radical Nephroureterectomy for Upper Tract
Urothelial Carcinoma.
Clin Genitourin Cancer. 2024;22:27-37.
Abstract
Related articles
Biparametric versus Multiparametric Magnetic Resonance Imaging for Assessing
Muscle Invasion in Bladder Urothelial Carcinoma with Variant Histology Using the
Vesical Imaging-Reporting and Data System.
Eur Urol Focus. 2024;10:131-138.
Abstract
Related articles
A Nomogram of MRI Features to Assess Muscle Invasion in VI-RADS 2 Tumors With
Stalk.
J Magn Reson Imaging. 2023 Aug 21. doi: 10.1002/jmri.28924.
Abstract
Related articles
Editorial for "A Nomogram of MRI Features to Assess Muscle Invasion in VI-RADS 2
Tumors With Stalk".
J Magn Reson Imaging. 2023 Aug 9. doi: 10.1002/jmri.28922.
Abstract
Related articles
Survival of Patients with Chronic Kidney Disease Treated with Radical Cystectomy
and Risk Factors of Glomerular Filtration Rate Loss Following Radical Cystectomy:
Two Systematic Reviews and Meta-analyses of Interplay Between Radical Cystectomy
and Ren
Eur Urol Focus. 2024;10:169-181.
Abstract
Related articles
Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance
in bladder cancer through operating a broad spectrum of cellular processes and
signaling mechanism.
Noncoding RNA Res. 2024;9:560-582.
Abstract
Related articles
Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and
presents therapeutic possibilities in an agent-based model.
Front Immunol. 2024;15:1358019.
Abstract
Related articles
Downstaging guided neoadjuvant strategy shift and bladder preservation in locally
advanced bladder cancer: A case report.
Heliyon. 2024;10:e27685.
Abstract
Related articles
SMMF: a self-attention-based multi-parametric MRI feature fusion framework for
the diagnosis of bladder cancer grading.
Front Oncol. 2024;14:1337186.
Abstract
Related articles
AURKB promotes bladder cancer progression by deregulating the p53 DNA damage
response pathway via MAD2L2.
J Transl Med. 2024;22:295.
Abstract
Related articles
Association of interleukin-17A and chemokine/vascular endothelial growth
factor-induced angiogenesis in newly diagnosed patients with bladder cancer.
BMC Immunol. 2024;25:20.
Abstract
Related articles
Cross-sectional and longitudinal analyses of urinary extracellular vesicle mRNA
markers in urothelial bladder cancer patients.
Sci Rep. 2024;14:6801.
Abstract
Related articles
Estimates of the lead time in screening for bladder cancer.
Urol Oncol. 2024;42:110-114.
Abstract
Related articles
Treatment patterns and prognosis in patients with Bacillus
Calmette-Guerin-exposed high-risk non-muscle invasive bladder cancer: a
real-world data analysis.
World J Urol. 2024;42:185.
Abstract
Related articles
Serum alpha-hydroxybutyrate dehydrogenase as a biomarker for predicting survival
outcomes in patients with UTUC after radical nephroureterectomy.
BMC Urol. 2024;24:62.
Abstract
Related articles
Determining the clinicopathological significance of the VI-RADS >==4 group: a
retrospective study.
BMC Urol. 2024;24:63.
Abstract
Related articles
The assessment of bladder cancer resectability with bimanual palpation: A
prospective study in laparoscopy and open cystectomy patients.
Urol Oncol. 2024 Mar 19:S1078-1439(24)00335.
Abstract
Related articles
Unveiling the challenges of UTUC biopsies and cytology: insights from a global
real-world practice study.
World J Urol. 2024;42:177.
Abstract
Related articles
Multiparametric Magnetic Resonance Imaging in the follow-up of
non-muscle-invasive bladder tumors after intravesical instillations: a promising
tool.
World J Urol. 2024;42:178.
Abstract
Related articles
Gender inequality in genitourinary malignancies clinical trials leadership.
World J Urol. 2024;42:174.
Abstract
Related articles
Disseminated BCGitis after intravesical Bacillus Calmette-Guerin therapy in a
patient with bladder cancer.
Pol Arch Intern Med. 2024 Mar 20:16710. doi: 10.20452/pamw.16710.
Abstract
Related articles
Unveiling the role of YARS1 in bladder cancer: A prognostic biomarker and
therapeutic target.
J Cell Mol Med. 2024;28:1-20.
Abstract
Related articles
CircRNA LOC729852 promotes bladder cancer progression by regulating macrophage
polarization and recruitment via the miR-769-5p/IL-10 axis.
J Cell Mol Med. 2024;28:e18225.
Abstract
Related articles
microRNA-15a-5p suppresses hypoxia-induced tumor growth and chemoresistance in
bladder cancer by binding to eIF5A2.
Neoplasma. 2024;71:60-69.
Abstract
Related articles
Association study of the polymorphisms rs2228611 of the DNMT1 gene and rs1569686
of the DNMT3B gene with bladder cancer development in a sample of the Algerian
population.
Mol Biol Res Commun. 2024;13:65-72.
Abstract
Related articles
The Role of Emodin in the Treatment of Bladder Cancer based on Network
Pharmacology and Experimental Verification.
Comb Chem High Throughput Screen. 2024.
Abstract
Related articles
A deep-learning workflow to predict upper tract urothelial carcinoma
protein-based subtypes from H&E slides supporting the prioritization of patients
for molecular testing.
J Pathol Clin Res. 2024;10:e12369.
Abstract
Related articles
Clinical effectiveness of a multitarget urine DNA test for urothelial carcinoma
detection: a double-blinded, multicenter, prospective trial.
Mol Cancer. 2024;23:57.
Abstract
Related articles
IGF2BP3 prevent HMGB1 mRNA decay in bladder cancer and development.
Cell Mol Biol Lett. 2024;29:39.
Abstract
Related articles
Performance of VI-RADS in predicting muscle-invasive bladder cancer after
transurethral resection: a single center retrospective analysis.
Abdom Radiol (NY). 2024 Mar 19. doi: 10.1007/s00261-024-04245.
Abstract
Related articles
Contrast-enhanced CT in the differential diagnosis of bladder cancer and
paraganglioma.
Abdom Radiol (NY). 2024 Mar 19. doi: 10.1007/s00261-024-04217.
Abstract
Related articles
Patterns of treatment of high-risk BCG-unresponsive non-muscle invasive bladder
cancer (NMIBC) patients among Arab urologists.
Arch Ital Urol Androl. 2024 Mar 19:12244. doi: 10.4081/aiua.2024.12244.
Abstract
Related articles
Office-based management of non-muscle invasive bladder cancer (NMIBC): a position
paper on current state of the art and future perspectives.
Arch Ital Urol Androl. 2024 Mar 19:12404. doi: 10.4081/aiua.2024.12404.
Abstract
Related articles
[Efficacy of combined treatment with pirfenidone and PD-L1 inhibitor in mice
bearing ectopic bladder cancer xenograft].
Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:210-216.
Abstract
Related articles
The RNA-binding protein sorbin and SH3 domain-containing 2 are transcriptionally
regulated by specificity protein 1 and function as tumor suppressors in bladder
cancer by stabilizing tissue factor pathway inhibitor.
Mol Carcinog. 2024 Mar 19. doi: 10.1002/mc.23717.
Abstract
Related articles
Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of
bladder cancer cells through its hem-immunoreceptor tyrosine-based activation
motif.
Pathol Int. 2024 Mar 19. doi: 10.1111/pin.13419.
Abstract
Related articles
The down-regulation of GADD45B leads to a conversion of cellular oxidative
phosphorylation to glycolysis and promotes the progression of bladder cancer.
Heliyon. 2024;10:e27427.
Abstract
Related articles
Diagnostic and prognostic potential of exosome non-coding RNAs in bladder cancer:
a systematic review and meta-analysis.
Front Oncol. 2024;14:1336375.
Abstract
Related articles
The evolution of metastatic upper tract urothelial carcinoma through
genomic-transcriptomic and single-cell protein markers analysis.
Nat Commun. 2024;15:2009.
Abstract
Related articles
A Selective-Tumor-Penetrating Strategy via Unidirectional Direct Transfer for
Intravesical Therapy of Bladder Cancer.
J Med Chem. 2024 Mar 18. doi: 10.1021/acs.jmedchem.4c00060.
Abstract
Related articles
Nomogram for predicting postoperative ileus after radical cystectomy and urinary
diversion: a retrospective single-center study.
Ann Med. 2024;56:2329125.
Abstract
Related articles
Author Correction: High expression of MMP14 is associated with progression and
poor short-term prognosis in muscle-invasive bladder cancer.
Eur Rev Med Pharmacol Sci. 2024;28:1640.
Abstract
Related articles
Unveiling therapeutic prospects: targeting MDM-2 in non-muscle invasive bladder
cancer.
J Biomol Struct Dyn. 2024 Mar 18:1-10. doi: 10.1080/07391102.2024.2329799.
Abstract
Related articles
Multidimensional pan-cancer analysis of HSPA5 and its validation in the
prognostic value of bladder cancer.
Heliyon. 2024;10:e27184.
Abstract
Related articles
Clinical Validation of the Proenkephalin (PENK) Methylation Urine Test for
Monitoring Recurrence of Non-muscle-invasive Bladder Cancer.
Eur Urol Open Sci. 2024;62:99-106.
Abstract
Related articles
A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated
with Radiotherapy.
Eur Urol Open Sci. 2024;62:131-139.
Abstract
Related articles
Editorial: Liquid biopsy in the detection and prediction of outcomes in bladder
cancer.
Front Oncol. 2024;14:1391466.
Abstract
Related articles
Uncovering Microbial Composition of the Tissue Microenvironment in Bladder Cancer
using RNA Sequencing Data.
J Cancer. 2024;15:2431-2441.
Abstract
Related articles
[A Case of Colon Metastasis after Surgery for Left Renal Pelvis Cancer].
Gan To Kagaku Ryoho. 2024;51:340-342.
Abstract
Related articles
Unusual Urothelial Tumors and Refractory Uremia Due to Balkan Endemic
Nephropathy: A Case Report.
J Investig Med High Impact Case Rep. 2024;12:23247096241238529.
Abstract
Related articles
[Advances in the treatment of anti-HER-2 antibody drug conjugates in pan-tumor
with low HER-2 expression].
Zhonghua Zhong Liu Za Zhi. 2024;46:211-220.
Abstract
Related articles
CircMCTP2 enhances the progression of bladder cancer by regulating the
miR-99a-5p/FZD8 axis.
J Egypt Natl Canc Inst. 2024;36:8.
Abstract
Related articles
Single-cell and multi-omics analyses highlight cancer-associated
fibroblasts-induced immune evasion and epithelial mesenchymal transition for
smoking bladder cancer.
Toxicology. 2024;504:153782.
Abstract
Related articles
Performance of the EORTC and CUETO Models to Predict Recurrence and Progression
in High-risk Non-muscle-invasive Bladder Cancer Patients.
Urol J. 2024 Mar 17. doi: 10.22037/uj.v20i.7854.
Abstract
Related articles
The influence of socioeconomic status and gender on incidence and survival in
bladder cancer: a longitudinal study based on the Hamburg Cancer Registry.
World J Urol. 2024;42:166.
Abstract
Related articles
Diabetes and the risk of bladder cancer subtypes in men and women: results from
the Netherlands Cohort Study.
Eur J Epidemiol. 2024 Mar 16. doi: 10.1007/s10654-024-01100.
Abstract
Related articles
"I think my vagina is still there?": Women's perspectives on sexual function and
dysfunction following radical cystectomy for bladder cancer, a qualitative study.
J Sex Med. 2024 Mar 15:qdae025. doi: 10.1093.
Abstract
Related articles
CircRAPGEF5 sponges miR-582-3p and targets KIF3A to regulate bladder cancer cell
proliferation, migration and invasion.
Int Immunopharmacol. 2024;131:111613.
Abstract
Related articles
The impact of perioperative risk factors on long-term survival after radical
cystectomy: a prospective, high-volume cohort study.
World J Urol. 2024;42:164.
Abstract
Related articles
Electronic Documentation of Intraoperative Observation of Cystoscopic Procedures
Using the cMDX Information System.
JCO Clin Cancer Inform. 2024;8:e2300114.
Abstract
Related articles
Biomarker Inference and the Timing of Next-Generation Sequencing in a
Multi-Institutional, Cross-Cancer Clinicogenomic Data Set.
JCO Precis Oncol. 2024;8:e2300489.
Abstract
Related articles
Predicting individual outcomes after radical cystectomy in urothelial variants
with Cancer of the Bladder Risk Assessment (COBRA) score.
World J Urol. 2024;42:155.
Abstract
Related articles
Reinforcement Learning and PK-PD Models Integration to Personalize the Adaptive
Dosing Protocol of Erdafitinib in Patients with Metastatic Urothelial Carcinoma.
Clin Pharmacol Ther. 2024;115:825-838.
Abstract
Related articles
Comparative pharmacokinetics of tyrosine kinase inhibitor, lapatinib, in dogs and
cats following single oral administration.
J Vet Med Sci. 2024;86:317-321.
Abstract
Related articles
Risk of secondary primary malignancies in survivors of upper tract urothelial
carcinoma: A nationwide population-based analysis.
Cancer Epidemiol. 2024;89:102536.
Abstract
Related articles
Cost-effectiveness analysis for avelumab first-line maintenance treatment of
advanced urothelial carcinoma in Scotland.
Future Oncol. 2024;20:459-470.
Abstract
Related articles
Retracted: lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer
through Enhancing IQGAP3 and CDCA5 Expression.
Biomed Res Int. 2024;2024:9783095.
Abstract
Related articles
Ferrous Selenide Stabilized Black Phosphorus Heterojunction Sonosensitizer for MR
Imaging-Guided Sonodynamic Therapy of Bladder Cancer.
Biomater Res. 2024;28:0014.
Abstract
Related articles
Narrow Bandgap Schottky Heterojunction Sonosensitizer with High Electron-Hole
Separation Boosted Sonodynamic Therapy in Bladder Cancer.
Adv Mater. 2024 Mar 28:e2401252. doi: 10.1002/adma.202401252.
Abstract
Related articles
Evaluating a combination treatment of NK cells and reovirus against bladder
cancer cells using an in vitro assay to simulate intravesical therapy.
Sci Rep. 2024;14:7390.
Abstract
Related articles
Differentiation of Muscular Invasion in Bladder Cancer: Additional Value of
Synthetic Magnetic Resonance Imaging.
Acad Radiol. 2024 Mar 27:S1076-6332(24)00153-3. doi: 10.1016/j.acra.2024.
Abstract
Related articles
Enzyme-labeled liquid-based cytology (ELLBC): a new noninvasive diagnostic method
for bladder cancers.
J Cancer Res Clin Oncol. 2024;150:169.
Abstract
Related articles
Retraction: 'ASPM predicts poor prognosis and regulates cell proliferation in
bladder cancer'. Zhen-Ya Gao, Fang Yu, Huan-Xia Jia, Zhuo Ye, Shi-Jie Yao,
Kaohsiung J Med Sci. 2020; 36: 1021-1029 (https://doi.org/10.1002/kjm2.12284).
Kaohsiung J Med Sci. 2024 Mar 28. doi: 10.1002/kjm2.12825.
Abstract
Related articles
Cytotoxicity and Apoptosis Studies of Brucein D against T24 Bladder Cancer Cells.
Asian Pac J Cancer Prev. 2024;25:921-930.
Abstract
Related articles
Differential Expression of CKLF-like MARVEL Transmembrane Domain-Containing
Protein 6 and Programmed Cell Death Ligand 1 as Prognostic Biomarkers in Upper
Tract Urothelial Carcinoma.
Int J Mol Sci. 2024;25:3492.
Abstract
Related articles
Plasma Levels of Pentraxin 3: A Potential Prognostic Biomarker in Urinary Bladder
Cancer Patients.
Int J Mol Sci. 2024;25:3473.
Abstract
Related articles
Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder
Cancer.
Int J Mol Sci. 2024;25:3462.
Abstract
Related articles
Unmasking the Metabolite Signature of Bladder Cancer: A Systematic Review.
Int J Mol Sci. 2024;25:3347.
Abstract
Related articles
Strategies for Overcoming Immune Evasion in Bladder Cancer.
Int J Mol Sci. 2024;25:3105.
Abstract
Related articles
Comparison of Oncological Outcomes between Transperitoneal and Retroperitoneal
Approaches in Laparoscopic Nephroureterectomies for Upper Tract Urothelial
Carcinoma.
Medicina (Kaunas). 2024;60:421.
Abstract
Related articles
Effectiveness of Preoperative Immunonutrition in Improving Surgical Outcomes
after Radical Cystectomy for Bladder Cancer: Study Protocol for a Multicentre,
Open-Label, Randomised Trial (INu-RC).
Healthcare (Basel). 2024;12:696.
Abstract
Related articles
Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for
Bladder Cancer: Efficacy and Synergistic Effects.
Biomedicines. 2024;12:647.
Abstract
Related articles
Redox System and Oxidative Stress-Targeted Therapeutic Approaches in Bladder
Cancer.
Antioxidants (Basel). 2024;13:287.
Abstract
Related articles
CD44 in Bladder Cancer.
Cancers (Basel). 2024;16:1195.
Abstract
Related articles
The Effect of Retinoic Acid on Arsenite-Transformed Malignant UROtsa Bladder
Cancer Cells: In Vitro Model of Basal Muscle-Invasive Bladder Cancer.
Cancers (Basel). 2024;16:1178.
Abstract
Related articles
[Not Available].
Aktuelle Urol. 2024;55:100-102.
Abstract
Related articles
Reply to "Knowledge-map analysis and bladder cancer immunotherapy: Comment".
Hum Vaccin Immunother. 2024;20:2325756.
Abstract
Related articles
Letter to the editor for the article "Nephron-sparing ureteroscopic surgery vs.
radical nephroureterectomy: comparable survival-outcomes in upper tract
urothelial carcinoma".
World J Urol. 2024;42:198.
Abstract
Related articles
[BCG instillation sepsis in bladder carcinoma].
Praxis (Bern 1994). 2024;113:44.
Abstract
Related articles
The Assessment of SF-36 Survey for Quality-of-Life Measurement after Radical
Cystectomy for Muscle-Invasive Bladder Cancer: A Systematic Review.
Diseases. 2024;12:56.
Abstract
Related articles
Prognostic Value of P63 Expression in Muscle-Invasive Bladder Cancer and
Association with Molecular Subtypes-Preliminary Report.
Curr Issues Mol Biol. 2024;46:2456-2467.
Abstract
Related articles
Comparison of red and green light for treating non-muscle invasive bladder cancer
in rats using singlet oxygen-cleavable prodrugs with PPIX-PDT.
Photochem Photobiol. 2024 Mar 27. doi: 10.1111/php.13933.
Abstract
Related articles
Examining the causal association between psoriasis and bladder cancer: A
two-sample Mendelian randomization analysis.
Skin Res Technol. 2024;30:e13663.
Abstract
Related articles
The Effect of Lymphovascular Invasion on Short-Term Tumor Recurrence and
Progression in Stage T1 Bladder Cancer.
Cureus. 2024;16:e54844.
Abstract
Related articles
Identification of novel protein biomarkers from the blood and urine for the early
diagnosis of bladder cancer via proximity extension analysis.
J Transl Med. 2024;22:314.
Abstract
Related articles
Preliminary findings on the development of a predictive model for BLCA based on
disulfidptosis-associated IncRNAs signature.
BMC Urol. 2024;24:69.
Abstract
Related articles
Quantitative differentiation of non-invasive bladder urothelial carcinoma and
inverted papilloma based on CT urography.
BMC Urol. 2024;24:73.
Abstract
Related articles
Unlocking the Therapeutic Potential of LncRNA BLACAT1 in Hypopharynx Squamous
Cell Carcinoma.
Discov Med. 2024;36:546-558.
Abstract
Related articles
Impacts of enhanced recovery after surgery nursing interventions on wound
infection and complications following bladder cancer surgery: A meta-analysis.
Int Wound J. 2024;21:e14781.
Abstract
Related articles
Prediction of pathological up-staging after radical nephroureterectomy in
patients with upper tract urothelial carcinoma.
World J Urol. 2024;42:192.
Abstract
Related articles
Nomogram for customized recurrence prediction in primary non-muscle-invasive
bladder cancer based on routine blood and urine parameters.
BMC Urol. 2024;24:67.
Abstract
Related articles
Endothelial cell proliferation and vascular patterns in urothelial carcinoma.
Rom J Morphol Embryol. 2024;65:61-67.
Abstract
Related articles
Parastomal Hernia Following Ileal Conduit: Incidence, Risk Factors, and
Health-Related Quality of Life.
J Wound Ostomy Continence Nurs. 2024;51:126-131.
Abstract
Related articles
Electrospun nanofibrous mats loaded with gemcitabine and cisplatin suppress
bladder tumor growth by improving the tumor immune microenvironment.
J Mater Sci Mater Med. 2024;35:21.
Abstract
Related articles
Enhancing recurrence risk prediction for bladder cancer using multi-sequence MRI
radiomics.
Insights Imaging. 2024;15:88.
Abstract
Related articles
Targeting the KAT8/YEATS4 Axis Represses Tumor Growth and Increases Cisplatin
Sensitivity in Bladder Cancer.
Adv Sci (Weinh). 2024 Mar 25:e2310146. doi: 10.1002/advs.202310146.
Abstract
Related articles
Antibiotic therapy impact on intravesical BCG therapy efficacy for high-risk
localized bladder cancer treatment.
Front Oncol. 2024;13:1240378.
Abstract
Related articles
CircITGA7 regulates malignant phenotypes in bladder cancer cells via targeting
miR-330-3p/KLF10 axis.
Kaohsiung J Med Sci. 2024 Mar 25. doi: 10.1002/kjm2.12821.
Abstract
Related articles
SGLT2 inhibition and three urological cancers: Up-to-date results.
Diabetes Metab Res Rev. 2024;40:e3797.
Abstract
Related articles
Immunochemistry-based quantification of tumor-infiltrating lymphocytes and
immunoscore as prognostic biomarkers in bladder cancer.
J Egypt Natl Canc Inst. 2024;36:9.
Abstract
Related articles
Trihalomethanes in global drinking water: Distributions, risk assessments, and
attributable disease burden of bladder cancer.
J Hazard Mater. 2024;469:133760.
Abstract
Related articles
Identifying the supportive care needs of people affected by non-muscle invasive
bladder cancer: An integrative systematic review.
J Cancer Surviv. 2024 Mar 23. doi: 10.1007/s11764-024-01558.
Abstract
Related articles
The mechanism of the contribution of ICAM-1 to epithelial-mesenchymal transition
(EMT) in bladder cancer.
Hum Cell. 2024 Mar 22. doi: 10.1007/s13577-024-01053.
Abstract
Related articles
A Prognostic Index Derived From LASSO-Selected Preoperative Inflammation and
Nutritional Markers for Non-Muscle-Invasive Bladder Cancer.
Clin Genitourin Cancer. 2024 Feb 29:102061. doi: 10.1016/j.clgc.2024.
Abstract
Related articles
Therapeutic Benefits and Prognostic Value of a Model Based on 7 Immune-associated
Genes in Bladder Cancer.
Altern Ther Health Med. 2024 Mar 22:AT10582.
Abstract
Related articles
The Mechanism of miR-29 in Bladder Cancer Released by Exosomes into Brain
Microglia to Promote M2 Polarization and Angiogenesis in Brain Metastasis of
Bladder Cancer.
Altern Ther Health Med. 2024 Mar 22:AT10593.
Abstract
Related articles
Arab world's impact on bladder cancer research and opportunities for growth: A
bibliometric review study.
Medicine (Baltimore). 2024;103:e37554.
Abstract
Related articles
Immune checkpoint inhibitor-related adrenal hypofunction and Psoriasisby induced
by tislelizumab: A case report and review of literature.
Medicine (Baltimore). 2024;103:e37562.
Abstract
Related articles
Multi-omics comprehensive analysis reveals the predictive value of
N6-methyladenosine- related genes in prognosis and immune escape of bladder
cancer.
Cancer Biomark. 2024 Jan 25. doi: 10.3233/CBM-230286.
Abstract
Related articles
Bladder cancer: An Update.
Nursing. 2024;54:39-40.
Abstract
Related articles
Bladder cancer: An Update.
Nursing. 2024;54:27-39.
Abstract
Related articles
Recurrent bladder leiomyoma: a case report.
J Med Case Rep. 2024;18:173.
Abstract
Related articles
Development of the multivariate administrative data cystectomy model and its
impact on misclassification bias.
BMC Med Res Methodol. 2024;24:73.
Abstract
Related articles
Spatial relationships in the urothelial and head and neck tumor microenvironment
predict response to combination immune checkpoint inhibitors.
Nat Commun. 2024;15:2538.
Abstract
Related articles
Chronic pelvic pain and dysmenorrhea disguising a rare submucosal leiomyoma of
the urinary bladder.
BMJ Case Rep. 2024;17:e258971.
Abstract
Related articles
Natural products and derivatives in renal, urothelial and testicular cancers:
Targeting signaling pathways and therapeutic potential.
Phytomedicine. 2024;127:155503.
Abstract
Related articles
Reduced burden of Arsenic-Related cancers after water mitigation in Taiwan.
Environ Int. 2024;185:108542.
Abstract
Related articles
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new
directions.
Nat Rev Clin Oncol. 2024;21:312-329.
Abstract
Related articles
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in
patients with solid tumors (POD1UM-203).
ESMO Open. 2024;9:102387.
Abstract
Related articles
Challenges, considerations, and approaches for developing a cost-effectiveness
model for the adjuvant treatment of muscle-invasive urothelial carcinoma: with a
spotlight on nivolumab versus placebo.
J Med Econ. 2024;27:473-481.
Abstract
Related articles
Blood-based liquid biopsy: A promising noninvasive test in diagnosis,
surveillance, and prognosis of patients with upper tract urothelial carcinoma.
Urol Oncol. 2024;42:118.
Abstract
Related articles
Symptomatic and functional recovery after transurethral resection of bladder
tumor: Data from ecological momentary symptom assessment.
Urol Oncol. 2024;42:117.
Abstract
Related articles
Combination strategies for advanced-stage urothelial carcinoma: a paradigm shift.
Nat Rev Clin Oncol. 2024;21:255-256.
Abstract
Related articles
Maximizing efficiency and ensuring safety: Exploring the outcomes of 2
consecutive open radical cystectomies by the same team within a single surgical
day.
Urol Oncol. 2024;42:118.
Abstract
Related articles
Longer time to radical cystectomy in patients treated with neoadjuvant
chemotherapy is associated with worse oncological outcomes.
Urol Oncol. 2024;42:117.
Abstract
Related articles
Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial
Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
Mod Pathol. 2024;37:100424.
Abstract
Related articles
A Fully Automated Artificial Intelligence System to Assist Pathologists'
Diagnosis to Predict Histologically High-grade Urothelial Carcinoma from
Digitized Urine Cytology Slides Using Deep Learning.
Eur Urol Oncol. 2024;7:258-265.
Abstract
Related articles
Role of multiparametric MRI in predicting muscle invasiveness in urinary bladder
neoplasms with pathological correlations.
Urologia. 2024;91:55-60.
Abstract
Related articles
Assessing pentafecta outcomes post radical cystectomy: A tertiary care center
study.
Urologia. 2024;91:49-54.
Abstract
Related articles
Long-term renal function following radical cystectomy and ileal conduit creation.
Ir J Med Sci. 2024;193:639-644.
Abstract
Related articles
The impact of multidisciplinary cancer meetings in guiding treatment intent in
patients with upper tract urothelial carcinoma.
Asia Pac J Clin Oncol. 2024;20:41-45.
Abstract
Related articles
[CpG-ODN instillation boosts ICAM-1 expression in an orthotopic murine UCC model:
immunohistochemical evaluation of the local response to immunostimulatory DNA].
Aktuelle Urol. 2024;55:154-160.
Abstract
Related articles
CLO24-074: Impact of Neoadjuvant Chemotherapy on Survival and Pathological
Response Among Octogenarians Who Underwent Radical Cystectomy for Muscle-Invasive
Bladder Cancer.
J Natl Compr Canc Netw. 2024;22.
Abstract
Related articles
CLO24-064: Evaluation of the Reliability of mpMRI in Diagnosing Prostate Cancer
Following Intravesical Bacillus Calmette Guerin Therapy for Bladder Cancer.
J Natl Compr Canc Netw. 2024;22.
Abstract
Related articles
QIM24-194: A Cost Effective, Noninvasive Mutiomics Assay (BCDx) for Diagnostic
Accuracy of Bladder Cancer Compares to the Gold Standard of Cytoscopy and
Cytology.
J Natl Compr Canc Netw. 2024;22.
Abstract
Related articles
MIR145 Core Promoter Methylation in Pretreatment Cell-Free DNA: A Liquid Biopsy
Tool for Muscle-Invasive Bladder Cancer Treatment Outcome.
JCO Precis Oncol. 2024;8:e2300414.
Abstract
Related articles
ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating
the tumor immune microenvironment.
Medicine (Baltimore). 2024;103:e37590.
Abstract
Related articles
Is trimodal therapy the current standard for muscle-invasive bladder cancer?
Actas Urol Esp (Engl Ed). 2024 Apr 2:S2173-5786(24)00028.
Abstract
Related articles
PAX2 mediated upregulation of ESPL1 contributes to cisplatin resistance in
bladder cancer through activating the JAK2/STAT3 pathway.
Naunyn Schmiedebergs Arch Pharmacol. 2024 Apr 4. doi: 10.1007/s00210-024-03061.
Abstract
Related articles
Beyond surgery: bladder preservation and the role of systemic treatment in
localised muscle-invasive bladder cancer.
World J Urol. 2024;42:210.
Abstract
Related articles
Organ preservation in muscle-invasive urothelial bladder cancer.
Curr Opin Oncol. 2024;36:155-163.
Abstract
Related articles
Change in the neutrophil-lymphocyte ratio may predict early recurrence in
operated bladder cancer.
Asia Pac J Clin Oncol. 2024 Apr 4. doi: 10.1111/ajco.14065.
Abstract
Related articles
Comparing surgical site wound infection after laparoscopic and open radical
cystectomies in patients with bladder cancer.
Int Wound J. 2024;21:e14718.
Abstract
Related articles
Deciphering the prognostic features of bladder cancer through gemcitabine
resistance and immune-related gene analysis and identifying potential small
molecular drug PIK-75.
Cancer Cell Int. 2024;24:125.
Abstract
Related articles
Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder
Cancer.
Target Oncol. 2024 Apr 3. doi: 10.1007/s11523-024-01056.
Abstract
Related articles
Changes in the Urinary Microbiome After Transurethral Resection of
Non-muscle-Invasive Bladder Cancer: Insights from a Prospective Observational
Study.
Ann Surg Oncol. 2024 Apr 3. doi: 10.1245/s10434-024-15198.
Abstract
Related articles
Secondary Involvement of the Urinary Bladder by Endometrial Carcinoma.
Mayo Clin Proc. 2024;99:680-682.
Abstract
Related articles
Association of preoperative sarcopenia with the long-term prognosis of patients
with bladder cancer undergoing radical cystectomy.
J Cancer Res Clin Oncol. 2024;150:173.
Abstract
Related articles
Comparison of intravesical chemotherapy regimens after radical nephroureterectomy
for upper tract urothelial carcinoma and analysis of risk factors for
postoperative recurrence.
Eur Rev Med Pharmacol Sci. 2024;28:2387-2395.
Abstract
Related articles
Assessing the Causal Relationship between Waterpipe Smoking and Bladder Cancer.
Cancer Epidemiol Biomarkers Prev. 2024;33:461-462.
Abstract
Related articles
Investigating the impact of regulatory B cells and regulatory B cell-related
genes on bladder cancer progression and immunotherapeutic sensitivity.
J Exp Clin Cancer Res. 2024;43:101.
Abstract
Related articles
Predictors of persistent opioid use in bladder cancer patients undergoing radical
cystectomy: A SEER-Medicare analysis.
Urol Oncol. 2024 Apr 1:S1078-1439(24)00362-4. doi: 10.1016/j.urolonc.2024.
Abstract
Related articles
Hsa_circ_0005320 affects cell proliferation and the cell cycle via the
IGF2BP3/CDK2 axis in bladder cancer.
Cell Signal. 2024 Mar 31:111154. doi: 10.1016/j.cellsig.2024.111154.
Abstract
Related articles
ASO Author Reflections: Vasohibin-1 as a Biomarker for Chemotherapeutic Response
in Patients with Advanced Bladder Cancer.
Ann Surg Oncol. 2024 Apr 2. doi: 10.1245/s10434-024-15122.
Abstract
Related articles
Prognostic significance of E-Cadherin and B-Catenin in non-muscle invasive
bladder cancer.
J Immunoassay Immunochem. 2024 Apr 1:1-10. doi: 10.1080/15321819.2024.2335154.
Abstract
Related articles
Sialylation on vesicular integrin beta1 determined endocytic entry of small
extracellular vesicles into recipient cells.
Cell Mol Biol Lett. 2024;29:46.
Abstract
Related articles
Robot-assisted intracorporeal ileal conduit urinary diversion: A two-center
comparative study of Bricker versus Wallace ureteroileal anastomosis.
Asian J Endosc Surg. 2024;17:e13307.
Abstract
Related articles
CD276-dependent efferocytosis by tumor-associated macrophages promotes immune
evasion in bladder cancer.
Nat Commun. 2024;15:2818.
Abstract
Related articles
Clinical implications of single cell sequencing for bladder cancer.
Oncol Res. 2024;32:597-605.
Abstract
Related articles
Enhancing m(6)A modification of lncRNA through METTL3 and RBM15 to promote
malignant progression in bladder cancer.
Heliyon. 2024;10:e28165.
Abstract
Related articles
Clinical Trial Protocol for "Replace Cysto": Replacing Invasive Cystoscopy with
Urine Testing for Non-muscle-invasive Bladder Cancer Surveillance-A Multicenter,
Randomized, Phase 2 Healthcare Delivery Trial Comparing Quality of Life During
Cancer Surv
Eur Urol Open Sci. 2024;63:19-30.
Abstract
Related articles
Characterization and impact of non-canonical WNT signaling on outcomes of
urothelial carcinoma.
Cancer Med. 2024;13:e7148.
Abstract
Related articles
Expression of Cyclin D1 in Urothelial Carcinoma of Urinary Bladder and its
Association with Tumour Grade.
Mymensingh Med J. 2024;33:461-465.
Abstract
Related articles
CT Image-Based Radiomic Analysis for Detecting PD-L1 Expression Status in Bladder
Cancer Patients.
Acad Radiol. 2024 Mar 30:S1076-6332(24)00138-7. doi: 10.1016/j.acra.2024.
Abstract
Related articles
Radiotherapy Combined with a Radiosensitizer for Bacillus
Calmette-Guerin-unresponsive Non-muscle-invasive Carcinoma In Situ Bladder
Cancer: An Open-label, Single-arm, Multicenter, Phase 2 European Organisation for
Research and Treatment of Cancer Tri
Eur Urol Oncol. 2024 Mar 30:S2588-9311(24)00084.
Abstract
Related articles
Prediction of histopathologic grades of bladder cancer with radiomics based on
MRI: Comparison with traditional MRI.
Urol Oncol. 2024 Mar 30:S1078-1439(24)00338.
Abstract
Related articles
Case report and literature review of penile metastasis of bladder cancer.
Asian J Surg. 2024 Mar 29:S1015-9584(24)00529.
Abstract
Related articles
MITD1 deficiency leads to poor survival via tissue factor-mediated coagulation in
bladder cancer.
J Thromb Haemost. 2024 Mar 28:S1538-7836(24)00173.
Abstract
Related articles
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I
Trial of Intravesical Bacillus Calmette-Guerin Combined with Intravenous
Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder
Cancer after Previo
Clin Genitourin Cancer. 2024;22:102059.
Abstract
Related articles
A comprehensive overview of selective and novel fibroblast growth factor receptor
inhibitors as a potential anticancer modality.
Acta Pharm. 2024;74:1-36.
Abstract
Related articles
A prospective study of smoking-related white blood cell DNA methylation markers
and risk of bladder cancer.
Eur J Epidemiol. 2024 Mar 30. doi: 10.1007/s10654-024-01110.
Abstract
Related articles
Impact of lymph node dissection on surgical and oncological outcomes in patients
undergoing robot-assisted radical cystectomy for bladder cancer: a multicenter
retrospective study.
J Robot Surg. 2024;18:141.
Abstract
Related articles
MANNosylation of Mesoporous Silica Nanoparticles Modifies TLR4 Localization and
NF-kappaB Translocation in T24 Bladder Cancer Cells.
Adv Healthc Mater. 2024 Mar 30:e2304150. doi: 10.1002/adhm.202304150.
Abstract
Related articles
Association of household net worth with healthcare costs after radical cystectomy
using real-world data.
Cancer Med. 2024;13:e7116.
Abstract
Related articles
Similar immune responses to alpha1-oleate and Bacillus Calmette-Guerin treatment
in patients with bladder cancer.
Cancer Med. 2024;13:e7091.
Abstract
Related articles
Evaluation of URO17(R) to improve non-invasive detection of bladder cancer.
Urol Oncol. 2024 Mar 28:S1078-1439(24)00345.
Abstract
Related articles
Clinical variables associated with immune checkpoint inhibitor outcomes in
patients with metastatic urothelial carcinoma: a multicentre retrospective cohort
study.
BMJ Open. 2024;14:e081480.
Abstract
Related articles
TDO2 promotes bladder cancer progression via AhR-mediated SPARC/FILIP1L
signaling.
Biochem Pharmacol. 2024 Mar 27:116172. doi: 10.1016/j.bcp.2024.116172.
Abstract
Related articles
From TURP to enucleation: navigating the complex relationship between BPH
treatments and bladder cancer.
World J Urol. 2024;42:203.
Abstract
Related articles
Elderly and bladder cancer: The role of radical cystectomy and orthotopic urinary
diversion.
Urologia. 2024 Mar 29:3915603241240644. doi: 10.1177/03915603241240644.
Abstract
Related articles
Cost-effectiveness of nivolumab versus surveillance for the adjuvant treatment of
patients with urothelial carcinoma who are at high risk of recurrence: a US payer
perspective.
J Med Econ. 2024;27:543-553.
Abstract
Related articles
Perioperative and Complication Related Outcomes for Robotic-Assisted vs Open
Radical Cystectomy: A Comparative National Surgical Quality Improvement Project
Analysis.
J Endourol. 2024;38:331-339.
Abstract
Related articles
Efficacy and safety of robot-assisted total cystectomy: A systematic review and
meta-analysis.
Asian J Surg. 2024;47:2028-2032.
Abstract
Related articles
Non-functional bladder paraganglioma with urinary frequency: A case report.
Asian J Surg. 2024;47:1990-1991.
Abstract
Related articles
Primary diffuse large B-cell lymphoma of the urinary bladder: A case report.
Asian J Surg. 2024;47:1930-1931.
Abstract
Related articles
Isolated myeloid sarcoma in the urinary bladder: A cases report.
Asian J Surg. 2024;47:1928-1929.
Abstract
Related articles
Obstructive ureteral calculi and upper-tract urothelial carcinoma: A tale of two
cases.
Asian J Surg. 2024;47:1825-1826.
Abstract
Related articles
TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint
Inhibitor-Naive Locally Advanced or Metastatic Urothelial Carcinoma.
Mol Cancer Ther. 2024;23:532-540.
Abstract
Related articles
Diagnostic Immunocytostaining with Peroxisome Proliferator-Activated
Receptor-Gamma in Urine Cytology Samples.
Acta Cytol. 2024;68:60-65.
Abstract
Related articles
Intravesical fat-fluid level as a warning sign of contained bladder perforation:
Correlation between cystoscopy and computed tomography findings.
Actas Urol Esp (Engl Ed). 2024;48:254-256.
Abstract
Related articles
Prevalence of urinary tract cancer in the Spanish cohort of the IDENTIFY study.
Actas Urol Esp (Engl Ed). 2024;48:228-237.
Abstract
Related articles
"Internet Plus" continuous nursing for patients with advanced bladder cancer: A
retrospective observational study.
Medicine (Baltimore). 2024;103:e37822.
Abstract
Related articles
Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder
Cancer.
Cells. 2024;13:627.
Abstract
Related articles
A meta-analysis of UCA1 accuracy in the detection of bladder cancer.
Expert Rev Anticancer Ther. 2024 Apr 12. doi: 10.1080/14737140.2024.2342528.
Abstract
Related articles
[Retracted] Propofol modulates the proliferation, invasion and migration of
bladder cancer cells through the miR?145?5p/TOP2A axis.
Mol Med Rep. 2024;29:94.
Abstract
Related articles
ASO Author Reflections: Changes in the Urinary Microbiome After Transurethral
Resection of Nonmuscle-Invasive Bladder Cancer: Insights from a Prospective
Observational Study.
Ann Surg Oncol. 2024 Apr 11. doi: 10.1245/s10434-024-15248.
Abstract
Related articles
Advances in tumor microenvironment and underlying molecular mechanisms of bladder
cancer: a systematic review.
Discov Oncol. 2024;15:111.
Abstract
Related articles
Experimental and New Approaches for Bladder Preservation in Intermediate and
High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC).
Res Rep Urol. 2024;16:89-113.
Abstract
Related articles
Theories behind Bacillus Calmette-Guerin failure in high-risk non-muscle-invasive
bladder cancer and update on current management.
Cancer Pathog Ther. 2023;2:74-80.
Abstract
Related articles
A paclitaxel-hyaluronan conjugate (ONCOFID-P-B) in patients with
BCG-unresponsive carcinoma in situ of the bladder: a dynamic assessment of the
tumor microenvironment.
J Exp Clin Cancer Res. 2024;43:109.
Abstract
Related articles
Impact of concurrent medications on clinical outcomes of cancer patients treated
with immune checkpoint inhibitors: analysis of Health Insurance Review and
Assessment data.
J Cancer Res Clin Oncol. 2024;150:186.
Abstract
Related articles
Optimal timing for the first cystoscopic follow-up using time-to-treatment
initiation analysis of oncologic outcomes in primary non-muscle invasive bladder
cancer.
Sci Rep. 2024;14:8440.
Abstract
Related articles
Stromal osseous metaplasia in urothelial carcinoma of the bladder: An unusual and
challenging feature. A case report.
Rev Esp Patol. 2024;57:116-119.
Abstract
Related articles
Development and validation of a clinical and ultrasound features-based nomogram
for preoperative differentiation of renal urothelial carcinoma and central renal
cell carcinoma.
World J Urol. 2024;42:227.
Abstract
Related articles
A study on the significance of serine hydroxymethyl transferase expression and
its role in bladder cancer.
Sci Rep. 2024;14:8324.
Abstract
Related articles
Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for
urinary bladder cancer diagnosis and classification.
Urol Oncol. 2024 Apr 8:S1078-1439(24)00361-2. doi: 10.1016/j.urolonc.2024.
Abstract
Related articles
Autophagy flux in bladder cancer: Cell death crosstalk, drug and
nanotherapetuics.
Cancer Lett. 2024 Apr 7:216867. doi: 10.1016/j.canlet.2024.216867.
Abstract
Related articles
Comparison of the efficacy of enfortumab vedotin between patients with metastatic
urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world
data from a multi-institutional study in Japan.
J Cancer Res Clin Oncol. 2024;150:182.
Abstract
Related articles
Evaluation of histological variants of upper tract urothelial carcinoma as
prognostic factor after radical nephroureterectomy.
World J Urol. 2024;42:225.
Abstract
Related articles
Does volumetric measurement of ADC values achieve higher diagnostic performance
in bladder cancer MRI?
Acta Radiol. 2024 Apr 9:2841851241241055. doi: 10.1177/02841851241241055.
Abstract
Related articles
Paraganglioma of the urinary bladder: A case report.
J Pak Med Assoc. 2024;74:570-572.
Abstract
Related articles
Challenges and technical aspects in the management of muscle invasive bladder
cancer as retrograde radical cystectomy with ileal conduit.
J Pak Med Assoc. 2024;74:513-518.
Abstract
Related articles
Disease progression in Bacillus Calmette Guerin unresponsive non-muscle invasive
bladder cancer patients with carcinoma in situ, participating in clinical trials
on bladder-sparing treatment.
Transl Androl Urol. 2024;13:479-482.
Abstract
Related articles
Biomarker challenges in the pursuit of personalized neoadjuvant chemotherapy for
muscle-invasive bladder cancer: conclusions from SWOG S1314.
Transl Androl Urol. 2024;13:458-462.
Abstract
Related articles
Predictors of Toxicity in a Randomized Study of Consolidation Chemoradiation
Versus Observation After First Line Chemotherapy in Advanced Gall Bladder
Cancers.
Adv Radiat Oncol. 2024;9:101468.
Abstract
Related articles
Immunotherapeutic value of NUSAP1 associated with bladder cancer through a
comprehensive analysis of 33 human cancer cases.
Am J Cancer Res. 2024;14:959-978.
Abstract
Related articles
Type III interferon inhibits bladder cancer progression by reprogramming
macrophage-mediated phagocytosis and orchestrating effective immune responses.
J Immunother Cancer. 2024;12:e007808.
Abstract
Related articles
Perioperative complications and oncological outcomes of open versus
robotic-assisted radical cystectomy: a propensity score-matched study.
World J Urol. 2024;42:220.
Abstract
Related articles
Potential-resolved electrochemiluminescence for simultaneous determination of
multiplex bladder cancer markers.
Chem Commun (Camb). 2024 Apr 8. doi: 10.1039/d4cc00996.
Abstract
Related articles
Editorial: Biomarkers and immunotherapy for genitourinary tumors.
Front Immunol. 2024;15:1394170.
Abstract
Related articles
The Safety, Tolerability, and Preliminary Efficacy of a Gemcitabine-releasing
Intravesical System (TAR-200) in American Urological Association-defined
Intermediate-risk Non-muscle-invasive Bladder Cancer Patients: A Phase 1b Study.
Eur Urol Open Sci. 2024;62:8-15.
Abstract
Related articles
MRI evaluation of vesical imaging reporting and data system for bladder cancer
after neoadjuvant chemotherapy.
Cancer Imaging. 2024;24:49.
Abstract
Related articles
Jolkinolide B synergistically potentiates the antitumor activity of GPX4
inhibitors via inhibiting TrxR1 in cisplatin-resistant bladder cancer cells.
Biochem Pharmacol. 2024;223:116194.
Abstract
Related articles
CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer
through nonhomologous end-joining pathway.
Cell Signal. 2024 Apr 5:111164. doi: 10.1016/j.cellsig.2024.111164.
Abstract
Related articles
Near-infrared fluorescence lymph node template region dissection plus backup
lymphadenectomy in open radical cystectomy for bladder cancer using an innovative
handheld device: A single center experience.
J Surg Oncol. 2024 Apr 7. doi: 10.1002/jso.27618.
Abstract
Related articles
The Prognostic Value of the Combination of the Prognostic Nutritional Index and
the Lymphocyte:Monocyte Ratio for the Prediction of Patients with Muscle-Invasive
Bladder Cancer.
Arch Esp Urol. 2024;77:164-172.
Abstract
Related articles
Analysis of the Clinicopathological Characteristics and Prognosis of Patients
with Nonurothelial Bladder Cancer.
Arch Esp Urol. 2024;77:148-157.
Abstract
Related articles
Natural Killer Cell Subsets in Tumor Draining Lymph Nodes of Patients with
Bladder Cancer and Their Clinical Implications.
Iran J Immunol. 2024;21.
Abstract
Related articles
Front-line Platinum Continues To Have a Role in Advanced Bladder Cancer.
Eur Urol Focus. 2024 Apr 5:S2405-4569(24)00049-X. doi: 10.1016/j.euf.2024.
Abstract
Related articles
Modifying Effects of Genetic Variations on the Association Between Dietary
Isothiocyanate Exposure and Non-muscle Invasive Bladder Cancer Prognosis in the
Be-Well Study.
Mol Nutr Food Res. 2024 Apr 6:e2400087. doi: 10.1002/mnfr.202400087.
Abstract
Related articles
Integrative analysis of the bladder cancer from a cell cycle NCAM1 perspective at
both single cell and bulk resolution.
Environ Toxicol. 2024 Apr 6. doi: 10.1002/tox.24260.
Abstract
Related articles
A chromosome-scale fishing cat reference genome for the evaluation of potential
germline risk variants.
Sci Rep. 2024;14:8073.
Abstract
Related articles
Clinical performance and utility of a noninvasive urine-based methylation
biomarker: TWIST1/Vimentin to detect urothelial carcinoma of the bladder.
Sci Rep. 2024;14:7941.
Abstract
Related articles
Updates on Urinary Bladder Tumors With Neuroendocrine Features.
Adv Anat Pathol. 2024;31:169-177.
Abstract
Related articles
Comprehensive analysis of scRNA-seq and bulk RNA-seq reveal the characteristics
of disulfidptosis and a prognostic signature in BLCA.
Aging (Albany NY). 2024;16:5751-5771.
Abstract
Related articles
Reply to: Letter to the Editor for the Article "Prognostic Impact of Preoperative
Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract
Urothelial Carcinoma," by Urabe, Fumihik et al.
Ann Surg Oncol. 2024;31:3565-3566.
Abstract
Related articles
Letter to the Editor for the Article "Prognostic Impact of Preoperative
Thrombocytosis on Recurrence-Free Survival in Patients with Upper Tract
Urothelial Carcinoma".
Ann Surg Oncol. 2024;31:3563-3564.
Abstract
Related articles
Efficacy of immune checkpoint inhibitors combinations as first-line systemic
treatment in patients with advanced urothelial carcinoma: A systematic review and
network meta-analysis.
Crit Rev Oncol Hematol. 2024;196:104321.
Abstract
Related articles
The association between paraneoplastic neurological syndromes (PNS) and
urothelial carcinoma - A review of the literature.
Crit Rev Oncol Hematol. 2024;196:104314.
Abstract
Related articles
Implementation of The Paris System for Reporting Urine Cytology improves
diagnostic accuracy of selective upper urinary tract cytology.
Cancer Cytopathol. 2024;132:242-249.
Abstract
Related articles
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients
with metastatic urothelial carcinoma progressing after platinum-based
chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes.
Ann Oncol. 2024;35:392-401.
Abstract
Related articles
Nectin-4 expression in a subset of cutaneous adnexal carcinomas: A potential
target for therapy with enfortumab vedotin.
J Cutan Pathol. 2024 Jan 10. doi: 10.1111/cup.14579.
Abstract
Related articles
Multiple Fluorescences in Situ Hybridization Status in Excreted Urine Improve
Diagnostic Efficacy for Upper Urinary Tract Urothelial Carcinomas.
Urol J. 2024;21:107-113.
Abstract
Related articles
Fish: A Promising Screening Tool for Malignancy After Augmentation Cystoplasty?
J Pediatr Surg. 2024;59:725-730.
Abstract
Related articles
Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data
System.
Nat Rev Urol. 2024;21:243-251.
Abstract
Related articles
Platinum ineligibility and survival outcomes in patients with advanced urothelial
carcinoma receiving first-line treatment.
J Natl Cancer Inst. 2024;116:547-554.
Abstract
Related articles
Prognostic Nomograms for Patients with Primary Sarcomatoid Carcinoma of The
Urinary Bladder: Based on The SEER Database.
Urol J. 2024;21:87-97.
Abstract
Related articles
Assessment of interleukin 17A and 23 in the course of bladder cancer and selected
benign urological diseases.
J Physiol Pharmacol. 2024;75.
Abstract
Related articles
Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder
Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524
and RTOG 0712.
Eur Urol Oncol. 2024 Apr 18:S2588-9311(24)00095.
Abstract
Related articles
Natural history and health care burden of non-curative treatment for
muscle-invasive bladder cancer.
Urol Oncol. 2024 Apr 18:S1078-1439(24)00365.
Abstract
Related articles
[Identification of lncrnas associated with aniline toxicity in male bladder
cancer and construction of tumor risk prediction models].
Zhonghua Nan Ke Xue. 2023;29:790-798.
Abstract
Related articles
Correction: Comprehensive analysis of mitochondria-related genes indicates that
PPP2R2B is a novel biomarker and promotes the progression of bladder cancer via
Wnt signaling pathway.
Biol Direct. 2024;19:27.
Abstract
Related articles
Predicting non-muscle invasive bladder cancer outcomes using artificial
intelligence: a systematic review using APPRAISE-AI.
NPJ Digit Med. 2024;7:98.
Abstract
Related articles
Disitamab Vedotin Alone or in Combination With Immune Checkpoint Inhibitors in
Bladder-Sparing Treatment of Muscle-Invasive Bladder Cancer: A Real-World Study.
Clin Genitourin Cancer. 2024;22:102085.
Abstract
Related articles
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma
after platinum-based chemotherapy: the ARON-2 study.
Cancer Immunol Immunother. 2024;73:106.
Abstract
Related articles
Hypoxia-mediated attenuation of EGLN2 inhibition of the NF-kappaB signaling pathway
leads to the formation of a loop between HIF-1alpha and MUC1-C promoting
chemoresistance in bladder cancer.
Mol Carcinog. 2024 Apr 18. doi: 10.1002/mc.23725.
Abstract
Related articles
Comparing fluorodeoxyglucose positron emission tomography with computed
tomography in staging for nodal and distant metastasis in urothelial/bladder
cancer.
BJUI Compass. 2024;5:473-479.
Abstract
Related articles
circKDM1A suppresses bladder cancer progression by sponging miR-889-3p/CPEB3 and
stabilizing p53 mRNA.
iScience. 2024;27:109624.
Abstract
Related articles
Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer:
a novel molecular subtyping strategy and immunotherapeutic prediction model.
J Transl Med. 2024;22:365.
Abstract
Related articles
Spatial comparison of molecular features associated with resistance to
pembrolizumab in BCG unresponsive bladder cancer.
J Immunother Cancer. 2024;12:e008571.
Abstract
Related articles
Diagnostic value of urine cyclic RNA-0071196 for bladder urothelial carcinoma.
BMC Urol. 2024;24:88.
Abstract
Related articles
Global burden of bladder cancer mortality in 2020 and 2040 according to GLOBOCAN
estimates.
World J Urol. 2024;42:237.
Abstract
Related articles
Expression of BCL2, TP53, FOXA1, and GATA3 in pTa bladder cancer recurrence.
Bratisl Lek Listy. 2024;125:311-317.
Abstract
Related articles
Chest wall tumor following intravesical BCG instillation for non-muscle invasive
bladder cancer.
J Clin Tuberc Other Mycobact Dis. 2024;35:100438.
Abstract
Related articles
A CAF subpopulation promotes LVI in early-stage bladder cancer.
Nat Rev Urol. 2024 Apr 15. doi: 10.1038/s41585-024-00881.
Abstract
Related articles
Implementation of new treatments for BCG-unresponsive non-muscle-invasive bladder
cancer. Considerations in Latin America.
Actas Urol Esp (Engl Ed). 2024 Apr 12:S2173-5786(24)00058.
Abstract
Related articles
Plasma metadherin mRNA expression in bladder cancer.
Egypt J Immunol. 2024;31:28-43.
Abstract
Related articles
Impact of Preoperative Plasma Potassium Levels on Oncological Outcomes, Major
Complications, and 30-Day Mortality in Bladder Cancer Patients Undergoing Radical
Cystectomy.
Clin Genitourin Cancer. 2024 Mar 21:102079. doi: 10.1016/j.clgc.2024.102079.
Abstract
Related articles
The role of histological subtype and chemotherapy on prognosis of ureteral
cancer.
J Cancer Res Clin Oncol. 2024;150:192.
Abstract
Related articles
A Multi-Gene Signature of Non-Muscle-Invasive Bladder Cancer Identifies Patients
Who Respond to Immunotherapies Including Bacillus Calmette-Guerin and Immune
Checkpoint Inhibitors.
Int J Mol Sci. 2024;25:3800.
Abstract
Related articles
Prognostic Value of Liquid-Biopsy-Based Biomarkers in Upper Tract Urothelial
Carcinoma.
Int J Mol Sci. 2024;25:3695.
Abstract
Related articles
Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic
Reprogramming beyond the Warburg Effect.
Cancers (Basel). 2024;16:1418.
Abstract
Related articles
Revolutionizing Treatment: Breakthrough Approaches for BCG-Unresponsive
Non-Muscle-Invasive Bladder Cancer.
Cancers (Basel). 2024;16:1366.
Abstract
Related articles
PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by
Intravesical Bacillus Calmette-Guerin (BCG) Therapy.
Cancers (Basel). 2024;16:1356.
Abstract
Related articles
Open versus Robot-Assisted Radical Cystectomy for the Treatment of pT4a Bladder
Cancer: Comparison of Perioperative Outcomes.
Cancers (Basel). 2024;16:1329.
Abstract
Related articles
Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light
Cystoscopy: Insights from a Multicenter Registry.
Cancers (Basel). 2024;16:1268.
Abstract
Related articles
Anti-Proliferative Effects of Lidocaine as an Autophagy Inducer in Bladder Cancer
via Intravesical Instillation: In Vitro and Xenograft Mouse Model Experiments.
Cancers (Basel). 2024;16:1267.
Abstract
Related articles
Treating BCG-Induced Cystitis with Combined Chondroitin and Hyaluronic Acid
Instillations in Bladder Cancer.
J Clin Med. 2024;13:2031.
Abstract
Related articles
The Long Noncoding RNA Gall Bladder Cancer-Associated Suppressor of Pyruvate
Carboxylase Inhibits the Proliferation, Migration, and Invasion of Colorectal
Cancer Cells and Induces Their Apoptosis.
Biochem Genet. 2024 Apr 12. doi: 10.1007/s10528-024-10786.
Abstract
Related articles
THE EFFECT OF A MULTIMODAL APPROACH ON THE RESULTS OF TREATMENT IN SURGERY:
INTEGRATION OF CHEMOTHERAPY, SURGERY, AND RADIOTHERAPY.
Georgian Med News. 2024;:41-46.
Abstract
Related articles
Evaluation of tumor response to immune checkpoint inhibitors by a 3D
immunotumoroid model.
Front Immunol. 2024;15:1356144.
Abstract
Related articles
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications:
Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1.
JCO Precis Oncol. 2024;8:e2300406.
Abstract
Related articles
Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth
Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial
(EAY131) Subprotocol K2.
JCO Precis Oncol. 2024;8:e2300407.
Abstract
Related articles
Whole-genome mapping of APOBEC mutagenesis in metastatic urothelial carcinoma
identifies driver hotspot mutations and a novel mutational signature.
Cell Genom. 2024;4:100528.
Abstract
Related articles
Functional and oncologic outcomes of prostate capsule-sparing radical cystectomy:
A systematic review and meta-analysis.
Urol Oncol. 2024;42:121-132.
Abstract
Related articles
Regional differences in upper tract urothelial carcinoma patients across the
United States.
Urol Oncol. 2024;42:162.
Abstract
Related articles
A lightweight bladder tumor segmentation method based on attention mechanism.
Med Biol Eng Comput. 2024;62:1519-1534.
Abstract
Related articles
The association between frailty, hypogonadism, and postoperative outcomes among
men undergoing radical cystectomy.
Urol Oncol. 2024;42:161.
Abstract
Related articles
Antibiotic use reduces the efficacy of immune checkpoint inhibitors in patients
with urothelial carcinoma: A systematic review and meta-analysis.
Urol Oncol. 2024;42:160.
Abstract
Related articles
Comprehensive analysis and prognostic assessment of senescence-associated genes
in bladder cancer.
Discov Oncol. 2024;15:130.
Abstract
Related articles
Active Surveillance in Non-Muscle Invasive Bladder Cancer, the Potential Role of
Biomarkers: A Systematic Review.
Curr Oncol. 2024;31:2201-2220.
Abstract
Related articles
GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent
N-Cadherin Cleavage in Invasive Bladder Cancer Cells.
Cells. 2024;13:708.
Abstract
Related articles
Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus
Calmette-Guerin Immunotherapy of Bladder Cancer.
Cells. 2024;13:699.
Abstract
Related articles
Microbiome Sex-Related Diversity in Non-Muscle-Invasive Urothelial Bladder
Cancer.
Curr Issues Mol Biol. 2024;46:3595-3609.
Abstract
Related articles
Detection of bladder cancer cells using quantitative interferometric label-free
imaging flow cytometry.
Cytometry A. 2024 Apr 26. doi: 10.1002/cyto.a.24846.
Abstract
Related articles
A potential strategy for bladder cancer treatment: inhibiting autophagy to
enhance antitumor effects of Nectin-4-MMAE.
Cell Death Dis. 2024;15:293.
Abstract
Related articles
An exploratory study investigating the impact of the bladder tumor microbiome on
Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer.
Urol Oncol. 2024 Apr 24:S1078-1439(24)00430.
Abstract
Related articles
Voided urine cytology is a useful tool predicting non-muscle-invasive bladder
cancer risk before surgery.
Urol Oncol. 2024 Apr 24:S1078-1439(24)00401.
Abstract
Related articles
Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway.
Exp Cell Res. 2024 Apr 23:114053. doi: 10.1016/j.yexcr.2024.114053.
Abstract
Related articles
The quantity, function and anti-tumor effect of Mucosal associated invariant T
cells in patients with bladder cancer.
Int Immunopharmacol. 2024;133:111892.
Abstract
Related articles
20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A
mechanism associated with deubiquitination and degradation of p65.
Transl Oncol. 2024;45:101958.
Abstract
Related articles
Findings of an Extraluminal Leiomyosarcoma of the Urinary Bladder in a Dog.
J Am Anim Hosp Assoc. 2024;60:109-113.
Abstract
Related articles
AKR1C2 genetic variants mediate tobacco carcinogens metabolism involving bladder
cancer susceptibility.
Arch Toxicol. 2024 Apr 25. doi: 10.1007/s00204-024-03737.
Abstract
Related articles
PD-L1 Expression in Nonbacterial Chronic Cystitis and Bladder Cancer.
Int Urogynecol J. 2024 Apr 25. doi: 10.1007/s00192-024-05782.
Abstract
Related articles
An endothelial-related prognostic index for bladder cancer patients.
Discov Oncol. 2024;15:128.
Abstract
Related articles
A Transformable Specific-Responsive Peptide for One-Step Synergistic Therapy of
Bladder Cancer.
Small. 2024 Apr 25:e2310416. doi: 10.1002/smll.202310416.
Abstract
Related articles
Inferring Bladder Cancer Evolution from Mucosal Field Effects by Whole-Organ
Spatial Mutational, Proteomic, and Metabolomic Mapping.
Res Sq [Preprint]. 2024 Apr 10:rs.3.rs-3994376. doi: 10.21203/rs.3.rs-3994376.
Abstract
Related articles
Perfusion drugs for non?muscle invasive bladder cancer (Review).
Oncol Lett. 2024;27:267.
Abstract
Related articles
PD-L1 expression in tumor and inflammatory cells is associated with favorable
tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of
the bladder not treated by immune checkpoint inhibitors.
BMC Urol. 2024;24:96.
Abstract
Related articles
Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and
Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer.
Mol Biotechnol. 2024 Apr 24. doi: 10.1007/s12033-024-01149.
Abstract
Related articles
The Future of Front-line Metastatic Bladder Cancer is Platinum-free.
Eur Urol Focus. 2024 Apr 23:S2405-4569(24)00057.
Abstract
Related articles
USP15 facilitates the progression of bladder cancer by amplifying the activation
of the NF-kappaB signaling pathway.
Aging (Albany NY). 2024;16.
Abstract
Related articles
Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage
Polarization and Bladder Cancer Cells Growth.
Technol Cancer Res Treat. 2024;23:15330338241246649.
Abstract
Related articles
Open or robotic? Radical cystectomies for patients with non-metastatic bladder
cancer: A systematic review and meta-analysis.
J Clin Transl Sci. 2024;8:e57.
Abstract
Related articles
Projection of the number of new cases of bladder cancer in the world.
Jpn J Clin Oncol. 2024 Apr 23:hyae050. doi: 10.1093.
Abstract
Related articles
Machine-learning prediction of a novel diagnostic model using
mitochondria-related genes for patients with bladder cancer.
Sci Rep. 2024;14:9282.
Abstract
Related articles
Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus
Calmette-Guerin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
Eur Urol Oncol. 2024 Apr 22:S2588-9311(24)00091.
Abstract
Related articles
HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences
from a high-volume center.
Urol Oncol. 2024 Apr 22:S1078-1439(24)00340.
Abstract
Related articles
Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary
multicenter analysis.
World J Urol. 2024;42:251.
Abstract
Related articles
Lethal Immune Myocarditis and Myasthenia Gravis Due to Anti-PD-1 Treatment for a
Bladder Cancer Patient: A Case Report and Possible Treatment Inspiration.
Int Med Case Rep J. 2024;17:359-365.
Abstract
Related articles
Research progress on the microbiota in bladder cancer tumors.
Front Cell Infect Microbiol. 2024;14:1374944.
Abstract
Related articles
In vivo assessment of bladder cancer with diffuse reflectance and fluorescence
spectroscopy: A comparative study.
Lasers Surg Med. 2024 Apr 22. doi: 10.1002/lsm.23788.
Abstract
Related articles
Bladder cancer variants - one disease with many faces.
Nat Rev Urol. 2024 Apr 22. doi: 10.1038/s41585-024-00886.
Abstract
Related articles
Bacillus Calmette-Guerin-induced kidney granulomas.
Kidney Int. 2024;105:1131.
Abstract
Related articles
Association Between CYP24A1 Polymorphisms and Bladder Cancer Risk in the Chinese
Han Population.
Biochem Genet. 2024 Apr 20. doi: 10.1007/s10528-024-10771.
Abstract
Related articles
Migration of double-J ureteral stent in patients with ureteroileal anastomosis
stricture undergoing radical cystectomy and orthotopic neobladder: Analysis risk
factors of stent migration.
Medicine (Baltimore). 2024;103:e37765.
Abstract
Related articles
Healthcare resource utilization and associated costs in patients with metastatic
urothelial carcinoma: a real-world analysis using German claims data.
J Med Econ. 2024;27:531-542.
Abstract
Related articles
On relevant features for the recurrence prediction of urothelial carcinoma of the
bladder.
Int J Med Inform. 2024;186:105414.
Abstract
Related articles
Sarcopenia is associated with leukopenia in urothelial carcinoma patients who
receive tislelizumab combined with gemcitabine and cisplatin therapy.
Int J Clin Oncol. 2024;29:592-601.
Abstract
Related articles
A new standard of care for advanced-stage urothelial carcinoma.
Nat Rev Clin Oncol. 2024;21:336.
Abstract
Related articles
Association between comorbidities and survival in patients with metastatic
urothelial carcinoma treated with pembrolizumab.
Int J Clin Oncol. 2024;29:612-619.
Abstract
Related articles
Peripheral neuropathy and nerve electrophysiological changes with enfortumab
vedotin in patients with advanced urothelial carcinoma: a prospective multicenter
cohort study.
Int J Clin Oncol. 2024;29:602-611.
Abstract
Related articles
Gene of the month: the uroplakins.
J Clin Pathol. 2024;77:291-296.
Abstract
Related articles
GEMIN4 Variants: Risk Profiling, Bioinformatics, and Dynamic Simulations Uncover
Susceptibility to Bladder Carcinoma.
Arch Med Res. 2024;55:102970.
Abstract
Related articles
Robot-assisted radical cystectomy with intracorporeal urinary diversion: an
updated systematic review and meta-analysis of its differential effect on
effectiveness and safety.
Int J Surg. 2024;110:2366-2380.
Abstract
Related articles
[(68 )Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial
carcinoma of the bladder prior to cystectomy: initial experiences from a pilot
analysis.
Eur J Nucl Med Mol Imaging. 2024;51:1786-1789.
Abstract
Related articles
pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of
Bladder Tumor Specimens.
Arch Pathol Lab Med. 2024;148:573-580.
Abstract
Related articles
p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher
Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer.
Anticancer Res. 2024;44:543-553.
Abstract
Related articles
Comparing Clinical Efficacy of Different Bacillus Calmette-Guerin Strains in
Patients With T1 High Grade Bladder Cancer.
Anticancer Res. 2024;44:1299-1307.
Abstract
Related articles
Comparison of Oncological Outcomes of Pembrolizumab as Second-line Therapy and
Maintenance Avelumab Therapy in Advanced Urothelial Carcinoma After
Platinum-based Chemotherapy.
Anticancer Res. 2024;44:1271-1279.
Abstract
Related articles
Assessment of Therapeutic Effects of Combined Treatment With Cisplatin and
Anti-mouse Programmed Death (PD)-1 Antibody in a Mouse Urothelial Cancer Model.
Anticancer Res. 2024;44:1417-1423.
Abstract
Related articles
Change in the Neutrophil-to-Eosinophil Ratio After Avelumab Maintenance for
Advanced Urothelial Carcinoma: The UROKYU Study.
Anticancer Res. 2024;44:1675-1681.
Abstract
Related articles
Near-infrared spectroscopy as a novel method of ex vivo bladder cancer tissue
characterisation.
BJU Int. 2024 Jan 18. doi: 10.1111/bju.16226.
Abstract
Related articles
Significant advances in chemotherapy for both urothelial and renal cancer.
BJU Int. 2024;133:122-123.
Abstract
Related articles
Continent diversion is losing its momentum: a nationwide trend analysis from
Germany 2005-2021.
BJU Int. 2024;133:154-157.
Abstract
Related articles
Microchip for detection of cell-free DNA in urine to help identify patients with
bladder cancer.
BJU Int. 2024 Jan 30. doi: 10.1111/bju.16271.
Abstract
Related articles
Influence of lamina propria invasion extension on T1 high-grade
non-muscle-invasive bladder cancer in patients undergoing BCG or radical
cystectomy.
BJU Int. 2024 Feb 19. doi: 10.1111/bju.16293.
Abstract
Related articles
A novel grading approach predicts worse outcomes in stage pT1 non-muscle-invasive
bladder cancer.
BJU Int. 2024 Feb 26. doi: 10.1111/bju.16298.
Abstract
Related articles
Lessons from a population-based bladder cancer registry: exploring why survival
is not improving.
BJU Int. 2024 Feb 26. doi: 10.1111/bju.16286.
Abstract
Related articles
The optimal number of induction chemotherapy cycles in clinically lymph
node-positive bladder cancer.
BJU Int. 2024 Mar 12. doi: 10.1111/bju.16319.
Abstract
Related articles
The SUB-urothelial DUrvalumab InjEction-1 (SUBDUE-1) trial: first-in-human trial
in patients with bladder cancer.
BJU Int. 2024 Mar 12. doi: 10.1111/bju.16325.
Abstract
Related articles
Trimodal therapy effect on survival in urothelial vs non-urothelial bladder
cancer.
BJU Int. 2024 Mar 18. doi: 10.1111/bju.16333.
Abstract
Related articles
Gynaecological organ involvement in females undergoing radical cystectomy: a
multicentre study.
BJU Int. 2024;133:474-479.
Abstract
Related articles
Adjuvant intravesical therapy in intermediate-risk non-muscle-invasive bladder
cancer.
BJU Int. 2024 Apr 16. doi: 10.1111/bju.16371.
Abstract
Related articles
Trimodal therapy vs radical cystectomy in patients with muscle-invasive bladder
cancer: a systematic review and meta-analysis of comparative studies.
BJU Int. 2024 Apr 15. doi: 10.1111/bju.16366.
Abstract
Related articles
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment
before radical cystectomy in bladder cancer patients.
BJU Int. 2024 Apr 15. doi: 10.1111/bju.16363.
Abstract
Related articles
Comparison of urological outcomes and quality of life after pelvic exenteration:
partial vs radical cystectomy.
BJU Int. 2024;133 Suppl 4:53-63.
Abstract
Related articles
Quality of transurethral resection of bladder tumour documentation: implications
for non-muscle-invasive bladder cancer risk stratification and management.
BJU Int. 2024;133 Suppl 4:7-10.
Abstract
Related articles
Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a
meta-analysis.
BJU Int. 2024 Apr 24. doi: 10.1111/bju.16364.
Abstract
Related articles
Integrative score based on CDK6, PD-L1 and TMB predicts response to
platinum-based chemotherapy and PD-1/PD-L1 blockade in muscle-invasive bladder
cancer.
Br J Cancer. 2024 Jan 11. doi: 10.1038/s41416-023-02572.
Abstract
Related articles
Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in
bladder cancer.
Br J Cancer. 2024 Feb 8. doi: 10.1038/s41416-024-02598.
Abstract
Related articles
Phase II trial of afatinib in patients with advanced urothelial carcinoma with
genetic alterations in ERBB1-3 (LUX-Bladder 1).
Br J Cancer. 2024;130:434-441.
Abstract
Related articles
Tumor-associated neutrophils suppress CD8(+) T cell immunity in urothelial
bladder carcinoma through the COX-2/PGE2/IDO1 Axis.
Br J Cancer. 2024;130:880-891.
Abstract
Related articles
Systemic anticancer therapy for urothelial carcinoma: UK oncologists'
perspective.
Br J Cancer. 2024;130:897-907.
Abstract
Related articles
Reliability, validity, and change thresholds of the NCCN/FACT Bladder Symptom
Index (NFBlSI-18) in patients with advanced urothelial cancer.
Cancer. 2024;130:31-40.
Abstract
Related articles
Major advancements in first-line treatments for advanced urothelial cancer.
Cancer. 2024;130:333-334.
Abstract
Related articles
Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in
Urothelial Carcinoma.
Cancer Res. 2024;84:725-740.
Abstract
Related articles
Construction and identification of lncRNA/circRNA-coregulated ceRNA networks in
gemcitabine-resistant bladder carcinoma.
Carcinogenesis. 2023;44:847-858.
Abstract
Related articles
Phase I Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E
Monotherapy in Patients with Metastatic Urothelial Carcinoma.
Clin Cancer Res. 2024;30:63-73.
Abstract
Related articles
Definitions, outcomes and perspectives for oligometastatic bladder cancer:
towards a standardized terminology.
Curr Opin Urol. 2024 Mar 1. doi: 10.1097/MOU.0000000000001170.
Abstract
Related articles
Molecular research in bladder cancer.
Curr Opin Urol. 2024 Apr 12. doi: 10.1097/MOU.0000000000001181.
Abstract
Related articles
Advances in preclinical assessment of therapeutic targets for bladder cancer
precision medicine.
Curr Opin Urol. 2024 Apr 11. doi: 10.1097/MOU.0000000000001177.
Abstract
Related articles
Is there a role for metastasis-directed therapy in bladder cancer?
Curr Opin Urol. 2024 Apr 5. doi: 10.1097/MOU.0000000000001174.
Abstract
Related articles
Preclinical models for bladder cancer therapy research.
Curr Opin Urol. 2024 Apr 17. doi: 10.1097/MOU.0000000000001182.
Abstract
Related articles
Recent contributions of single-cell and spatial profiling to the understanding of
bladder cancer.
Curr Opin Urol. 2024 Apr 23. doi: 10.1097/MOU.0000000000001183.
Abstract
Related articles
Predicting Response in TIME and Space: Neoadjuvant Chemoimmunotherapy in
Muscle-invasive Bladder Cancer.
Eur Urol. 2023 Dec 23:S0302-2838(23)03296-7. doi: 10.1016/j.eururo.2023.
Abstract
Related articles
A 23-Gene Prognostic Index Predicts Progression and Bacillus Calmette-Guerin
Response in Non-muscle-invasive Bladder Cancer.
Eur Urol. 2024 Jan 11:S0302-2838(24)00001-0. doi: 10.1016/j.eururo.2024.
Abstract
Related articles
Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab
in Patients with Muscle-invasive Bladder Cancer.
Eur Urol. 2024 Jan 5:S0302-2838(23)03341-9. doi: 10.1016/j.eururo.2023.
Abstract
Related articles
Towards Tailored Adjuvant Therapy in Bladder Urothelial Carcinoma: How Should We
Fit Each Size?
Eur Urol. 2024;85:123-124.
Abstract
Related articles
Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from
JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before
Maintenance.
Eur Urol. 2024;85:154-163.
Abstract
Related articles
Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3
IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive
Urothelial Carcinoma.
Eur Urol. 2024;85:114-122.
Abstract
Related articles
Circulating Tumour Dna Detection By The Urine-Informed Analysis Of Archival Serum
Samples From Muscle-Invasive Bladder Cancer Patients.
Eur Urol. 2024 Jan 31:S0302-2838(24)00017-4. doi: 10.1016/j.eururo.2024.
Abstract
Related articles
Re: Gemcitabine and Cisplatin plus Nivolumab as Organ-sparing Treatment for
Muscle-invasive Bladder Cancer: A Phase 2 Trial. Galsky MD, Daneshmand S,
Izadmehr S, et al. Nat Med 2023;29:2825-34.
Eur Urol. 2024 Feb 14:S0302-2838(24)00066-6. doi: 10.1016/j.eururo.2024.
Abstract
Related articles
Re: Petros Grivas, Se Hoon Park, Eric Voog, et al. Avelumab First-line
Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical
Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial. Eur Urol
2023;84:95-108.
Eur Urol. 2023;84:e145.
Abstract
Related articles
Reply to Deng-Xiong Li, De-Chao Feng, and Shi Deng's Letter to the Editor re:
Gyrithe Lynghoj Pedersen, Marie Schmidt Erikson, Karin Mogensen, Susanne Rosthoj,
Gregers Gautier Hermann. Outpatient Photodynamic Diagnosis-guided Laser
Destruction of Blad
Eur Urol. 2023;84:e154.
Abstract
Related articles
Re: Gyrithe Lynghoj Pedersen, Marie Schmidt Erikson, Karin Mogensen, Susanne
Rosthoj, Gregers Gautier Hermann. Outpatient Photodynamic Diagnosis-guided Laser
Destruction of Bladder Tumors Is as Good as Conventional Inpatient Photodynamic
Diagnosis-gui
Eur Urol. 2023;84:e152-e153.
Abstract
Related articles
Re: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for
muscle-invasive bladder cancer: a phase 2 trial.
Eur Urol. 2024 Feb 17:S0302-2838(24)00068-X. doi: 10.1016/j.eururo.2023.
Abstract
Related articles
International Society of Urological Pathology Consensus Conference on Current
Issues in Bladder Cancer: Main Conclusions and Recommendations.
Eur Urol. 2024 Feb 26:S0302-2838(24)00080-0. doi: 10.1016/j.eururo.2024.
Abstract
Related articles
LEAP-011 in Urothelial Cancer. Unraveling the Puzzle: Combination or Cohort?
Eur Urol. 2024;85:239-241.
Abstract
Related articles
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and
Non-organ-confined Upper Tract Urothelial Carcinoma.
Eur Urol. 2024;85:283-292.
Abstract
Related articles
Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with
Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind
Trial.
Eur Urol. 2024;85:229-238.
Abstract
Related articles
Reply to Arnulf Stenzl, Morgan Roupret, J. Alfred Witjes, Paolo Gontero.
High-quality Transurethral Resection of Bladder Tumour Needs Additional Forms of
Tumour Delineation. Eur Urol 2023;83:193-4.
Eur Urol. 2024;85:309-312.
Abstract
Related articles
Assessing Long-term Treatment Benefits Using Complementary Statistical
Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214
Immune Checkpoint Inhibitor Trials.
Eur Urol. 2024;85:293-300.
Abstract
Related articles
Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and
Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024)
17-31].
Eur Urol. 2024 Mar 15:S0302-2838(24)02194-8. doi: 10.1016/j.eururo.2024.
Abstract
Related articles
Re: Longer is Better for Endoscopic Follow-up of Upper Tract Urothelial Carcinoma
After Ureteroscopic Treatment: An Evaluation Spanning 10 Years of Data.
Eur Urol. 2024;85:392.
Abstract
Related articles
The Elusive Horizon: Biomarkers in Urothelial Carcinoma.
Eur Urol. 2024;85:317-319.
Abstract
Related articles
Re: Pramit Khetrapal, Joanna Kae Ling Wong, Wei Phin Tan, et al. Robot-assisted
Radical Cystectomy Versus Open Radical Cystectomy: A Systematic Review and
Meta-analysis of Perioperative, Oncological, and Quality of Life Outcomes Using
Randomized Contr
Eur Urol. 2024;85:e116.
Abstract
Related articles
Atlas of Intracorporeal Orthotopic Neobladder Techniques After Robot-assisted
Radical Cystectomy and Systematic Review of Clinical Outcomes.
Eur Urol. 2024;85:348-360.
Abstract
Related articles
Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic
Evolution.
Eur Urol. 2024;85:328-332.
Abstract
Related articles
Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder Cancer.
Eur Urol. 2024 Mar 26:S0302-2838(24)02206-1. doi: 10.1016/j.eururo.2024.
Abstract
Related articles
Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in
Preclinical Models of Bladder Cancer.
Eur Urol. 2024 Mar 23:S0302-2838(24)02231-0. doi: 10.1016/j.eururo.2024.
Abstract
Related articles
Re: Erdafitinib in BCG-treated High-risk Non-muscle-invasive Bladder Cancer.
Eur Urol. 2024 Apr 9:S0302-2838(24)02262-0. doi: 10.1016/j.eururo.2024.
Abstract
Related articles
Re: FGFR Inhibition Augments Anti-PD-1 Efficacy in Murine FGFR3-mutant Bladder
Cancer by Abrogating Immunosuppression.
Eur Urol. 2024 Apr 12:S0302-2838(24)02259-0. doi: 10.1016/j.eururo.2024.
Abstract
Related articles
Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion Versus
Open Radical Surgery: All Is in the Eye of the Beholder.
Eur Urol. 2024;85:431-432.
Abstract
Related articles
Robot-assisted Radical Cystectomy with Totally Intracorporeal Urinary Diversion
Versus Open Radical Cystectomy: 3-Year Outcomes from a Randomised Controlled
Trial.
Eur Urol. 2024;85:422-430.
Abstract
Related articles
Systemic versus localized Bacillus Calmette Guerin immunotherapy of bladder
cancer promotes an anti-tumoral microenvironment: Novel role of trained immunity.
Int J Cancer. 2024 Mar 14. doi: 10.1002/ijc.34897.
Abstract
Related articles
[Retracted] Interaction of YAP1 and mTOR promotes bladder cancer progression.
Int J Oncol. 2024;64:50.
Abstract
Related articles
Response to Comment: Future goals of upper tract urothelial carcinoma endoscopic
management.
Int J Urol. 2024;31:90.
Abstract
Related articles
Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial
carcinoma: A systematic review and network meta-analysis.
Int J Urol. 2024;31:25-31.
Abstract
Related articles
Controversies in terminology associated with management of BCG-unresponsive NMIBC
in Asia-Pacific.
Int J Urol. 2024;31:32-38.
Abstract
Related articles
Future goals of upper tract urothelial carcinoma endoscopic management.
Int J Urol. 2024;31:89.
Abstract
Related articles
Editorial Comment on Does intensity-modulated radiation therapy by helical
tomotherapy for prostate cancer increase the subsequent risk of bladder cancer?
A propensity score-matched analysis.
Int J Urol. 2024 Jan 10. doi: 10.1111/iju.15392.
Abstract
Related articles
Does intensity-modulated radiation therapy by helical tomotherapy for prostate
cancer increase the subsequent risk of bladder cancer? A propensity score-matched
analysis.
Int J Urol. 2024 Jan 9. doi: 10.1111/iju.15373.
Abstract
Related articles
Clinical features and oncological outcomes of bladder cancer microsatellite
instability.
Int J Urol. 2024 Jan 9. doi: 10.1111/iju.15370.
Abstract
Related articles
Editorial Comment to Prognostic significance of subclassifying pathological T3
upper tract urothelial carcinoma: Results from a multicenter cohort study.
Int J Urol. 2024;31:133.
Abstract
Related articles
Prognostic significance of subclassifying pathological T3 upper tract urothelial
carcinoma: Results from a multicenter cohort study.
Int J Urol. 2024;31:125-132.
Abstract
Related articles
Summary of the Clinical Practice Guidelines for Upper Tract Urothelial Carcinoma
2023 by the Japanese Urological Association.
Int J Urol. 2024;31:194-207.
Abstract
Related articles
Incidence and predictors of intraoperative hypotension during transurethral
bladder tumor resection with oral 5-aminolevulinic acid.
Int J Urol. 2024;31:238-244.
Abstract
Related articles
Chronic kidney disease and Charlson comorbidity index predict complications after
robot-assisted radical cystectomy: A single-center study in Japan.
Int J Urol. 2024;31:231-237.
Abstract
Related articles
Effectiveness of adjuvant chemotherapy for patients who undergo radical
cystectomy without neoadjuvant chemotherapy: A retrospective cohort study of 115
advanced bladder cancer patients with pathological lymph node classification.
Int J Urol. 2024 Apr 12. doi: 10.1111/iju.15465.
Abstract
Related articles
Variant histology is associated with more non-urothelial tract recurrence but
less intravesical recurrence upper tract urothelial carcinoma after radical
nephroureterectomy.
Int J Urol. 2024;31:421.
Abstract
Related articles
Editorial Comment on Variant histology is associated with more non-urothelial
tract recurrence but less intravesical recurrence for upper tract urothelial
carcinoma after radical nephroureterectomy.
Int J Urol. 2024;31:418-419.
Abstract
Related articles
Editorial comment to Lower bleeding volume contributes to decreasing surgical
site infection in radical cystectomy: A propensity score-matched comparison of
open versus robot-assisted radical cystectomy.
Int J Urol. 2024;31:437.
Abstract
Related articles
Letter to the Editor Re: Variant histology is associated with more non-urothelial
tract recurrence but less intravesical recurrence upper tract urothelial
carcinoma after radical nephroureterectomy.
Int J Urol. 2024;31:420.
Abstract
Related articles
Editorial comment to "The clinical impact of ureteroscopy for upper tract
urothelial carcinoma: A multicenter study".
Int J Urol. 2024;31:402-403.
Abstract
Related articles
Editorial Comment on "The clinical impact of ureteroscopy for upper tract
urothelial carcinoma: A multicenter study".
Int J Urol. 2024;31:401-402.
Abstract
Related articles
Editorial comment from Dr Taguchi to Real world evidence of enfortumab vedotin in
patients with advanced urothelial cancer: A multicenter observational study.
Int J Urol. 2024;31:348.
Abstract
Related articles
Older versus younger patients in robot-assisted radical cystectomy with
intracorporeal ileal conduit comparing safety and clinical outcomes.
Int J Urol. 2024;31:370-378.
Abstract
Related articles
Lower bleeding volume contributes to decreasing surgical site infection in
radical cystectomy: A propensity score-matched comparison of open versus
robot-assisted radical cystectomy.
Int J Urol. 2024;31:430-437.
Abstract
Related articles
Prognostic factors for overall survival in clinical node-positive patients with
upper tract urothelial carcinoma.
Int J Urol. 2024;31:386-393.
Abstract
Related articles
Variant histology is associated with more non-urothelial tract recurrence but
less intravesical recurrence for upper tract urothelial carcinoma after radical
nephroureterectomy.
Int J Urol. 2024;31:410-418.
Abstract
Related articles
The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A
multicenter study.
Int J Urol. 2024;31:394-401.
Abstract
Related articles
Letter to the Editor Re: Balancing diagnostic advancements with cardiovascular
considerations in 5-aminolevulinic acid use for bladder tumors.
Int J Urol. 2024;31:452.
Abstract
Related articles
Geriatric nutritional risk index as a prognostic factor in elderly patients with
non-muscle-invasive bladder cancer: a propensity score-matched study.
Int Urol Nephrol. 2024 Jan 4. doi: 10.1007/s11255-023-03905.
Abstract
Related articles
Prognostic impact of tumor ureteral invasion on recurrence after radical
cystectomy.
Int Urol Nephrol. 2024;56:129-135.
Abstract
Related articles
Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial
carcinoma of the bladder.
Int Urol Nephrol. 2024;56:499-508.
Abstract
Related articles
Secondary tumours in orthotopic neobladder using isolated gut segment post
radical cystectomy for urothelial carcinoma: a systematic review.
Int Urol Nephrol. 2024;56:519-525.
Abstract
Related articles
Early diagnosis and prognostic potential of RAC3 in bladder tumor.
Int Urol Nephrol. 2024;56:475-482.
Abstract
Related articles
Intravesical thermochemotherapy in the treatment of high-risk and very high-risk
non-muscle-invasive urothelial bladder cancer: a single-arm study.
Int Urol Nephrol. 2024 Feb 8. doi: 10.1007/s11255-023-03924.
Abstract
Related articles
Preoperative low plasma creatine kinase levels predict worse survival outcomes in
bladder cancer after radical cystectomy.
Int Urol Nephrol. 2024 Feb 5. doi: 10.1007/s11255-024-03957.
Abstract
Related articles
Strong apoptotic response of testis tumor cells following cisplatin treatment.
Int Urol Nephrol. 2023 Oct 27. doi: 10.1007/s11255-023-03825.
Abstract
Related articles
Clinicopathological characteristics, surgical treatments, and oncological
outcomes of localized primary unifocal urothelial carcinoma involving the
ureterovesical junction.
Int Urol Nephrol. 2024;56:941-955.
Abstract
Related articles
Lymphadenectomy before and after radical cystectomy: does this affect the
radicality? A prospective randomized comparative study.
Int Urol Nephrol. 2024;56:965-972.
Abstract
Related articles
Patients with periodontitis might increase the risk of urologic cancers: a
bidirectional two-sample Mendelian randomization study.
Int Urol Nephrol. 2024;56:1243-1251.
Abstract
Related articles
The influence of the initial clinical presentation of upper tract urothelial
carcinoma on histopathological tumor features.
Int Urol Nephrol. 2024;56:1335-1341.
Abstract
Related articles
Low Cubilin/Myeloperoxidase ratio as a promising biomarker for prognosis of
high-grade T1 bladder cancer.
Int Urol Nephrol. 2024 Mar 26. doi: 10.1007/s11255-024-03971.
Abstract
Related articles
Editorial comment to the paper: RE: low cubilin/myeloperoxidase's ratio as a
promising biomarker for prognosis of high grade T1 bladder cancer.
Int Urol Nephrol. 2024 Apr 2. doi: 10.1007/s11255-024-04035.
Abstract
Related articles
Comparison of morbidity and mortality after radical cystectomy between
individuals older and younger than 80 years: a systematic review and
meta-analysis.
Int Urol Nephrol. 2024;56:1525-1535.
Abstract
Related articles
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth
Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A
Combined Analysis of Two Phase II Clinical Trials.
J Clin Oncol. 2024;42:1391-1402.
Abstract
Related articles
Feasibility, Acceptability, and Outcomes of a Mobile Health Tool for Radical
Cystectomy Recovery.
J Urol. 2024;211:266-275.
Abstract
Related articles
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline:
2024 Amendment.
J Urol. 2024 Jan 24:101097JU0000000000003846. doi: 10.1097/JU.0000000000003846.
Abstract
Related articles
Clearing the Smoke: Underreporting of Smoking Status in Food and Drug
Administration-Approved Bladder Cancer Therapeutic Trials.
J Urol. 2024 Feb 1:101097JU0000000000003853. doi: 10.1097/JU.0000000000003853.
Abstract
Related articles
Letter: Treatment of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder
Cancer with UGN-102 +/- Transurethral Resection of Bladder Tumor Compared to
Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled,
Phase 3 Trial (ATL
J Urol. 2024;211:482-483.
Abstract
Related articles
Robotic Radical Cystectomy for Bladder Cancer: The Way Forward.
J Urol. 2024;211:476-480.
Abstract
Related articles
Open vs Robotic Cystectomy: Case Closed?
J Urol. 2024;211:473-475.
Abstract
Related articles
Impact of Divergent Differentiation and/or Histological Subtype of Urothelial
Carcinoma on Patient Outcomes in the GETUG-AFU V05 VESPER Trial.
J Urol. 2024;211:564-574.
Abstract
Related articles
Bladder Cancer Survivors Who Do Not Smoke Have Better Longitudinal Health Related
Quality of Life Measures: An Assessment of the Comparative Effectiveness of
Survivorship Health in Bladder Cancer (CEASE-BC) Study.
J Urol. 2024 Apr 11:101097JU0000000000003964. doi: 10.1097/JU.0000000000003964.
Abstract
Related articles
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO
GUIDELINE (2017; Amended 2020, 2024).
J Urol. 2024 Apr 25:101097JU0000000000003981. doi: 10.1097/JU.0000000000003981.
Abstract
Related articles
DLGAP5 triggers proliferation and metastasis of bladder cancer by stabilizing
E2F1 via USP11.
Oncogene. 2024 Jan 5. doi: 10.1038/s41388-023-02932.
Abstract
Related articles
Ubiquitin-specific protease 5 promotes bladder cancer progression through
stabilizing Twist1.
Oncogene. 2024 Jan 13. doi: 10.1038/s41388-023-02936.
Abstract
Related articles
An empirical survey on the adaption of neoadjuvant chemotherapy in bladder
cancer.
Urol Int. 2024 Jan 19. doi: 10.1159/000536321.
Abstract
Related articles
Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New
Therapies.
Urol Int. 2024;108:1-8.
Abstract
Related articles
Upstaging after Transurethral Resection of the Bladder for Non-Muscle-Invasive
Cancer of the Bladder: Who Is at Highest Risk?
Urol Int. 2024;108:42-48.
Abstract
Related articles
The efficacy and safety of Hyperthermia intravesical chemotherapy in the
treatment non-muscle invasive bladder cancer:A meta analysis.
Urol Int. 2024 Mar 20. doi: 10.1159/000538373.
Abstract
Related articles
Hemangioma of the Urinary Bladder: A Brief Narrative Review of Their Diagnosis,
Histology, and Treatment Options.
Urol Int. 2024;108:83-88.
Abstract
Related articles
Cyclin A2 Expression as Predictive Biomarker in Muscle-Invasive Upper Tract
Urothelial Carcinoma.
Urol Int. 2024;108:128-136.
Abstract
Related articles
Patients' emotional talk during surveillance cystoscopy for non-muscle invasive
bladder cancer - opportunities for improving communication.
Urology. 2023 Dec 29:S0090-4295(23)01116-0. doi: 10.1016/j.urology.2023.
Abstract
Related articles
Replicating Florence Intracorporeal Neobladder Technique in Laparoscopic Radical
Cystectomy: A Retrospective Study.
Urology. 2024;183:106-110.
Abstract
Related articles
Indiana Pouch Continent Cutaneous Urinary Diversion After Robotic-assisted
Radical Cystectomy: A 16-Year Experience.
Urology. 2024;183:e325-e327.
Abstract
Related articles
Malignancy in the public life: the story of Hubert Humphrey's bladder cancer.
Urology. 2024 Jan 31:S0090-4295(24)00017-7. doi: 10.1016/j.urology.2023.
Abstract
Related articles
Immune Checkpoint Inhibitors for Kidney and Bladder Cancer: Adrenotoxic
Consequences.
Urology. 2024 Feb 29:S0090-4295(24)00129-8. doi: 10.1016/j.urology.2024.
Abstract
Related articles
A Randomized Clinical Trial Evaluating Indigo Carmine as a Visualization Aid for
Evaluating Ureteral Patency.
Urology. 2024;184:105-111.
Abstract
Related articles
Near Complete Response to Platinum-based Systemic Chemotherapy in High-risk Upper
Tract Urothelial Carcinoma With an ERBB2 Gene Mutation: A Case Report.
Urology. 2024;184:75-78.
Abstract
Related articles
Cost-Utility of Initial Management of High-grade T1 Bladder Cancer with
Intravesical BCG vs Immediate Radical Cystectomy.
Urology. 2024 Mar 9:S0090-4295(24)00126-2. doi: 10.1016/j.urology.2024.
Abstract
Related articles
Incidence of Ureteroenteric Anastomotic Strictures After Robotic vs Open
Cystectomy in Adults.
Urology. 2024;185:100-108.
Abstract
Related articles
Robotic simple cystectomy as a last resort for antibiotic-recalcitrant recurrent
urinary tract infections in women.
Urology. 2024 Feb 21:S0090-4295(24)00108-0. doi: 10.1016/j.urology.2024.
Abstract
Related articles
Female Bladder Dysfunction Following Boari Bladder Flap Ureteral Reconstruction.
Urology. 2024;186:31-35.
Abstract
Related articles
Perioperative outcomes and continence following robotic-assisted radical
cystectomy with mainz pouch II urinary diversion in patients with bladder cancer.
BMC Cancer. 2024;24:127.
Abstract
Related articles
Feasibility and safety of laparoscopic radical cystectomy for male octogenarians
with muscle-invasive bladder cancer.
BMC Cancer. 2024;24:159.
Abstract
Related articles
Radical cystectomy or trimodality therapy for muscle-invasive bladder cancer: a
qualitative study exploring patient priorities and counselling needs when making
a treatment choice.
BMC Cancer. 2024;24:160.
Abstract
Related articles
The efficacy and safety of tislelizumab combined with gemcitabine plus cisplatin
in the treatment of postoperative patients with muscle-invasive upper tract
urothelial carcinoma.
BMC Cancer. 2024;24:202.
Abstract
Related articles
Inflammatory markers predict survival in patients with postoperative urothelial
carcinoma receiving tislelizumab (PD-1 inhibitor) adjuvant therapy.
BMC Cancer. 2024;24:196.
Abstract
Related articles
The impact of squamous cell transformation on the prognosis of patients treated
with radical nephroureterectomy.
BMC Cancer. 2024;24:247.
Abstract
Related articles
Identification of BACH1-IT2-miR-4786-Siglec-15 immune suppressive axis in bladder
cancer.
BMC Cancer. 2024;24:328.
Abstract
Related articles
Proliferation and immunohistochemistry for p53, CD25 and CK20 in predicting
prognosis of non-muscle invasive papillary urothelial carcinomas.
PLoS One. 2024;19:e0297141.
Abstract
Related articles
Association of spironolactone use with risk of urinary tract cancer in the
general population: A matched population-based cohort study.
PLoS One. 2024;19:e0300391.
Abstract
Related articles
Retraction: SATB1 Overexpression Regulates the Development and Progression in
Bladder Cancer through EMT.
PLoS One. 2024;19:e0301572.
Abstract
Related articles
Thank you for your interest in scientific medicine.
